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1. Zusammenfassung 
DNA-Replikation in S-Phase und Chromosomensegregation in Mitose sind im 
Zellzyklus getrennte Ereignisse. Die Identität der jeweiligen Schwesterchromatiden wird 
durch den ringförmigen Kohäsin-Multiproteinkomplex sichergestellt, der die beiden 
DNA-Stränge umschließt. Shugoshin-Proteine verhindern die vorzeitige Dissoziation von 
Kohäsin und tragen somit entscheidend zur genomischen Integrität bei. 
In dieser Arbeit konnte gezeigt werden, dass hSgo2, eines der beiden humanen 
Shugoshin-Homologe, in der Prophase erst an Kinetochore rekrutiert wird, danach 
während Prometaphase an Zentromere bindet, um schließlich in Metaphase wieder an die 
Kinetochore zurückzukehren. Des Weiteren wurde nachgewiesen, dass (1) die 
Chromatin-Bindung von hSgo2 durch seinen C-Terminus vermittelt wird, dass (2) die 
katalytische Aktivität der Kinase Aurora B benötigt wird, um hSgo2 am Zentromer 
anzureichern und dass (3) die Bindung von Mikrotubuli an Kinetochore ausreichend ist 
für die Relokalisierung von hSgo2 in Metaphase; durch Mikrotubuli ausgeübte Zugkräfte 
sind hierfür nicht zwingend notwendig. Durch diese neu identifizierten 
Regulationsmechanismen ist es möglich, ein Modell für die subzelluläre Lokalisierung 
von Shugoshin aufzustellen. 
Gegenwärtig gibt es in der Literatur widersprüchliche Angaben darüber, ob und in 
wiefern hSgo1 und hSgo2 in der Mitose benötigt werden. Detaillierte zellbiologische 
Untersuchungen im Rahmen dieser Arbeit zeigen, dass hSgo2 entgegen früherer 
Annahmen an mehreren Prozessen während der Mitose nicht beteiligt ist. Insofern kann 
darauf geschlossen werden, dass die Funktionsbereiche der Shugoshin-Homologe 
weitestgehend getrennt sind: Sgo1 fungiert in Mitose während Sgo2 in der Meiose 
benötigt wird. 
Zu Beginn dieser Arbeit war es noch nicht klar, wie Shugoshin-Proteine auf molekularer 
Ebene positiv auf die Schwesterchromatid-Kohäsion wirken können. Es konnte hier 
mittels eines biochemischen Ansatzes die Proteinphosphatase 2A (PP2A) als neuer 
Interaktionspartner von hSgo1 identifiziert werden. Obwohl in der Zwischenzeit bekannt 
wurde, dass Shugoshin-gebundene PP2A Kohäsin durch direkte Dephosphorylierung 
schützt, konnte hier erstmals gezeigt werden, dass hSgo2 mittels seines N-Terminus an 
PP2A bindet. Außerdem bewirkt hSgo2-Bindung eine deutliche Stimulierung der 
katalytischen Aktivität von PP2A. Deshalb ist die Schlussfolgerung möglich, dass die 
Zusammenfassung 
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Funktion von Shugoshin über eine bloße Verbindung zwischen Kohäsin und PP2A 
hinausgeht.  
Der Spindelaufbau-Kontrollpunkt (SAC) verzögert als essentieller Regulator von Mitose 
und Meiose den Beginn der Anaphase so lange, bis alle Chromosomen korrekt an der 
mitotischen Spindel angebracht sind. Der Signaltransduktionsweg des SAC beinhaltet 
einen Kinetochor-gebundenen Mad1-Mad2-Komplex, der eine Komformationsänderung 
von löslichem Mad2 katalysiert, das hierdurch die Fähigkeit erlangt, das Cdc20-Protein 
durch Bindung zu inhibieren. Die durch den SAC bewirkte Verhinderung von Anaphase 
überlappt mit dem Zeitraum, in dem Shugoshin benötigt wird. In dieser Arbeit konnte 
Mad2 als ein weiterer neuer Interaktor von hSgo2 gefunden werden. Die exakte 
Kartierung der Mad2-Bindestelle führte zur Entdeckung eines konservierten Mad2-
Interaktionsmotivs (MIM) im N-terminalen Bereich von hSgo2, wie es auch in den schon 
bekannten Mad2-Bindepartnern Mad1 und Cdc20 vorkommt. Durch eine eingehende 
Charakterisierung des Sgo2-Mad2-Komplexes konnte gezeigt werden, dass dieser in 
seiner Struktur den Mad1-Mad2- und Cdc20-Mad2-Komplexen sehr ähnlich ist. Die hier 
durchgeführten biochemischen Analysen stellen die bisherige Überzeugung in Frage, 
nach der der SAC lediglich einen Signalgeber (Mad1 am Kinetochor) und ein Zielobjekt 
(Cdc20) hat. Die Mad2-Bindung ist für das einzige Shugoshin-Homolog in Xenopus 
laevis, xSgo1, konserviert. Dies legt eine wichtige Funktion dieser Interaktion in der 
Meiose nahe. 
   - 8 - 
 
 
2. Summary 
Sister chromatids are embraced and held together by a ring-shaped multiprotein complex 
called cohesin, from the time of their generation in S-phase until their separation in M-
phase. Shugoshins protect centromeric cohesin from premature dissociation and, hence, 
are important regulators of genome stability. 
This work demonstrates that hSgo2, one of the two shugoshins in humans, first binds to 
kinetochores in prophase, then localizes to centromeres in prometaphase before finally 
traveling back to kinetochores in metaphase. It is further shown that (1) chromatin 
binding requires the C-terminus of hSgo2, (2) the catalytic activity of the aurora B kinase 
is essential to focus hSgo2 at centromeres, and (3) attachment of microtubules to 
kinetochores is not only necessary for the metaphase-specific re-localization of hSgo2 
but also sufficient; pulling forces are not required. These newly discovered regulations 
allow to formulate a mechanistic model that explains shugoshin’s dynamic subcellular 
localization. 
An existing conflict in the literature concerns the relative importance of mammalian 
Sgo1 and Sgo2 in mitosis. Cell biological analyses now demonstrate unambiguously that, 
contrary to earlier claims, hSgo2 is dispensable for several aspects of mitotic cell 
divisions. Thus, shugoshin functions are strictly separated, being fulfilled by hSgo1 in 
mitosis and by hSgo2 in meiosis. 
Initially, it was unclear how shugoshins exert their cohesin protective function at the 
molecular level. Using a biochemical approach, protein phosphatase 2A (PP2A) was 
identified as a prominent interactor of shugoshins in this thesis. Shortly thereafter, it was 
reported that shugoshins protect cohesin by mediating PP2A-dependent 
dephosphorylation. Nevertheless, it is shown here for the first time that hSgo2 binds 
PP2A via its N-terminus. A Sgo2 point mutant deficient in PP2A binding is created and 
characterized by cell biological experiments. Importantly, biochemical assays 
demonstrate that hSgo2 greatly stimulates PP2A’s enzymatic activity. Shugoshin 
function therefore extends beyond simple provision of a linkage between cohesin and 
PP2A. 
Mitosis and meiosis are chiefly controlled by the spindle assembly checkpoint (SAC), 
which allows anaphase to take place only after all chromosomes have become properly 
attached to the mitotic spindle. Central to SAC signaling, kinetochore bound Mad1-Mad2 
complex catalyzes a conformational switch of soluble Mad2, thereby allowing its 
Summary 
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inhibitory binding to the downstream effector protein Cdc20. SAC-dependent inhibition 
of anaphase correlates well in timing with shugoshin-dependent protection of cohesin. 
Here, Mad2 is identified as another novel interactor of hSgo2. Precise mapping reveal a 
conserved Mad2 interaction motif (MIM) in hSgo2, which is shared by the known Mad2 
interactors Mad1 and Cdc20. In fact, several lines of evidence show that the Sgo2-Mad2 
complex is structurally very similar to the Mad1-Mad2 and the Cdc20-Mad2 complexes. 
These biochemical studies challenge the current “one source (kinetochore bound Mad1) 
– one target (Cdc20)” dogma in the field of SAC research. Mad2 binding is conserved in 
the only Xenopus laevis shugoshin, xSgo1, indicating an important function of this 
interaction during vertebrate meiosis. 
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3. Introduction 
3.1. The cell cycle and mitosis 
Proliferation of tissues relies on the amplification of cell number by means of cell growth 
and cell division (Alberts et al., 2008). Cell cycle regulation involves several basic 
principles: among them is the cyclic synthesis of key regulatory proteins, e.g. the cyclin 
family proteins. Furthermore, reversible post-translational modifications like protein 
phosphorylation or acetylation play an important role. The cell cycle has a clear 
directionality that relies on irreversible, switch-like protein degradation events. Two 
main functions of the cell cycle are the replication of the genome and the actual cell 
division. Separated in time, replication and division are executed in S-phase (for 
synthesis) and M-phase (for mitosis, from greek mitos, thread), respectively. The two 
other cell cycle phases are the "gap" phases G1 (between M and S) an G2 (between S and 
M). The gap phases provide time for growth of the cell, synthesis of components required 
for the next phase and control points for cell cycle regulation. G1, S and G2 phase are 
collectively referred to as interphase. Mitosis in mammalian cells can again be 
subdivided into distinct phases. During prophase, DNA condenses into densely packed 
chromosomes. Cell-cell contacts are reduced and cells detach from their substrate. Also 
in prophase, assembly of the mitotic spindle is initiated (see chapter 3.2). Prometaphase 
in mammalian cells starts with the breakdown of the nuclear envelope. Chromosomes are 
aligned on the mitotic spindle until they all gather in the equatorial plane of the cell at 
metaphase, an arrangement called "metaphase plate". Finally, the two copies of each 
chromosome are separated and pulled to opposite poles of the cell by the mitotic spindle 
in anaphase. During telophase and cytokinesis, the cell elongates and a contractile actin-
myosin ring in collaboration with the secretory pathway mediates cleavage and 
abscission of the two daughter cells. 
The key regulator of mitosis is cyclin-dependent kinase 1 (Cdk1). During S-phase and 
G2-phase, B-type cyclins slowly accumulate and bind to Cdk1. Cyclin B1 binding is 
necessary but not sufficient for Cdk1 activation. Cdk1 has to be additionally activated by 
Cdk activating kinase (CAK) dependent phosphorylation of T161. Furthermore, 
inhibitory phosphorylations at T14 and Y15, imposed by the kinases Wee1 and Myt1, 
have to be removed by the dual specificity phosphatase Cdc25. Mitotic entry is a switch 
like event due to positive feedback loops. Once Cdk1 is activated, it contributes to 
activation of Cdc25 and inhibition of Wee1. 
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Active Cdk1-cyclin B1 complex phosphorylates a series of cellular targets leading to the 
morphological changes characteristic of mitotic cells. For example, the disassembly of 
the nuclear envelope is facilitated by direct phosphorylation of nuclear lamins, leading to 
their depolymerization (Heald and McKeon, 1990). In cell free extracts of Xenopus eggs, 
DNA compaction into highly condensed mitotic chromosomes is influenced by the 5-
subunit condensin protein complex. In vitro, the ATP dependent introduction of positive 
writhe into DNA ("knotting activity") by condensin requires Cdk1-cyclin B1 (Kimura 
and Hirano, 1997). Furthermore, formation of the mitotic spindle (see below) depends on 
the phosphorylation of microtubule associated proteins (MAPs) by Cdk1-cyclin B1. 
 
3.2. Spindle assembly and error correction by Aurora B 
One of the hallmarks of mitosis is the formation of the mitotic spindle. Spindle formation 
involves a global rearrangement of the microtubule cytoskeleton. In G2 phase, 
microtubules (MTs) emanate from the cellular microtubule organizing center (MTOC) 
composed of two centrosomes and a series of accessory proteins, the pericentriolar 
material (PCM). Microtubules are an inherently polar structure with a plus end distal of 
the MTOC and a minus end proximal to the MTOC. Plus ends of microtubules are 
defined by a higher growth rate than minus ends. 
In early prophase, centrosome separation and migration of the two centrosomes to 
opposite sides of the nucleus set the stage for the formation of a bipolar structure, the 
mitotic spindle (Fig. 1A). The mitotic spindle comprises mainly three different types of 
microtubule (MT) arrangements. (1) Polar MTs from the two opposing spindle poles 
overlap in an antiparallel fashion in the spindle midzone, where they are linked by bi- or 
multivalent MAPs or motor proteins (Blangy et al., 1995). They define the overall 
spindle geometry. (2) Astral MTs point from the centrosomes towards the cell cortex and 
serve to position the mitotic spindle within the cell. (3) The third type of spindle 
microtubules are the kinetochore-fibers (K-fibers), that link MTOCs and chromosomes. 
The site of MT attachment at chromosomes is the kinetochore, a huge multi-subunit 
protein complex that assembles at the centromeric heterochromatin region of the 
chromosomes (Cleveland et al., 2003; Santaguida and Musacchio, 2009) (Fig. 1B). 
Especially in anaphase, maintenance of stable kinetochore-microtubule attachment is 
challenging since kinetochores are pulled towards the spindle poles by following the ends 
of depolymerizing microtubules.  
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Fig. 1: The mitotic spindle and chromosome attachment. (A) The three main types of spindle 
microtubules (MTs). Polar microtubules (1) range from centrosomes to the spindle midzone. 
There they overlap in an antiparallel fashion. Astral MTs (2) link the centrosomes with the cell 
cortex. K-fibers (3) are microtubule bundles that link the kinetochores of chromosomes with the 
spindle poles. (B) Types of kinetochore-spindle attachments. Amphitelic attachment: correct 
bipolar attachment with both kinetochores linked to opposite spindle poles. Syntelic attachment: 
both kinetochores are bound to microtubules emanating from the same spindle pole. Monotelic 
attachment: only one kinetochore is attached to K-fibers. Merotelic attachment: one kinetochore 
is attached to K-fibers from the two spindle poles. 
 
Different components of the kinetochore have been implicated in microtubule binding. A 
large molecular complex named the KMN network (KNL-Mis12-Ndc80) is both 
associated with kinetochore subunits as well as with microtubules (Cheeseman et al., 
2006; Ciferri et al., 2008). The motor protein CENP-E is able to bind to microtubules 
(Neumann et al., 2006) and on the other hand to Nuf2 (Liu et al., 2007), a component of 
the Ndc80 complex. CENP-E deficient cells have problems capturing their chromosomes 
with the mitotic spindle (McEwen et al., 2001). In yeast, Bir1 and Sli15, both 
components of the chromosomal passenger complex (Vagnarelli and Earnshaw, 2004) 
have been shown to build an accessory connection between kinetochores and 
microtubules that might possess regulatory functions (Sandall et al., 2006).  
Although MTs can be nucleated at kinetochores, the most common mechanism of K-
fiber formation is based on "search and capture" of MTs emanating from centrosomes 
(Kirschner and Mitchison, 1986). A characteristic property of microtubules is their 
dynamic instability, i.e. they undergo alternating growth and shrinkage at their plus ends. 
 
A B 
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As cells enter mitosis, the dynamic instability of MTs increases (Verde et al., 1990). 
Dynamically instable microtubules probe the cellular space and eventually get captured 
by kinetochores via their plus ends. Ideally, the two kinetochores of a chromosome 
should be attached to opposing poles of the spindle, an arrangement referred to as bipolar 
or amphitelic. Although there is an inherent bias towards this bipolar configuration 
(Indjeian and Murray, 2007; Sakuno et al., 2009), the stochastic nature of the search and 
capture mechanism also leads to a series of unproductive chromosome attachments 
(Cimini and Degrassi, 2005). In the case of monotelic attachment, only one kinetochore 
is attached to K-fibers. Syntelic attachment refers to a chromosome having both 
kinetochores attached to the same spindle pole. A merotelic attachment denotes a 
situation where one kinetochore is attached to K-fibers emanating from both spindle 
poles. Any chromosome orientation apart from the amphitelic case would result in 
breakage or missegregation of chromosomes in anaphase, if uncorrected. This is avoided 
in living cells due to activation of the spindle assembly checkpoint (SAC) allowing time 
to resolve erroneous attachments by a repair mechanism. In yeast as well as in higher 
eukaryotes the kinase Ipl1/Aurora B is instrumental in this error correction (Tanaka et al., 
2002). Ipl1/Aurora B together with Sli15 and Bir1 (INCENP and survivin in higher 
eukaryotes) form the chromosomal passenger complex (CPC) (Vagnarelli and Earnshaw, 
2004). The CPC concentrates specifically at centromeres of those chromosomes that do 
not display amphitelic attachment (Knowlton et al., 2006). Interestingly, Aurora B kinase 
activity is able to disrupt interactions of microtubules with the KMN network in vitro. 
This activity is, at least in part, mediated by direct phosphorylation of the Ndc80 N-
terminal MT interaction domain (Cheeseman et al., 2006; Ciferri et al., 2008). In 
vertebrates, another important downstream factor of Aurora B is the mitotic centromere-
associated kinesin (MCAK). This microtubule depolymerase is recruited by Aurora B to 
incorrect microtubule-kinetochore contacts (Knowlton et al., 2006). Since MCAK has an 
in vitro microtubule depolymerizing activity (Hunter et al., 2003), it is thought to 
destabilize K-fibers that do not lead to bipolar attachments. The now free kinetochores 
can undergo a new round of search and capture based attachment. When all 
chromosomes have achieved stable bipolar attachment, they are aligned in one plane at 
the center of the mitotic spindle, the metaphase plate. 
Aurora B activity has to be lowered once correct attachments are forming. On the one 
hand, this can happen by reducing centromeric Aurora B to basal levels (Knowlton et al., 
2006). On the other hand, productive kinetochore-MT attachments generate 
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intrakinetochore tension (Maresca and Salmon, 2009) which pulls outer kinetochore 
components like Ndc80 further away from centromeric Aurora B, resulting in 
dephosphorylation of Aurora B substrates by competing phosphatases (Liu et al., 2009). 
As a consequence, tension generating bipolar attachments within the mitotic spindle, are 
preferentially stabilized. 
3.3. Sister chromatid cohesion 
Species that organize their genomes in multiple chromosomes are facing the problem of 
how to identify the respective sister chromatids when it comes to distribution of the 
previously replicated genomes in a subsequent mitosis. An elegant mechanism 
preventing this problem is cohesion, i.e. the fact that the two copies of a chromosome 
stay together from the time of replication until the onset of anaphase. Two distinct 
properties of chromosomes contribute to cohesion. The first is DNA concatenation which 
naturally occurs during S-phase when two replication forks encounter each other (Sundin 
and Varshavsky, 1980). In theory, catenation could account for keeping sister chromatids 
together (Murray and Szostak, 1985). However, most catenations are resolved already 
prior to anaphase and cohesion is maintained even in the absence of catenation 
(Koshland and Hartwell, 1987). Nevertheless, a small fraction of catenations persists at 
centromeres until the onset of anaphase in human cells. They can be visualized as thin 
DNA threads labeled by the marker protein Plk1 interacting checkpoint helicase (PICH) 
(Baumann et al., 2007). PICH positive threads connect the separating chromatin masses 
until the catenations are resolved, presumably by Topoisomerase II (TOPO II) (Porter 
and Farr, 2004). The second source for sister chromatid cohesion is the cohesin protein 
complex (Nasmyth and Haering, 2005). Cohesin is the more crucial factor compared to 
catenation since the latter cannot sustain sister chromatid pairing in the absence of 
cohesin (Sonoda et al., 2001). How centromeric DNA catenation is maintained until 
anaphase and what purpose – if any –  it might serve in chromosome segregation, is still 
an open question. 
3.4. Cohesin 
3.4.1. Components of the cohesin complex 
Factors required for sister chromatid cohesion have initially been discovered in yeast 
genetic screens (Guacci et al., 1997; Michaelis et al., 1997). The respective protein 
products are specifically required for cohesion before the onset of anaphase. Among 
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them are two large coiled-coil proteins, structural maintenance of chromosomes 1 and 3 
(Smc1 and Smc3). Smc proteins are characterized by their highly elongated shape. They 
fold back onto themselves at a globular hinge domain in the middle of the molecule 
which allows the formation of a very long antiparallel intramolecular coiled-coil (Melby 
et al., 1998). The very N- and C-termini of Smc proteins come in close proximity and 
together adopt a globular fold, the head domain which is associated with ATPase activity 
(Arumugam et al., 2003). Additional components of the cohesin complex involve Pds5 
(Panizza et al., 2000), Scc1 and Scc3 (Michaelis et al., 1997). While Pds5 is a 
substoichiometric cohesin component (Sumara et al., 2000), Scc1 and Scc3 are integral 
subunits of the cohesin complex. Scc1 interacts with the head domains of Smc1 and 
Smc3 via its C- and N-terminus, respectively (Gruber et al., 2003). Scc3, which in higher 
eukaryotes comes in the two mutually exclusive "flavors" SA1 and SA2, is a binding 
partner of Scc1. 
3.4.2. The cohesin ring model 
How does cohesin hold sister chromatids together? Smc1 and Smc3 form heterodimers 
mediated by interaction via their hinge domains (Melby et al., 1998). In electron 
micrographs, Smc dimers appear either as V-shaped structures, linked at the hinge 
domain or as closed circles with an additional contact involving the head domains. 
The circular structure of the cohesin complex and the appropriate molecular dimensions 
inspired the hypothesis that DNA strands might be entrapped within the cohesin ring 
(Fig. 2). The linkage between sister chromatids in this model is hence topological rather 
than mediated by direct protein-DNA contacts. Although the Smc1 and Smc3 head 
domains can interact directly (Mc Intyre et al., 2007; Melby et al., 1998), integrity of 
Scc1 is clearly required for cohesin function (Uhlmann et al., 1999) and for stable closure 
of the three-partite ring (Gruber et al., 2003). 
Substantial proof for this model has been contributed by a series of elegant studies from 
the Nasmyth lab. Proteolytic cleavage of one of the three members of the cohesin ring 
does not cause dissociation of the cleavage fragments from each other because they 
remain linked by the other cohesin subunits. Yet, artificial cleavage of engineered Scc1 
or Smc3 leads to sister chromatid separation in vivo and to dissociation of cohesin from 
circular plasmid DNA in vitro (Gruber et al., 2003; Uhlmann et al., 2000). The 
topological nature of the cohesin-DNA interaction was further underscored by the 
finding that cleavage of circular plasmid DNA by a restriction endonuclease also leads to 
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its dissociation from associated cohesin (Haering et al., 2008; Ivanov and Nasmyth, 
2005, 2007). Consistent with the model, cohesin is able to slide along DNA. This is 
reflected by the accumulation of cohesin at sites of convergent transcription (Lengronne 
et al., 2004). Cohesin complexes are highly conserved from yeast to mammals (Darwiche 
et al., 1999). 
 
Fig. 2: The cohesin ring complex. The two large 
anti-parallel coiled coil proteins Smc1 and Smc3 form 
a V-shaped structure connected via their hinge 
domains. The N- and C-termini of Smc1/3 form a 
globular head domain that has ATPase activity. The 
Smc1/3 head domains are linked by Scc1. SA1/2 is 
associated with Scc1 while Pds5 shows binding to 
both Scc1 and SA1/2. Two chromosomal DNA 
strands can be accomodated within the cohesin ring. 
Image with modifications from Peters et al. (2008). 
 
 
3.4.3. Loading of cohesin and establishment of cohesion 
In genetic screens for sister chromatid cohesion factors were picked up that are not direct 
members of the cohesin complex but rather required for the establishment of cohesion. 
Two main steps can be distinguished: loading of cohesin onto DNA and the subsequent 
establishment of the physical linkage between sister chromatids. Cohesin loading onto 
DNA requires a complex of Scc2 and Scc4 and occurs in late mitosis (vertebrates) or late 
G1 phase (yeast). While the Scc2/Scc4 complex becomes dispensable after cohesin 
loading (Ciosk et al., 2000), other factors including Ctf4, Ctf18 and the acetyl transferase 
Eco1 mediate the proper cohesin dependent pairing of the emerging sister chromatids 
during the subsequent S-phase (Toth et al., 1999) and consistently co-localize with DNA 
replication forks (Lengronne et al., 2006). Surprisingly, entering the two sister 
chromatids into the cohesin ring seems to involve transient opening of the otherwise 
extremely stable Smc1/3 interaction at the hinge region (Gruber et al., 2006). Mutations 
in the gene sequence of the human Eco1 homolog Esco2 are found in patients suffering 
from Robert's syndrome, an autosomal recessive genetic disorder, characterized by 
defects in sister chromatid cohesion (Vega et al., 2005). 
3.4.4. Resolving cohesion in mitosis 
To allow equal segregation of the two genome copies to the newly arising daughter cells, 
physical linkages between sister chromatids have to be removed in mitosis. In cells of 
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higher eukaryotes, this is ensured by two different pathways (Waizenegger et al., 2000) 
(Fig. 3A). Most cohesin is displaced from chromatin early in mitosis by action of the so-
called "prophase pathway" (Sumara et al., 2000). It requires the cohesin associated factor 
Wapl (Gandhi et al., 2006; Kueng et al., 2006), the polo like kinase 1 (Plk1) (Sumara et 
al., 2002) and phosphorylation of several serine and threonine residues within the C-
terminal part of the cohesin subunit SA1/2 (Hauf et al., 2005).  
 
 
Fig. 3: Resolution of sister chromatid cohesion in mitosis and meiosis. (A) Cohesin removal 
in mitosis is a two-step process. The majority of cohesin complexes is removed from 
chromosome arms in prophase and prometaphase of mitosis. Opening of the cohesin ring 
complex requires Wapl, Plk1 and phosphorylation of SA1/2. Centromeric cohesin is not targeted 
by the prophase pathway due to presence of the cohesin protector shugoshin 1 (Sgo1). Sgo1 is 
associated with protein phosphatase 2A (PP2A), which supposedly keeps SA1/2 
dephosphorylated. At the metaphase-anaphase transition, separase becomes active and cleaves 
Scc1 thereby removing residual cohesin complexes from centromeres. (B) Cohesin removal in 
meiosis. Crossing-over formation in prophase of meiosis I results in chiasmata. As a 
consequence, homologous chromosome pairs are held together by arm cohesion. At the transition 
from metaphase to anaphase of meiosis I, arm cohesin is removed by separase. This leads to 
segregation of homologs and reductional division. Rec8, the meiotic counterpart of Scc1 needs to 
be phosphorylated to become a separase substrate. Centromeric cohesin is protected in meiosis I 
by a complex of Sgo2 and PP2A which keeps Rec8 dephosphorylated and hence shielded from 
cleavage by separase.  In meiosis II, Sgo2 is somehow inactivated which is why in anaphase II 
separase can remove the remaining centromeric cohesin. Sister chromatid separation and 
cytokinesis lead to the formation of haploid germ cell precursors. 
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Although Plk1 is able to phosphorylate cohesin, it has not been formally shown that 
direct phosphorylation of SA1/2 by Plk1 is required for prophase cohesin removal. 
A small fraction of cohesin at the centromere is spared from the prophase pathway and 
persists until the metaphase-anaphase transition (Fig. 3A). In S. cerevisiae, removal of 
cohesin complexes requires the proteolytic cleavage of its Scc1 subunit (Uhlmann et al., 
1999) mediated by the giant cysteine protease separase (Uhlmann et al., 2000). This 
process is conserved in higher eukaryotes (Hauf et al., 2001). At the onset of anaphase, 
cohesin cleavage initiates K-fiber mediated movement of chromosomes towards the 
spindle poles.  
3.4.5. Regulation of separase 
Premature or delayed activation of separase would be detrimental to cells. Therefore, it 
comes at no surprise that the protease is highly regulated (Fig. 4). Inhibition of separase 
is mediated by the binding of the stoichiometric proteinaceous factor Pds1/securin 
(Yamamoto et al., 1996). The facts that securin-/- mice are viable (Wang et al., 2003) and 
that human cells can maintain their genomic integrity in the absence of securin 
(Pfleghaar et al., 2005) suggested alternative regulatory mechanisms. One such 
mechanism is the phosphorylation of separase by Cdk1-cyclin B1 and the subsequent 
phosphorylation dependent binding of Cdk1-cyclin B1 to separase (Gorr et al., 2005; 
Stemmann et al., 2001). The most critical inhibitory Cdk1 phosphorylation site within 
human separase is the residue serine 1126 (serine 1121 in murine separase). 
Homozygous securin knockout mice that in addition carry at the endogenous locus one 
separase allele that can no longer be phosphorylated at a serine 1121 (securin-/- 
separase+/S1121A) have been created (Huang et al., 2005). Comparison of the phenotypes 
of various combination of alleles shows that securin and separase phosphorylation 
collaborate to ensure proper separase regulation. 
3.5. The anaphase promoting complex or cyclosome (APC/C) 
In order to exit mitosis, cells have to revert properties that define the mitotic state. The 
two main inhibitors of late mitotic events are the Cdk1-cyclin B1 complex and 
Pds1/securin (Thornton and Toczyski, 2003). Their downregulation leads to the 
dephosphorylation of Cdk1-cyclin B1 targets by counteracting phosphatases and to the 
activation of separase, thereby initiating anaphase. Securin as well as the cyclin B1 
subunit of the Cdk1-cyclin B1 complex are inactivated by means of proteolytic 
destruction via the 20S proteasome (Cohen-Fix et al., 1996; Glotzer et al., 1991). This 
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multi-subunit ATP-dependent degradation machinery specifically recognizes and 
degrades proteins which are labeled by chains of covalently coupled monomers of the 76 
amino acid polypeptide ubiquitin (Pickart, 1997). Ubiquitin attachment to target proteins 
is a three step process catalyzed by the enzymes E1 (ubiquitin activating enzyme), E2 
(ubiquitin carrier protein or ubiquitin conjugating enzyme) and E3 (ubiquitin protein 
ligase). Ubiquitin is activated for covalent coupling to substrates by the hydrolysis of 
ATP to AMP + PPi. The free energy of this reaction is conserved in a relay system 
involving a thioester bond between ubiquitin's C-terminal glycine residue and a cysteine 
residue of the E1 or later the E2. E3 enzymes come in two flavors. E3s of the HECT type 
also form a thioester intermediate with ubiquitin while RING type E3s catalyze the direct 
transfer from the E2 to substrates by optimally aligning both reaction partners. At the 
substrate level, the first ubiquitin becomes attached via an isopeptide bond of its C-
terminal glycine residue and the ε-amino group of a substrate lysine side chain. If a 
substrate is to be labeled for proteasomal destruction, additional ubiquitin moieties are 
coupled to lysine 48 or preconjugated ubiquitin (Hershko and Ciechanover, 1992).  
Substrate specificity is achieved at the level of E3 enzymes. There are many specific 
enzymes of the E3 class, compared to only one E1 and few E2 enzymes. The RING type 
E3 enzyme responsible for cyclin B1 and securin ubiquitylation is the anaphase 
promoting complex or cyclosome (APC/C) (Irniger et al., 1995; King et al., 1995; 
Sudakin et al., 1995). Important subunits of this large complex are summarized briefly 
below. Apc1 is the largest APC/C subunit and acts as a scaffold. Apc11, the subunit with 
the E3 enzyme activity, is linked to this scaffold by Apc2, which shares a cullin fold with 
other ubiquitin ligases. The subunits Apc3, and Apc6-Apc8 comprise tetratrico peptide 
repeats (TPR) important for protein-protein interactions (Vodermaier, 2004). 
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Fig. 4: Regulatory network of mitotic sister chromatid separation. Separase triggers an 
important aspect of anaphase. Via its protease activity, it mediates the resolution of sister 
chromatid separation. In early mitosis, separase is inhibited by securin and cyclin B1. At 
anaphase onset, the two separase inhibitors are ubiquitylated by the APC/CCdc20 and subsequently 
degraded. The APC/CCdc20 is kept inactive by the SAC until all chromosomes have achieved 
correct bipolar attachment to the mitotic spindle. 
 
For full functionality, the APC/C requires either of the substrate recruiting factors Cdc20 
and Cdh1 (Sigrist et al., 1995; Sigrist and Lehner, 1997; Visintin et al., 1997). Both 
factors bind to the APC/C via their C-terminal isoleucine-arginine (IR) motif, which 
interacts with the TPR containing APC subunits (Vodermaier et al., 2003). Cdc20 and 
Cdh1 recognize their substrates via an extended C-terminal WD40 repeat domain (Kraft 
et al., 2005). Short sequence motifs (degrons), predominantly close to the N- and C-
termini, qualify APC/C substrates. The destruction box (D-box, Arg-X-X-Leu) is 
common to APC/CCdc20 substrates while substrates harboring either a D-box or a KEN-
box (Lys-Glu-Asn) become recruited to APC/CCdh1. In addition to substrate recruitment, 
Cdc20 also stimulates the ubiquitin ligase activity of the APC/C. This function requires a 
motif called the C-box located within the N-terminal part of Cdc20 (Kimata et al., 2008). 
The APC/CCdc20 is tightly controlled by the spindle assembly checkpoint (SAC, see 
chapter 3.9) and only becomes active when the metaphase plate has properly formed. 
Cdh1 is kept inactive until anaphase due to inhibitory phosphorylations mainly imposed 
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by cyclin B1/Cdk1 (Jaspersen et al., 1999; Zachariae et al., 1998). As Cdh1 becomes 
gradually dephosphorylated, APC/CCdh1 starts to ubiquitylate its substrates in late 
anaphase. Among them are mitotic regulators like Plk1 but also Cdc20 (Charles et al., 
1998). As APC/CCdc20 activity diminishes, APC/CCdh1 takes over as an important 
regulator of G1 phase that prevents premature entry into the next S-phase (Irniger et al., 
1995). 
3.6. Specific properties of meiosis 
Meiosis is a modified type of cell division with several deviations from mitosis, all aimed 
at producing haploid gametes from diploid precursor cells. One such difference is the 
functional incorporation of different subunits into the cohesin complex and the use of 
these complexes for cohesion establishment during the pre-meiotic S-phase. In S. 
cerevisiae as well as in higher eukaryotes, Rec8 is the meiotic counterpart of Scc1 
(Michaelis et al., 1997; Watanabe et al., 2001). In addition, Smc1 is replaced by Smc1β 
and SA1/2 by Stag3 in mammalian meiosis.  
In the first meiotic division (meiosis I), homologous chromosomes are segregated to the 
two daughter cells. This requires a series of deviations from the mitotic program. The 
two sister kinetochores of a chromosome behave as one unit and become attached to one 
pole of the meiotic spindle. Meiosis specific proteins, such as Moa1 in S. pombe (Martin-
Castellanos et al., 2005; Yokobayashi and Watanabe, 2005) or the monopolin complex in 
S. cerevisiae (Toth et al., 2000), as well as cohesin bound to the core centromere (Sakuno 
and Watanabe, 2009) are responsible for kinetochore fusion and monopolar attachment. 
In order to build tension and thus to allow stable formation of K-fibers, homologous 
chromosomes need a physical linkage. This is achieved by recombination events in 
prophase of meiosis I. A meiosis specific nuclease induces double strand break (DSB) 
formation (Keeney et al., 1997). For DSB repair by means of homologous recombination, 
mainly the homologous chromosome and not the corresponding sister chromatid is used. 
Resolution of the intermediate Holliday junction structures will sometimes result in 
crossing-overs between homologous chromosomes, which later manifest as visible 
chiasmata. The arm cohesin complexes distal of these crossing-overs/chiasmata are what 
keeps homologous chromosomes paired (Fig. 3B). 
The reductional character of the first meiotic division is due to the lack of DNA 
replication between meiosis I and II. This is achieved by only partial but not full 
downregulation of Cdk1 activity after meiosis I enabling spindle disassembly but not 
formation of prereplicative complexes required for DNA replication. Meiosis II largely 
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resembles a normal mitotic division with bipolar attachment of chromosomes and 
segregation of sister chromatids.  
In mammalian males, four haploid spermatids are the result of meiosis. In females, only 
one oocyte is produced due to extremely asymmetric cell divisions leading to the 
extrusion of a so-called polar body both in meiosis I and in meiosis II. While male germ 
cells progress through meiosis to the post-meiotic G1 phase, female vertebrate oocytes 
will arrest in metaphase of meiosis II until fertilization. This arrest is due to APC/CCdc20 
inhibition by a signaling cascade collectively referred to as "cytostatic factor" (CSF) 
(Haccard et al., 1993; Masui and Markert, 1971). The most downstream component of 
the CSF pathway is xErp1 in X. laevis or Emi2 in H. sapiens. It acts as a direct and 
stoichiometric inhibitor of APC/CCdc20. Upon fertilization, an influx of Ca2+ ions triggers 
the proteolytic degradation of xErp1, leading to APC/CCdc20 activation and rapid exit 
from meiosis II (Rauh et al., 2005; Schmidt et al., 2005). Following the fusion of female 
and male pronuclei, the zygote can now progress into G1 phase of the first embryonic 
cell cycle. 
3.7. Cohesin removal during meiosis 
Once cohesin has fulfilled its role as a molecular glue between homologous 
chromosomes, it has to be removed from chromosome arms. This happens at the 
metaphase-anaphase transition of meiosis I. The cohesin ring is opened by separase 
mediated proteolytic cleavage of the subunit Rec8 (Buonomo et al., 2000) and the 
meiotic spindle can now pull homologs towards the spindle poles (Fig. 3B). Centromeric 
cohesin is left intact and keeps sister chromatids paired until anaphase of meiosis II. 
Then, the remaining cohesin fraction is removed, again by separase cleavage of Rec8. 
The two step process with a resistant centromeric cohesin population is faintly 
reminiscent of the mitotic situation. However, in meiosis both steps involve proteolysis 
and spread over two rounds of cell division.  
Mitotic (Scc1) and meiotic (Rec8) cohesin become phosphorylated in the vicinity of their 
separase cleavage sites by Cdc5/Plk1 and possibly other kinases in S. cerevisiae 
(Alexandru et al., 2001) and human cells (Hauf et al., 2005; Hornig and Uhlmann, 2004). 
Phosphorylation merely ameliorates the separase dependent cleavage of Scc1, while it is 
an essential precondition for the proteolysis of Rec8 by separase in vitro (Hauf et al., 
2005; Kudo et al., 2009). Accordingly, Scc1 phosphorylation of cohesin is largely 
dispensable in vivo (Hauf et al., 2005), while Rec8 phosphorylation is a crucial aspect of 
meiosis (Brar et al., 2006). 
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The full dependence on phosphorylation is a shared characteristic of meiotic Rec8 
cleavage and of proteolysis independent opening of cohesin in the mitotic prophase. As 
outlined below, it is the key to understanding how resolution of meiotic cohesin is solely 
dependent on separase activity, yet occurs in two, temporally well separated steps. 
3.8. Shugoshin proteins protect centromeric cohesin 
Centromeric cohesin resists its removal in prophase of mitosis as well as in anaphase of 
meiosis I. The molecular basis of centromeric cohesin protection remained elusive until 
the Drosophila meiosis mutant mei-S332 (Sandler et al., 1968) was found to be defective 
in centromeric cohesion during meiosis (Kerrebrock et al., 1992). The MEI-S332 protein 
localizes to meiotic centromeres. While not containing any conserved domains, an N-
terminal coiled-coil region was predicted, that is required for oligomerization. 
Furthermore, the C-terminal end of MEI-S332 is rich in basic amino acid residues 
(Kerrebrock et al., 1995; Tang et al., 1998). 
The identification of MEI-S332 homologs in other species has been precluded for almost 
a decade due to its low degree of sequence conservation. Only the N-terminal coiled-coil 
region and the C-terminal basic motif are weakly conserved. This fact, combined with 
yeast genetic screens led to the discovery of MEI-S332 homologs in other eukaryotic 
genomes (Katis et al., 2004; Kitajima et al., 2004; Rabitsch et al., 2004). MEI-S332 
homologs were named "shugoshin" (Sgo) - Japanese for the Samurai's guardian spirit. 
While S. cerevisiae and flies express only one shugoshin, both S. pombe and mammals 
have two. 
3.8.1. Cohesin protection by human Sgo1 in mitosis 
The function of the mammalian Sgo1 has first been studied by siRNA mediated depletion 
from cultured cells (McGuinness et al., 2005). Sgo1 depleted cells separate their sister 
chromatids already in early mitosis. Premature sister chromatid separation is not a result 
of separase activity since it also occurs under conditions, in which separase is inactive. 
Sister chromatid cohesion in Sgo1 depleted cells can be rescued by the expression of a 
mutant form of SA2 that is resistant to the prophase pathway (McGuinness et al., 2005). 
This SA2 mutant lacks a series of potential phosphorylation sites required for cohesin 
removal by the prophase pathway. It was therefore assumed that Sgo1 interferes with 
SA1/2 phosphorylation by the prophase pathway (Fig. 3A). Interestingly, Sgo1 interacts 
with protein phosphatase 2A (PP2A), the major cellular Ser-/Thr-phosphatase (Kitajima 
et al., 2006; Riedel et al., 2006). 
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The PP2A holoenzyme consists of the three subunits A, B and C. The A subunit 
constitutes a scaffold of PP2A. It consists mainly of HEAT repeats and is a founding 
member of this protein family. The PP2A-A subunit entertains interactions with both the 
B and the C subunit. The C subunit is the smallest PP2A subunit and harbors the catalytic 
phosphatase activity of the enzyme. A manganese ion bound to the C subunit is essential 
for the enzymatic hydrolase activity. Substrate specificity and subcellular localization are 
determined by the choice of the mutually exclusive regulatory B subunit. Several coding 
genes as well as alternative splicing give rise to at least 16 different B subunits. Based on 
sequence homology they are grouped into the three main categories B, B' and B''. 
Cells expressing a mutant version of Sgo1 that cannot bind PP2A have similar cohesion 
defects as Sgo1 depleted cells (Tang et al., 2006). The main function of mammalian Sgo1 
is thus the recruitment of PP2A to centromeres. Here, it is thought to keep cohesin 
dephosphorylated, thereby protecting it from phosphorylation dependent displacement. 
Sgo1 is dispensable for mammalian meiosis. Depletion of Sgo1 from in vitro cultured 
mouse oocytes did not result in any cohesion defects (Lee et al., 2008). 
3.8.2. Cohesin protection by Sgo2 during meiosis 
Sgo2 is mainly required during meiosis. While separase removes cohesin complexes 
from the arms of homologous chromosomes in anaphase I, Sgo2 protects cohesin at 
centromeres (Fig. 3B). Oocytes lacking Sgo2 lose sister chromatid cohesion already at 
the metaphase I to anaphase I transition (Lee et al., 2008; Llano et al., 2008). Sgo2 co-
localizes both with PP2A and with the cohesin subunit Rec8 at the centromeres of 
meiotic chromosomes (Gomez et al., 2007; Lee et al., 2008; Llano et al., 2008). It has 
been proposed that Rec8 cleavage by separase depends on prior Rec8 phosphorylation 
(Brar et al., 2006). The current model suggests dephosphorylation of Rec8 by Sgo2 
associated PP2A as the molecular basis of meiotic cohesin protection. Evidence for this 
theory stems from experiments in yeast and mouse meiosis. Normally, only centromeric 
cohesin is protected by PP2A in meiosis I. If PP2A is artificially forced to generic 
chromatin in S. pombe, all cohesin becomes resistent to separase in meiosis I (Riedel et 
al., 2006). Furthermore, meiotic S. pombe shugoshin with a mutated PP2A binding site is 
non-functional (Xu et al., 2009). Also in mammalian (mouse) meiosis, PP2A seems to be 
important. Treatment of mouse oocytes with the PP2A inhibitor okadaic acid leads to 
premature sister separation of chromatids already in meiosis I (Mailhes et al., 2003). To 
the contrary, forced overexpression of mitotic Sgo1 in mouse oocytes results in the 
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recruitment of PP2A along the whole length of chromosome arms. In this case, cohesin 
will not be removed from these chromosome arms in anaphase of meiosis I (Xu et al., 
2009). However, it has not yet been formally shown, that PP2A binding to mammalian 
Sgo2 is indeed required for Sgo2-dependent cohesin protection. A more precise 
characterization of PP2A binding to Sgo2 could therefore provide a tool to study the 
effects of the Sgo2-PP2A interaction in mammalian meiosis. 
3.8.3. Localization of shugoshin 
In human mitotic cells, two factors have been identified that are important for the 
subcellular localization of Sgo1 as well as Sgo2: the kinases Aurora B and Bub1. 
Depletion of any of these two factors leads to complete dissociation of both Sgo1 and 
Sgo2 from chromatin (Huang et al., 2007). However, Sgo2 localization is far more 
complex. While Sgo2 is found at centromeres in meiosis I, it relocalizes to kinetochores 
in metaphase of meiosis II (Gomez et al., 2007). The change of localization has been 
proposed to deprotect centromeric cohesin in meiosis II and to enable separase to cleave 
this remaining chromosomal subfraction of cohesin in order to trigger sister chromatid 
separation in anaphase of meiosis II. 
A similar relocalization pattern has been observed for Sgo2 at metaphase of mitosis in 
human cultured cells. So far, studies on Sgo2 relocalization have been purely descriptive. 
Cellular factors regulating the decision of Sgo2 binding to either centromere or 
kinetochore have not yet been identified. Above all, it remains unknown if the 
relocalization of Sgo2 has anything to do with its ill-understood inactivation between 
meiosis I and II. 
3.9. The spindle assembly checkpoint (SAC) 
The metaphase to anaphase transition has to be extremely well regulated. Due to its 
irreversible nature, any spindle defects present at anaphase onset will invariably lead to 
chromsome missegregation. As a consequence of the resulting aneuploidy, the daughter 
cells will either be inviable or they will head towards oncogenic transformation due to an 
inappropriate ratio of tumor suppressors versus protooncogenes (Weaver and Cleveland, 
2006). 
The spindle assembly checkpoint (SAC) is a safety mechanism that halts mitotic cells 
until they have attached all kinetochores to the mitotic spindle and more precisely have 
done so in an amphitelic fashion. The SAC is not absolutely crucial in mitosis of some 
organisms like D. melanogaster (Buffin et al., 2007). There it only becomes essential if 
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cells are challenged with conditions disturbing the MT cytoskeleton. In mammalian cells 
however, the SAC is essential even in unperturbed cell cycles and it is triggered in each 
and every mitosis until correct spindle assembly has taken place (Wassmann and 
Benezra, 1998). 
3.9.1. Attachment and tension 
Two main branches of the SAC can be distinguished: On the one hand the detection of 
unattached kinetochores and on the other hand the detection of inappropriately attached 
kinetochores. But how can a cell measure inappropriate attachments? If both 
kinetochores of a chromosome are attached to the same spindle pole, no pulling force can 
occur between kinetochores. The tension that the mitotic spindle exerts on a correctly 
attached chromosome is a physical property which - at least in theory - can be measured 
by cells (Stern and Murray, 2001). Nevertheless, the molecular nature of the "tension 
sensor" has remained elusive. In yeast, the Sli15-Bir1 complex linking kinetochores and 
microtubules has been implicated in tension sensing (Sandall et al., 2006). In agreement 
with this finding, studies in higher eukaryotes suggest that tension is measured within the 
kinetochore rather than at centromeres (Maresca and Salmon, 2009; Uchida et al., 2009). 
An important distinction between attachment and tension SAC is the requirement of the 
kinase Ipl1/Aurora B. Ipl1 mutant yeast cells as well as Aurora B depleted human cells 
are no longer able to arrest in response to lack of tension but they are still proficient in 
detecting unattached chromosomes (Biggins and Murray, 2001; Ditchfield et al., 2003; 
Hauf et al., 2003). Aurora B could indirectly trigger the SAC by converting mis-attached 
kinetochores into unattached kinetochores (Pinsky et al., 2006). However, at present the 
literature is not clear as to whether there could be a direct signal from Aurora B to the 
SAC (Vader et al., 2007).  
For SAC research, chemicals also referred to as spindle poisons, have been extremely 
helpful. One class of compounds leads to depolymerization of microtubules. These 
include for example nocodazole, vinblastine and colcemid. Cells treated with MT 
depolymerizing drugs will exhibit unattached kinetochores and therefore trigger the 
attachment sensing branch of the SAC. The other class of spindle poisons (e.g. 
paclitaxel/taxol) leads to stabilization of microtubules, abolishing microtubule dynamics. 
MTs will still attach to kinetochores but they are no longer exerting forces. 
Consequently, kinetochores lack tension and cells arrest in mitosis via activation of the 
tension sensing SAC. 
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Fig. 5: The mitotic spindle assembly checkpoint (SAC). (A) The SAC template model. 
Unattached kinetochores attract a complex of Mad1 and Mad2 (1). Mad2 is in its closed (C) 
conformation in this complex. An additional (open, O) Mad2 molecule (2) binds to Mad1 
associated Mad2 (3). In a catalytic mechanism, open Mad2 is activated to a hypothetical 
structural intermediate (I) between open and closed state (4). Now, it can efficiently bind to 
Cdc20, adopting the closed conformation (5). (B) Formation and function of the mitotic 
checkpoint complex (MCC). Once the Mad2-Cdc20 complex has been formed, additional 
checkpoint proteins (BubR1, Bub3) associate and build the MCC. This complex is more potent in 
APC/CCdc20 inhibition than Mad2 alone. A further step in APC/C inhibition is MCC induced 
ubiquitylation of Cdc20 by the APC/C. (C) Current models for inactivation of the SAC. (1) p31 
specifically binds to closed Mad2. On the one hand, this blocks Mad2 activation by the Mad1-
Mad2 template complex, on the other hand, APC/CCdc20 can be active despite bound Mad2. (2) 
Cdc20 ubiquitylation might contribute to the dissociation of Mad2 from Cdc20. (3) The 
phosphorylation of several serine/threonine residues of Mad2 negatively influences binding to 
Mad1 and Cdc20 and could therefore be a negative regulator of SAC. 
3.9.2. Kinetochores as signaling hubs of the SAC 
Already quite early it has become clear that unattached chromosomes induce a mitotic 
delay and that the centromere/kinetchore region of the chromosomes is essential for the 
arrest. Live cell imaging experiments elegantly demonstrated that the kinetochore of the 
A 
B 
C 
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last unaligned chromosome is sufficient for mediating a mitotic arrest (Rieder et al., 
1995; Rieder et al., 1994). In order to achieve robustness and an appropriate signal-to-
noise ratio, it seemed logical that erroneously attached chromosomes generate a negative 
"wait" signal rather than correctly attached chromosomes sending a positive signal. The 
fact that a single unattached kinetochore is able to trigger the SAC suggested a catalytic 
nature of SAC signaling. 
3.9.3. The molecular components of the SAC 
In an attempt to identify genes required for the drug induced mitotic arrest in yeast, two 
genetic screens have been performed in the early 1990s (Hoyt et al., 1991; Li and 
Murray, 1991). Mutants isolated from the screens were named "mitotic arrest deficient" 
(Mad) and "budding uninhibited by benzimidazole" (Bub). The Mad and Bub genes are 
widely conserved among eukaryotes. 
The SAC delays anaphase in response to spindle defects by directly targeting the Cdc20 
co-factor of APC/C. Mad2, a 24 kDa protein, is the core component of the SAC. Mad2 
binds to Cdc20 that remains associated with the APC/C. APC/CCdc20 activity is inhibited 
in this complex and the bulk of substrates like securin or cyclin B1 will not become 
ubiquitylated (Fang et al., 1998; Li et al., 1997). In order to achieve full inhibition, the 
assembly of the so-called mitotic checkpoint complex (MCC) is required (Sudakin et al., 
2001; Tang et al., 2001). In this complex, in addition to Mad2, also BubR1 and Bub3 are 
bound to APC/CCdc20 (Fig. 5B). In the MCC, Cdc20 itself can become ubiquitylated by 
the APC/C and subsequently degraded. This Cdc20 destabilization during a SAC arrest is 
thought to further reduce APC/C activity (Nilsson et al., 2008). Inhibition of APC/CCdc20 
is subject to precise regulation since the Mad2-Cdc20 complex only forms with slow 
kinetics by itself (Sironi et al., 2001). How Mad2 is activated to only bind Cdc20 when 
the SAC becomes triggered, is explained by the currently most accepted view of the 
SAC, the "template model" (Nasmyth, 2005). 
The template model requires an additional checkpoint factor: Mad1, an 83 kDa coiled-
coil protein that interacts with Mad2. Briefly, the template model constitutes a signaling 
pathway with Mad1 as an upstream component, localized at unattached kinetochores. 
One of the most downstream steps of SAC signaling is the inhibitory binding of Mad2 to 
Cdc20. To delineate the template model, first some crucial findings will be summarized 
and subsequently put into a common framework. 
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(1) In contrast to most other proteins, Mad2 can adopt two distinct native folds. Due to 
different surface-exposed residues, the two Mad2 conformers can be separated by ion 
exchange chromatography (Luo et al., 2004). An interchange between the two 
conformations is possible and involves global structural rearrangements (Luo et al., 
2000; Mapelli et al., 2007). The Mad2 conformations are referred to as "open" and 
"closed". (2) Mad2 physically interacts with the upstream SAC component Mad1 as well 
as with the downstream target Cdc20. The Mad1-Mad2 and the Cdc20-Mad2 interaction 
are highly similar. Both Mad1 and Cdc20 contain a conserved four amino acid Mad2 
interaction motif (MIM). When Mad2 binds to either of the two interactors, it switches to 
its closed conformation (Luo et al., 2002; Luo et al., 2004). A C-terminal loop of Mad2 
entraps Mad1 or Cdc20 in an almost topological fashion analogous to a car's safety belt 
locking the passenger (Sironi et al., 2002). (3) Mad1 and Cdc20 binding to Mad2 is 
competitive. Nevertheless, Mad1 is able to stimulate the formation of Cdc20-Mad2 
complexes (Kulukian et al., 2009; Sironi et al., 2001). (4) Mad2 in its open conformation 
can bind to closed Mad2 which is associated with Mad1 (De Antoni et al., 2005; Mapelli 
et al., 2007). This gives rise to a Mad1-Mad2closed-Mad2open complex. Closed Mad2, 
which is bound directly to Mad1, is kinetically stable, while the second, open Mad2 
molecule in the trimeric complex shows a high turnover rate (Vink et al., 2006). 
According to the template model of the SAC (Fig. 5A), a complex of Mad1 and closed 
(C) Mad2 is recruited to unattached kinetochores. Open (O) Mad2 from a cytosolic pool 
transiently binds to closed Mad2 associated with Mad1. The Mad1-Mad2 complex serves 
as a "template" to catalytically transform this open Mad2 molecule into closed Mad2, 
which facilitates its binding to Cdc20. Alternatively, Mad2 transformation involves an 
activated "intermediate" (I) conformation that adopts its closed fold only upon Cdc20 
binding. 
Once all requirements for proper spindle formation have been fulfilled, the SAC has to 
be switched off. There are several pathways implicated in SAC inactivation (Fig. 5C). (1) 
The p31 protein mimicks the structure of open Mad2 (Yang et al., 2007). It can bind to 
both Mad1-Mad2 and Cdc20-Mad2 complexes. By that means it blocks the Mad1-Mad2 
template and thus the source for any further "wait anaphase" signal. Furthermore, it 
enables APC/CCdc20 to regain activity despite the continued presence of active Mad2 (Xia 
et al., 2004). (2) Another method of SAC inactivation is ubiquitylation of Cdc20. This is 
thought to displace Mad2 from Cdc20 which in turn re-activates the APC/C (Reddy et 
al., 2007; Stegmeier et al., 2007). It should be mentioned that this finding clashes to some 
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extent with the aforementioned positive effect of Cdc20 ubiquitylation on the SAC 
(Nilsson et al., 2008) (3) Mad2 becomes increasingly phosphorylated as cells progress 
towards the metaphase-anaphase transition, most probably owing to the activation of 
mitotic kinases. Specifically the phosphorylation of a series of serine/threonine residue at 
the C-terminus of Mad2 inhibits its binding to Mad1 and abrogates its SAC function 
(Wassmann et al., 2003a). Mad2 phosphorylation could therefore act as a negative 
regulator of SAC. Mechanisms (1) and (2) might act as constitutive buffers of the SAC 
that poise the system for rapid inactivation once the SAC is satisfied. Another, inherently 
regulated, SAC inactivation mechanism (not depicted in Fig. 5) involves a complex of 
cytoplasmic dynein and dynactin. This complex can use micotubule based transport to 
move Mad1-Mad2 complexes away from kinetochores and towards the spindle poles 
once microtubules have become attached (Howell et al., 2001).  
So far, the SAC signaling pathway is essentially linear. Mad1 is the only upstream signal 
source feeding into the pathway and Cdc20 is the only target of SAC signaling.  
3.10. Implications of yeast shugoshin homologs in the SAC 
The first evidence that members of the shugoshin family play a role in the SAC came 
from S. cerevisiae. Mutants in the SGO1 gene are partially SAC deficient. They are 
capable to arrest, when the mitotic spindle is completely depolymerized but they lack a 
checkpoint when chromosomes are not under tension (Indjeian et al., 2005). This led to 
the theory that Sgo1p is required for the tension sensitive branch of the SAC. In contrast 
to S. cerevisae, fission yeast has two shugoshin homologs. The shugoshin SAC function 
seems to be conserved among yeast species since also S. pombe Sgo2 is involved in SAC 
signaling. A loss of cohesin function in mitosis normally triggers the tension sensitive 
SAC. However, S. pombe strains lacking the SGO2 gene fail to arrest in response to lack 
of tension (Kawashima et al., 2007). Also the human shugoshin homolog Sgo2 has been 
discussed in connection with the SAC. Yen and coworkers report that Sgo2 depleted 
human cells exit mitosis in spite of spindle defects and lagging chromosomes (Huang et 
al., 2007). 
Nevertheless, the above findings do not provide a link between shugoshin and the mitotic 
checkpoint on a molecular level. 
3.11. Clinical relevance of human shugoshin homologs 
Human shugoshin homologs have been implicated in a series of cancers. Human Sgo1 
has been shown to be overexpressed in a series of breast cancers (Scanlan et al., 2001). 
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Another example is downregulation of hSgo1 in colon cancer patient samples, compared 
to unaffected adjacent tissue (Iwaizumi et al., 2009). When hSgo1 is depleted from 
HCT116 colon cancer tissue culture, a delay in mitosis is observed. However, if Sgo1 
depletion is continued for longer periods of time, mitotic slippage occurs that can lead to 
tetraploidy and an increased centrosome number (Iwaizumi et al., 2009). Such tetraploid 
intermediates are prone to chromosomal instability in case they undergo another round of 
cell division. Mainly the higher number of centrosomes causes an increase in merotelic 
attachments due to altered spindle geometry (Ganem et al., 2009). Merotelic attachments 
in turn pose a high risk to chromosome missgregation (Cimini, 2008). 
3.12. Aim of this work 
The analysis of protein complexes can provide insight into how a protein can perform its 
cellular tasks. For the human Sgo1 protein, an unbiased biochemical approach was taken 
to identify new interaction partners. Sgo1 was overexpressed in human cell culture and 
subsequently purified by a two step affinity strategy. Out of the Sgo1 interactors 
identified by mass spectrometry, mainly the protein phosphatase 2A (PP2A) was 
characterized further. Since PP2A can interact with both human shugoshin homologs 
Sgo1 and Sgo2, it was investigated whether the two interactions are structurally similar. 
Furthermore a potential influence of Sgo2 on the catalytic activity of PP2A was 
measured. Data from other research groups showed that the interaction of shugoshin 
family members with PP2A contributes to the protection of centromeric cohesin. Besides 
that, shugoshin family members have also been implicated in the spindle assembly 
checkpoint (SAC), at least in yeast. Since no molecular details of the SAC function of 
shugoshin were known, the hypothesis of direct binding of shugoshin to a component of 
the SAC was tested for X. laevis Sgo1. The SAC component Mad2 was found to directly 
bind to xSgo1. In the following, it was tested whether the interaction was conserved also 
in mammalian cells. This was the case for human hSgo2. The structural features of the 
hSgo2-Mad2 interaction were further analyzed. For this purpose, aspects of the well 
characterized Mad1-Mad2 and Cdc20-Mad2 complexes were compared to the novel 
Sgo2-Mad2 interaction. Following precise mapping of the respective binding sites, the 
interplay of the two newly identified Sgo2 interactors PP2A and Mad2 was investigated. 
In a second part of this work, determinants of Sgo2 subcellular localization were 
investigated. The localization of Sgo2 to subdomains of mitotic chromosomes changes 
during mitosis and meiosis. This feature of Sgo2 has been temporally correlated with its 
cohesin protective activity in a previous report. However, no regulators involved in fine-
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tuning of the Sgo2 localization pattern have been identified so far. Of special interest 
were the relative contributions of microtubule-chromosome attachments on the one side 
and spindle pulling forces on the other side. Furthermore, an involvement of mitotic 
kinases in the regulation of Sgo2 localization was tested. 
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4. Results 
4.1. Identification of new shugoshin interaction partners 
Initially, it was unclear how shugoshin can fulfill its cohesin protective function. It 
neither contains known catalytic protein domains nor does it have any apparent 
enzymatic activities. Furthermore, despite its implication in the mitotic spindle assembly 
checkpoint (SAC), no molecular link between shugoshin and the SAC had been 
established. Therefore, different approaches were taken to identify potential new 
interaction partners of shugoshin proteins. First, human Sgo1 was purified from 
transiently overexpressing 293T cells and assayed for interaction partners by mass 
spectrometry (see chapter 4.1.1). Second, a candidate in vitro binding screen was 
performed to test SAC components for binding to Xenopus laevis shugoshin (see chapter 
4.1.6). 
4.1.1. Interaction partners of hSgo1 identified by mass spectrometry  
Due to the absence of catalytic domains in shugoshin family members, it was 
hypothesized that associated factors could mediate shugoshin functions. To identify such 
factors, human Sgo1 with tags at its N- and C-termini was overexpressed by transient 
transfection in 293T cells. hSgo1 and associated factors were purified by two step 
affinity chromatography (Fig. 6A). Samples were then separated by SDS-PAGE and 
Coomassie stained bands that appeared specifically in the Sgo1 pulldown and not in the 
control lane were cut out and sent for indentification by mass spectrometry. Fig. 6B 
shows the most significant hits for each band.  
A majority of the candidates belong to the group of protein phosphatase 2A (PP2A) 
subunits. Specifically B' PP2A subunits were identified while none of the other B subunit 
classes (B, B'') were found. Besides, a PP2A inhibitory protein SET/I-2 (PP2A) and the 
protein kinase CK2 (formerly known as casein kinase 2) were found. Identification of 
protein kinase CK2 as a potential interactor of the mitotic regulator Sgo1 was intriguing 
since CK2 also performs mitotic functions. For example, CK2 phosphorylates and 
regulates topoisomerase II (Ackerman et al., 1985). CK2 is a heterotetrameric Ser/Thr 
kinase consisting of two catalytic alpha subunits and two regulatory beta subunits.  
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Fig. 6: Identification of Sgo1 interaction partners by mass spectrometry. (A) hSgo1 was 
overexpressed in 293T cells using a contruct encoding an N-terminal ZZ- (Protein A) tag that 
could be removed by TEV protease and a C-terminal (His6-Flag)2-tag. In a first affinity 
purification step Sgo1 was bound to IgG sepharose beads via its ZZ-tag. Following elution by 
TEV protease cleavage, NaCl (400 mM) and Imidazole (10 mM) were added and a second 
purification step using Ni2+-NTA agarose was carried out. Following extensive washing, proteins 
bound to beads were eluted with SDS-PAGE sample buffer. (B) Samples were run on an SDS-
PAGE gel, Coomassie stained and bands specifically present in the Sgo1 lane but not in the 
control (empty vector) were sent for identification by mass spectrometry (H. Urlaub, MPI 
Goettingen). The most significant hits (peptide coverage) are indicated. 
 
 
Data obtained from mass spectrometric analysis are statistical predictions of potential 
interaction partners. Hence, the results needed confirmation by an independent method. 
To confirm the interaction between Sgo1 and protein kinase CK2, a co-I.P. (co-
immunoprecipitation) approach was used (Fig. 7A). The beta subunit of CK2 (CK2beta) 
was expressed in 293T cells together with Sgo1. When Sgo1 was isolated from cell 
lysates, CK2beta co-purified. The interaction was specific, since it did not occur in a 
mock control without Sgo1. This finding could also be confirmed in a yeast-2-hybrid 
assay (Fig. 7B, "Sgo1 full"). The beta subunit of CK2 also showed interaction with Sgo1 
in this experimental system, . The yeast-2-hybrid assay was also used to map the binding 
of CK2beta within Sgo1. Towards this end, fragments representing N-terminal, middle 
and C-terminal thirds of human Sgo1 were probed for binding of CK2beta. Only for the 
N-terminal fragment of Sgo1 an interaction with CK2beta could be observed. 
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Fig. 7: Confirmation and mapping of the Sgo1-CK2 interaction. (A) Co-I.P. experiments 
from transiently transfected 293T cells expressing HA-tagged CK2beta, alone or together with 
Flag-tagged hSgo1. Flag-hSgo1 was isolated from cell lysates with anti-Flag agarose beads. 
Immobilized proteins were analyzed by SDS-PAGE and immunoblotting using anti-HA and anti-
Flag antibodies. (B) The Sgo1 N-terminus interacts with CK2 in a yeast-2-hybrid assay. Full-
length Sgo1 ("full") as well as non-overlapping fragments representing the Sgo1 N-terminus 
("N"), middle part ("M") or C-terminus ("C") were expressed from pACT (in fusion with the 
activation domain of Gal4). In all cases, interaction with CK2beta expressed from pAS (fused to 
the DNA binding domain of Gal4) was tested. All constructs were tested for the absence of 
autoactivation in combination with the corresponding empty vector. 
 
Thus, the beta subunit of protein kinase CK2 is an N-terminal interactor of human Sgo1. 
Also a specific interaction of the catalytic alpha subunit of CK2 with Sgo1 could be 
detected in a co-I.P. experiment (data not shown).  
In contrast, the other human shugoshin homolog Sgo2 only showed weak interaction 
with CK2beta and no interaction above background levels with CK2alpha (data not 
shown). This suggests that CK2 interaction is a specific property of the human Sgo1 
homolog. 
 
The interaction between Sgo1 and PP2A could be confirmed in a yeast-2-hybrid assay 
(Fig. 8, "fl."). This assay was also used to map the Sgo1-PP2A interaction. To this end, 
fragments of Sgo1 were cloned that together covered the whole length of the Sgo1 
sequence. The fragments were designed to encode polypeptides with a length of about 66 
amino acids and a mutual overlap of 33 amino acids (Fig. 8, "1"-"16"). As an interaction 
partner, the PP2A regulatory subunit B'delta was chosen, which was considered the most 
likely direct binding PP2A subunit. Only fragment "2" in combination with PP2A-B'delta 
led to growth of the test strain on selective medium. Therefore, the Sgo1-PP2A 
interaction maps to the N-terminus of Sgo1, more precisely to a region between amino 
acid residues 33 and 100. 
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Fig. 8: PP2A is a specific interactor of the Sgo1 N-terminus. Yeast-2-Hybrid assay to confirm 
and to map the binding of PP2A to hSgo1. Full-length hSgo1 (f.l.) as well as fragments of 100 
amino acid residues (a.a.) with an overlap of 33 a.a. covering the whole length of hSgo1 (1-16) 
were expressed from pACT. As a counterpart, the PP2A subunit B'delta was expressed from 
pAS. All constructs involved in positive interactions - "2" (pACT-hSgo133-100), "f.l." (pACT-
hSgo1), and "B' " (pAS-PP2A-B'delta) - were tested for absence of auto-activation ("auto"). 
 
4.1.2. Conserved binding mode of PP2A between Sgo1 and Sgo2 
Shortly after my discovery, it was reported by other researchers that PP2A interacts with 
Sgo1 and Sgo2 (Huang et al., 2007; Kitajima et al., 2006; Riedel et al., 2006; Tang et al., 
2006). As these competing groups had functionally characterized the Sgo1-PP2A 
interaction, I focused my attention on a more detailed analysis of the Sgo2-PP2A 
interaction.  
First, to confirm the Sgo2-PP2A interaction, a co-I.P. experiment was performed. 
Endogenous Sgo2 was affinity isolated from Hela cell lysate using a specific antibody. 
Western blot analysis showed that the catalytic subunit of PP2A indeed bound to Sgo2 
(Fig. 9A). This was further confirmed in a yeast-2-hybrid assay. Full-length Sgo2 
showed specific interaction with the PP2A B'delta subunit (Fig. 9B). PP2A binding to the 
human Sgo1 homolog is mediated via the Sgo1 N-terminus. In order to test whether this 
also holds true for human Sgo2, again a yeast-2-hybrid assay was used. Indeed, a 
fragment comprising the N-terminal 250 amino acid residues (a.a.) of the 1265 a.a. 
protein Sgo2 retained interaction with PP2A (Fig. 9B). Thus, the Sgo2 N-terminus is 
sufficient for PP2A binding, similar to what has been described for Sgo1.  
The binding site of PP2A had been previously mapped for human Sgo1 (Tang et al., 
2006). Mutation of Asn 61 to Ile in Sgo1 (Sgo1-N61I) leads to a complete loss of PP2A 
binding. Sequence alignment (Fig. 9D, red box) showed that the residues around the 
PP2A binding site of Sgo1 are well conserved in Sgo2. Especially, the characteristic di-
asparagine motif required for PP2A binding to Sgo1 is present in both Sgo1 and Sgo2. It 
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was therefore conceivable that a conserved PP2A binding site might be present in both 
human shugoshin homologs.  
 
 
Fig. 9: Identification of the PP2A binding site of Sgo2. (A) Endogenous hSgo2 was immuno-
precipitated from lysate of approx. 108 Hela cells using 5 µg of immobilized anti-Sgo2 antibody. 
Non-specific rabbit IgG served as negative control. Immunoprecipitates were probed by 
immunoblotting for Sgo2 and PP2A-C. (B) hSgo2 full-length or hSgo21-250 fused to Gal4-AD 
were tested for binding to PP2A-B' fused to Gal4-DBD. The left panel shows equal plating by 
growth on selective medium for the transformed plasmids. (C) 293T cells were transfected with 
plasmids encoding Flag-tagged wild-type (wt) hSgo2 or hSgo2-N58I. Following anti-Flag-I.P., 
material bound to the beads was analyzed by immunoblotting using anti-Flag and anti-PP2A 
antibodies. (D) The PP2A binding motif is conserved between Sgo2 and Sgo1. The N-termini of 
human Sgo1 and Sgo2 were aligned using the Clustal-W algorithm. The red box indicates 
conserved residues surrounding the shugoshin PP2A binding site. The asterisk denotes an 
asparagine residue important for PP2A binding in both Sgo1 and Sgo2. 
 
To test this possibility, a Sgo2 mutant (Sgo2 N58I) - analogous to Sgo1-N61I - was 
created and assayed for PP2A binding. Tagged versions of wild-type Sgo2 and the 
potential PP2A binding mutant were immunoprecipitated from lysates of transfected 
293T cells. While wild-type Sgo2 specifically bound to PP2A-C, Sgo2-N58I no longer 
interacted with PP2A-C (Fig. 9C). This result shows that the mode of PP2A binding is 
conserved between hSgo1 and hSgo2. Xu et al. (2009) have very recently solved the 
crystal structure of hSgo1 in complex with the PP2A holoenzyme. PP2A binds to a 
coiled-coil region around N61. Consistent with the findings presented here, bioinformatic 
analysis indicated that also the Sgo2 N-terminus can form a coiled-coil structure (data 
not shown). 
A 
C 
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4.1.3. Sgo2 regulates PP2A 
Phosphorylation is an important post-translational modification that regulates protein 
function. Mitosis is characterized by increased kinase activity and the extensive 
phosphorylation of many target proteins. In terms of regulation of protein 
phosphorylation, the prevalent opinion had been that kinases are tightly controlled while 
the counteracting phosphatases are more or less constitutively active. This view has 
recently been challenged by the discovery of several tightly regulated functions of PP2A 
(Trinkle-Mulcahy and Lamond, 2006). The trimeric PP2A is well suited for regulation 
due to a variety of different isoforms of its subunits (especially the regulatory B subunit). 
So far, mainly recruitment of specific PP2A subtypes to distinct subcellular 
compartments has been proposed to confer specificity of PP2A (Trinkle-Mulcahy and 
Lamond, 2006). One example is the recruitment of PP2A-B' to the centromere of mitotic 
cells by Sgo2 (Kitajima et al., 2006). 
But is there also a direct regulation of PP2A activity by shugoshin binding? To shed light 
on this issue, the activity of Sgo2 associated PP2A was studied in more detail. First, it 
was determined whether Sgo2 showed any associated phosphatase activity. Towards this 
end, overexpressed Sgo2 was isolated from 293T cells. Phosphatase activity was 
measured using a malachite green based peptide dephosphorylation assay. Wild-type 
Sgo2 showed a much higher phosphatase activity than PP2A binding deficient Sgo2-
N58I (Fig. 10). Thus, Sgo2 was associated with phosphatase activity and more 
specifically with PP2A activity in human cells.  
Next, phosphatase activity of Sgo2-less PP2A of the B' subtype was compared to the 
activity of Sgo2 bound PP2A. The protein complexes were isolated from 293T cells 
transiently transfected with plasmids encoding tagged versions of PP2A-B'delta or Sgo2, 
respectively. Due to the strong overexpression, PP2A-B'delta samples could be 
considered essentially free from Sgo2. After competitive elution using a Flag3 peptide, 
free PP2A and Sgo2-PP2A were subjected to malachite green phosphatase assay (Fig. 
10). Sgo2-PP2A had an about 3-fold higher phosphatase activity compared to PP2A-
B'delta alone. The observed differences were not due to the presence or absence of the 
Flag-tag on a PP2A subunit since a similar result was obtained when tags were removed 
using TEV protease cleavage (Suppl. fig. 1) 
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Fig. 10: Sgo2 is specifically associated with phosphatase (PPase) activity and stimulates 
PP2A activity in vitro. Flag-tagged versions of wild-type Sgo2 (wt), Sgo2-N58I (PP2A binding 
deficient) or PP2A-B'delta were expressed in 293T cells. The proteins were isolated from cell 
lysates using anti-Flag agarose beads and eluted by competition with Flag3 peptide. Semi-
quantitative immuno-blotting was used to adjust equal Sgo2 concentrations (to compare between 
Sgo2-wt and Sgo2-N58I) or equal PP2A-C concentrations (to compare between Sgo2-wt and 
PP2A-B'delta). Subsequently, Ser-/Thr PPase activities were measured using a peptide 
dephosphorylation assay followed by detection of free phosphate using the malachite green 
method. Control indicates a PPase assay without enzyme addition. Stimulation of PP2A by Sgo2 
association was statistically significant. Error bars show standard deviation of three independent 
measurements. (Student's t-test: *: p < 0.001). 
 
Sgo2 is therefore able to stimulate PP2A in vitro. A potential function on the cellular 
level could be that Sgo2 is not merely a recruiting factor for PP2A but also locally 
increases its catalytic activity. 
4.1.4. Human Sgo1 but not Sgo2 is required to protect centromeric cohesin in 
mitosis 
While human Sgo1 is dispensable for cohesin protection in meiosis (Lee et al., 2008), it 
is essential for protection of mitotic cohesin from the prophase pathway (McGuinness et 
al., 2005). In the case of human Sgo2, the published literature is less clear. There is one 
report stating that depletion of Sgo2 from mitotic human cells leads to a considerable 
degree of cohesion loss. The authors also show that PP2A is downstream of Sgo2 in 
terms of centromeric localization (Kitajima et al., 2006). However, similar experiments 
were published by the laboratory of Tim Yen. According to their findings, knock-down 
of Sgo2 in human cells leaves cohesion unaffected (Huang et al., 2007). Consistent with 
the latter report, sgo2-/- mouse embryonic fibroblasts are perfectly able to execute a 
precise mitosis without suffering premature sister chromatid separation (Llano et al., 
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2008). However, this result should be taken with care since mice express another Sgo2 
homolog from a different genomic locus. 
 
 
Fig. 11: Sgo2 is dispensable for 
cohesion in mitosis. (A) Hela cells 
were transfected with Sgo1 siRNA 
(40 nM) or mock transfected (-) and 
immediately synchronized using a 
thymidine-nocodazole protocol. 
Lysates of mitotic cells were 
analyzed by SDS-PAGE and 
immunoblotting for p31 as an input 
control and for Sgo1. In addition, 
chromosome spreads were prepared 
as described in the Materials and 
Methods section. (B) Hela cells were 
transfected with Sgo2 siRNA 
(40 nM) or mock transfected (Ctrl.). 
24 h later cells were synchronized 
via a thymidine-nocodazole 
protocol. 
Chromosome spreads were prepared 
from mitotic cells as in (A). Spreads 
were stained with Hoechst 33342 
(blue) and by immunofluorescence 
(I.F.) against the outer kinetochore marker Hec1 (red) and against Sgo2 (green). (C) 
Quantification of sister chromatid cohesion in spreads from (A) and (B). Spreads comprising 
predominantly cohesed or separated chromosomes were assigned to the respective categories. For 
Sgo2 depletion, only spreads were selected that were devoid of Sgo2 in immunofluorescence. 
 
In order to get insight into the relative contribution of Sgo1 and Sgo2 to sister chromatid 
cohesion in mitosis, the two factors were depleted using specific siRNAs. Subsequently, 
mitotic cells were prepared for chromosome spreads. Immunofluorescence staining of the 
kinetochore marker Hec1 and fluorescence labeling of DNA enabled a reliable 
differentiation of cohesed or separated sister chromatids. The depletion efficiency for 
Sgo1 was determined by immunoblotting. Compared to the input control p31, merely a 
mild reduction of Sgo1 levels by RNAi was observed (Fig. 11A). Nevertheless, in 
chromosome spreads about 60% of Sgo1 RNAi cells showed premature sister chromatid 
separation, while the control revealed intact cohesion (Fig. 11C).  
Next, the contribution of Sgo2 to mitotic cohesion protection was assayed. Here the 
siRNA efficiency was determined by co-staining of chromosome spreads with antibodies 
specific for Sgo2 (Fig. 11B). For the Sgo2 RNAi sample, only cells that did not show a 
detectable signal were counted. None of the Sgo2 depleted cells analyzed had signs of 
A B 
C 
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premature sister chromatid separation (Fig. 11C). These results show that hSgo1 but not 
hSgo2 is required to protect centromeric cohesin in mitosis. 
4.1.5. Cohesin protects DNA catenations until the metaphase-anaphase transition 
The proposed mechanism by which Sgo2 fulfills its protective function involves cohesin 
dephosphorylation via associated PP2A. While this process is crucial in meiosis (Lee et 
al., 2008; Llano et al., 2008), Sgo2 is not required for protection of centromeric cohesin 
in mitosis (Llano et al., 2008). Cohesin is not the only entity that has been implicated in 
keeping sister chromatids together from S-phase until mitosis. Long before the 
components of the cohesin complex had been identified, DNA catenation has been 
suggested as a potential source of chromatid cohesion (Murray and Szostak, 1985; 
Nasmyth and Haering, 2005). Like the proteinacious cohesion, DNA catenation arises 
during S-phase along with DNA replication (Sundin and Varshavsky, 1980). Findings 
from yeast showing that minichromosomes are decatenated before anaphase (Koshland 
and Hartwell, 1987) argue against an essential role of catenation in cohesion of 
chromatids. However, in mammalian cells, DNA catenation at centromeres is only 
resolved during anaphase (Baumann et al., 2007; Wang et al., 2008). Topoisomerase II 
(TOPO II) is the main enzyme involved in decatenation in mitosis. During prophase it 
resolves arm catenation but spares residual catenation at centromeres (Porter and Farr, 
2004). How centromeric catenation is protected from TOPO II has been unclear, however 
its resolution correlates in time with the removal of cohesin complexes. Furthermore, 
TOPO II is a mitotic phosphoprotein (Taagepera et al., 1993) which serves as a substrate 
for kinases like Aurora B and CK2 (Ackerman et al., 1985; Morrison et al., 2002). CK2 
phosphorylation stimulates TOPO II activity in vitro (Ackerman et al., 1985). 
Two main factors were tested as candidates for the protection of centromeric catenation: 
(1) Sgo2, which together with PP2A could dampen the activity of centromeric TOPO II 
by keeping it dephosphorylated, and (2) cohesin, which might represent a "road-block" 
for TOPO II.  
The first model was tested by siRNA mediated depletion of Sgo2 from Hela cells. Cells 
were fixed and the degree of catenation in anaphase cells was determined. To this end,  
an immunofluorescence staining was performed using an antibody directed against the 
helicase PICH, which is a marker for persistent anaphase DNA threads (Baumann et al., 
2007). Both in control as well as in Sgo2 depleted cells an equal number of PICH 
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positive DNA threads was observed (Suppl. fig. 2). Therefore, Sgo2 is not responsible 
for the protection of centromeric catenation. 
 
Experiment in collaboration with Lily H.C. Wang 
 
Fig. 12: Cohesin counteracts TOPO II at centromeres of metaphase chromosomes. (A) 
Immunofluorescence staining of isolated metaphase chromosomes using antibodies directed 
against the condensin subunit Smc2 and against the kinetochore marker Hec1. Together with 
Hoechst 33342 labeling of DNA, precise judgement of sister chromatid cohesion ("double") or 
separation ("single") was possible. (B) In vitro sister chromatid separation assay: Purified 
metaphase chromosomes were treated with wild-type ("active") or protease-dead mutant separase 
in the presence or absence of the TOPO II inhibitor ICRF-193. Immunofluorescence staining as 
in (A) was used to quantify separated and cohesed chromosomes. (C) SDS-PAGE analysis of the 
samples from (B) using antibodies against Scc1 (to detect cohesin cleavage), separase (to detect 
separase self-cleavage as a measure of activity) and SMC2 (input control). 
 
The second hypothesis, a potential involvement of cohesin complexes in catenation 
protection, was tested in collaboration with Lily Wang (Nigg laboratory, MPI for 
Biochemistry, Martinsried). As a tool, an in vitro sister chromatid cohesion assay was 
used. Human prometaphase chromosomes were purified from cultured cells arrested with 
nocodazole (Fig. 12A). These typical X-shaped chromosomes still maintain cohesin 
complexes including the Scc1 subunit at their centromeres (Waizenegger et al., 2000) as 
well as presumably also catenations (Wang et al., 2008). Moreover, they were associated 
with TOPO II, which proved to be highly active upon chromosome extraction (data not 
shown).  
C A 
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If cohesin complexes were an impediment for TOPO II, then removal of cohesin should 
enable decatenation, i.e. physical separation of sister chromatids. To remove cohesin, 
chromosomes were treated with recombinant active separase or with a protease-dead 
separase mutant as negative control. While in the control most chromsomes stayed 
paired, addition of active wild-type separase lead to sister chromatid separation in more 
than 30% of cases (Fig. 12B). This result was consistent with the removal of catenation 
following cohesin cleavage. Nevertheless, a formal proof for the presence of DNA 
catenation on isolated metaphase chromosomes was required. To achieve this, the 
cleavage assay was performed in the presence of the TOPO II inhibitor ICRF-193. Now, 
separase could no longer induce sister chromatid separation (Fig. 12B). Immunoblotting 
for the cohesin subunit Scc1 revealed an equally efficient cleavage by separase, 
independent of ICRF-193 addition (Fig. 12C). 
Therefore, separase mediated cohesin removal is sufficient for sister chromatid 
separation in vitro. Together with the failure to separate chromatids upon TOPO II 
inhibition, it can be concluded that cohesin indeed blocks TOPO II mediated resolution 
of centromeric catenations during metaphase. 
4.1.6. Candidate binding screen - Mad2 interacts with X. laevis Sgo1 
Motivated by the temporal correlation between SAC activity and shugoshin functions in 
mitosis and meiosis, a candidate screen had been carried out in the Stemmann lab. 
X. laevis Sgo1 (xSgo1) and various checkpoint proteins were recombinantly expressed, 
purified and used for in vitro binding assays. As a result a new interaction between 
xSgo1 and Mad2 was found (Olaf Stemmann, personal communication). Since 
recombinant full-length xSgo1 derived from E. coli is prone to degradation, the initial 
experiment was repeated in a different setup. Full-length xSgo1 was produced by 
coupled in vitro transcription/translation ("IVT") in the presence of [35S]methionine. 
Then, Mad2 was immobilized on beads and incubated with xSgo1 IVT. Empty beads 
served as negative control. Material bound to beads was assayed via SDS-PAGE and 
autoradiography (Fig. 13). Significant xSgo1 binding to beads could only be detected in 
the presence of Mad2. Thus, Mad2 could be identified as a new interaction partner of the 
shugoshin xSgo1. 
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Fig. 13: X. laevis Sgo1 (xSgo1) is a 
specific interaction partner of the 
mitotic checkpoint factor Mad2. 10 µl 
of Ni2+-NTA beads were incubated with 
buffer DP1 alone (-) or with 5 µg His6-
Mad2 for 2 h at 4°C. Then beads were 
washed, incubated with 8 µl each of 
[35S]methionine labeled xSgo1 for 2 h at 
RT and washed again. Bound material 
was finally eluted with SDS-PAGE 
sample buffer and analyzed by SDS-
PAGE and autoradiography. Asterisks 
highlight unspecific bands that were 
present in both control and Mad2 
pulldown. 
 
 
 
 
 
 
4.1.7. Human Sgo2 but not Sgo1 interacts with Mad2 
Searches in the annotated genome of X. laevis only revealed the existence of one 
shugoshin family member (xSgo1). Since higher vertebrates (mammals) contain two 
distinct shugoshin genes, frogs could in fact either lack the second homolog or annotation 
of the X. laevis genome is incomplete with respect to shugoshin genes. In collaboration 
with Kay Hofmann (Miltenyi Biotech, Cologne) it could be demonstrated that, 
surprisingly, a second sugoshin is indeed missing in the genus Xenopus as well as in 
zebrafish. In an evolutionary context, it is remarkable that D. melanogaster and 
S. cerevisiae also harbor only one shugoshin gene, whereas S. pombe contains two. 
Potential explanations include an independent gene duplication in mammals and fission 
yeast (convergent evolution) or – less likely - selective deletion of one of two shugoshin 
genes once present in an archetypal common ancestor. A special situation in mice is 
worthwile mentioning. In contrast to humans, they have two independent genes encoding 
Sgo2 homologs: Sgo2.1 and Sgo2.2. 
With respect to the interaction of xSgo1 and Mad2 the following questions arose: is the 
interaction also conserved in human cells and if so, which of the two human shugoshin 
homologs interacts with Mad2? The putative binding of hSgo1 and hSgo2 to Mad2 was 
first investigated in a yeast-2-hybrid assay. Growth on selective medium indicated 
Autoradiography 
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physical interaction between Sgo2 and Mad2 (Fig. 14) but not between Sgo1 and Mad2. 
This finding was validated by showing that the individual contructs did not give rise to 
non-specific growth ("auto-activation") and that PP2A B'delta subunit interacted with 
both Sgo1 and Sgo2, as expected.  
Thus, Sgo2 has acquired the conserved Mad2 interaction in human cells. This is 
surprising since xSgo1 is more closely related to hSgo1 (28% identity, 33% gaps) than to 
hSgo2 (13% identity, 60% gaps). The evolutionary conservation of shugoshin-Mad2 
indicates an important role of this interaction in vertebrates. 
 
               
 
Fig. 14: Interaction with Mad2 is conserved in human Sgo2 but not Sgo1. For yeast-2-hybrid 
analysis, Sgo1 or Sgo2 were fused to the Gal4 activating domain, while Mad2 and PP2A B'delta 
were linked to the Gal4 DNA binding domain. Plasmids were transformed in the indicated 
combinations into the S. cerevisiae strain PJ69-4A. Comparable amounts of cells were spotted on 
SC-Leu-Trp plates (input control) and SC-Leu-Trp-His plates (selective medium for interaction). 
Transformations of single constructs together with the corresponding empty vector were used to 
control for autoactivation. 
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4.2. Sgo2 is dispensable for mitosis 
4.2.1. Sgo2 does not cause an override of a short-term SAC arrest 
There is evidence from different yeast species that shugoshin family members are 
required for the tension sensitive branch of the SAC (Indjeian et al., 2005; Vanoosthuyse 
et al., 2007). Nevertheless, no mechanistic explanation for the shugoshin-SAC 
connection has been demonstrated to date. In addition, there are no direct data showing 
an involvement of higher eukaryotic shugoshin homologs in the SAC. A role of 
mammalian Sgo1 can almost certainly be excluded here because Sgo1-less human cells 
show premature separation of sister chromatids followed by a robust, SAC mediated 
arrest (McGuinness et al., 2005). It has been reported that Sgo2 depleted Hela cells, 
although delayed in mitosis, finally exit mitosis despite persistence of erroneous 
kinetochore-microtubule attachments (Huang et al., 2007). Although this would be 
consistent with a Sgo2-Mad2 interaction, it contrasts with the report that murine cells 
lacking Sgo2.1 (but not Sgo2.2) do not suffer from mitotic defects and remain fully SAC 
proficient (Llano et al., 2008). Thus, the putative positive role of mammalian Sgo2 in the 
mitotic SAC response has remained controversial.  
 
Fig. 15: Mad2 depletion but not Sgo2 depletion causes an override of a short-term SAC 
arrest. Hela cells were transfected with control (Ctrl), Mad2, or Sgo2 siRNAs (40 nM) and 
presynchronized with thymidine. 6 h after release, DMSO (as control) or drugs were added 
(Noc: 200 ng/ml, loVBL (low conc. vinblastine): 6.7 nM, hiVBL (high conc. vinblastine): 0.5 
µM). Another 8 h later, the mitotic index was determined by immunofluorescence staining for 
phosphorylated Histone H3 (as a mitotic marker) and counterstaining of DNA with Hoechst 
33342. The mitotic index was calculated as ratio of phospho-Histone H3 positive over all 
Hoechst 33342 labeled cells. The relatively low mitotic indices were most probably due to an 
inefficient thymidine release, i.e. only about half of the cells entered mitosis in the first place. 
hi 
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To clarify this issue, Sgo2 function was tested in a first assay for SAC function. Hela 
cells were released from a thymidine arrest into a synchronous mitosis in the absence or 
presence of different spindle poisons to trigger a SAC arrest. The mitotic index was 
determined about 3 h after mitotic entry, when untreated control cells had already 
completed mitosis (mitotic index 10%). Upon addition of various SAC inducing drugs, 
about 40% of cells remained arrested in mitosis at this time point. While loss of Mad2 
caused a dramatic decrease of the mitotic index under these conditions, a Sgo2 depleted 
cell population maintained a high mitotic index. Thus, Sgo2 is not required to establish a 
short-term mitotic checkpoint arrest. This is true for loss of attachment (nocodazole, 
0.5 µM vinblastine) as well as for loss of tension (6.7 nM vinblastine (Skoufias et al., 
2001)). 
4.2.2. Sgo2 is not required for maintenance of a prolonged mitotic SAC arrest 
A short term response of cultured cells to spindle poisons constitutes quite a simple 
situation with predictable outcomes. However, when spindle poisons are applied for 
longer periods of time, several factors have to be considered. Cells can undergo various 
fates including apoptotic cell death or adaptation resulting in "mitotic slippage" into G1 
phase (Weaver and Cleveland, 2005). Mitotic cell death upon prolonged drug treatment 
indeed shows classical signs of apoptosis like activation of caspase-3 (Tao et al., 2005). 
It has been shown that mitotic slippage happens in spite of an active SAC via slow 
continued cyclin B1 degradation (Brito and Rieder, 2006). Which fate decision is taken 
depends on the type of spindle poison applied and also on the cell type (Gascoigne and 
Taylor, 2008; Orth et al., 2008).  
To study a possible involvement of Sgo2 in the subtle fate decisions upon prolonged 
mitotic arrest, the response of Sgo2 depleted cells to long-term nocodazole or taxol arrest 
was studied. Thereby, the ability to maintain a prolonged SAC arrest was tested. Hela 
cells pre-synchronized with thymidine were released into nocodazole containing 
medium. The mitotic index was determined by flow cytometry 17, 25 and 30 h thereafter 
(Fig. 16A). 
At the early time point, the mitotic index was found to be slightly lower for Sgo2 RNAi 
compared to the control. Nevertheless, the difference did not become more pronounced 
during the arrest. It was hence attributed to a less efficient thymidine release and/or 
mitotic entry. 30 h after release, control as well as Sgo2 RNAi cells showed a 
comparable decrease of the mitotic index, presumably due to mitotic slippage. In 
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conclusion, depletion of Sgo2 did not significantly affect a prolonged arrest in 
nocodazole. 
 
 
 
Fig. 16: Sgo2 is not required to maintain a prolonged mitotic checkpoint arrest. HeLa cells 
were presynchronized at the G1/S transition with thymidine and subsequently released for the 
indicated time periods into medium containing spindle poisons (A) 200 ng/ml nocodazole or (B) 
200 ng/ml taxol. (A) and (B) The mitotic index was determined using immunostaining for 
phospho-Histone H3 and flow cytometry. (C) Sgo2 RNAi efficiency was determined by 
immunoblotting. Comparison of the Sgo2 depleted sample to a dilution series of the control 
shows a >90% depletion of Sgo2 by siRNA. Tubulin staining was used to confirm equal loading. 
 
 
When the response to taxol was measured, similar observations were made (Fig. 16B). 
Comparable mitotic indices were found 17 h after thymidine release for Sgo2 depleted 
samples and the control. At later time points the taxol arrest turned out to be less robust 
than the nocodazole arrest. At the 30 h time point, only a minor fraction of cells remained 
in mitosis. Again Sgo2-less cells behaved similar to control cells. The highly efficient 
depletion of Sgo2 of more than 90% is documented in Fig. 16C.  
Thus, even under conditions of prolonged drug treatment, Sgo2 is not required to 
maintain the mitotic checkpoint arrest. 
4.2.3. Sgo2 does not regulate mitotic checkpoint complex composition 
In vitro, both Mad2 and BubR1 inhibit the APC/C on their own (Li et al., 1997; Tang et 
al., 2001). However, they were shown to be much more efficient in APC/C inhibition 
when acting together with Bub3 in the mitotic checkpoint complex (MCC) which 
includes Cdc20 (Sudakin et al., 2001). Recently, it became clear that Mad2, despite 
acting upstream of BubR1, might only be a minor or transient component of the final 
A B C 
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MCC once this has formed (Nilsson et al., 2008). The question therefore arose whether 
Sgo2 as a novel interactor of Mad2 might be involved in the regulation of MCC 
composition.  
 
 
Fig. 17: Depletion of Sgo2 does not 
affect binding of Mad2 or BubR1 to 
Cdc20. Hela cells were transfected 
with control or Sgo2 siRNA for a total 
of 50 h and synchronized using a 
thymidine-nocodazole protocol. 
Endogenous Cdc20 was immuno-
precipitated from lysates and 
associated Mad2 and BubR1 were 
detected by immuno-blotting. 
 
 
 
To test this possibility, Cdc20 was immunoprecipitated from mitotic Hela cells and the 
amount of associated BubR1 and Mad2 was measured by immunoblotting (Fig. 17). 
Cdc20 could be efficiently isolated from control cells as well as from Sgo2 depleted 
cells. In both cases, comparable amounts of BubR1 and Mad2 were bound to Cdc20. 
Thus, Sgo2 depletion did not influence MCC composition. 
4.2.4. Cdc20 is the only known Mad2 binding partner that becomes destabilized in 
mitosis  
A newly described function of the mitotic checkpoint complex is targeting of Cdc20 for 
APC/C mediated ubiquitylation followed by proteasomal degradation (Ge et al., 2009; 
Nilsson et al., 2008). This dropping of Cdc20 levels helps to sustain a robust checkpoint 
arrest. Mad2 binding is essential for this SAC mediated instability of Cdc20. However, 
whether the stability of the other known Mad2 binding partners, Mad1 and the newly 
discovered Sgo2, would also change in a SAC arrest, has not yet been tested. To clarify 
this issue, mitotic Hela cells were treated with the translation inhibitor cycloheximide 
(CHX) and protein levels were followed in a time course by immunoblotting (Fig. 18). In 
agreement with the literature, Cdc20 levels dropped during the experiment to about 20% 
(densitometry, data not shown), while the controls Actin and Mad2 did not change  
(Fig. 18).  
Now, the stability of the two other Mad2 interactors Mad1 and Sgo2 was determined 
during a SAC arrest. Mad1 was stable in the cycloheximide shutoff. This was not 
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unexpected since Cdc20 instability requires Cdc20's C-terminal "IR" motif, which allows 
for direct APC/C binding. Mad1 does not contain such a motif. In the case of Sgo2 the 
situation was less clear, since its C-terminus consists of the amino acid residues "MRR". 
Nevertheless, no drop of Sgo2 protein levels could be detected when translation was 
blocked in SAC arrested cells (Fig. 18).  
This shows that Sgo2 is stable during a mitotic arrest. The function of the Sgo2-Mad2 
interaction is therefore not to destabilize Sgo2.  
 
 
Fig. 18.: Cdc20 is degraded in prolonged mitosis while Mad1 and Sgo2 are stable. Hela cells 
were transfected with control (GL2) or Sgo2 siRNAs for a total of 50 h and synchronized using a 
thymidine-nocodazole arrest. Mitotic cells were enriched by shake-off and incubated with 20 
µg/ml cycloheximide for the indicated periods of time. Thereafter, cells were lysed in SDS-
PAGE sample buffer, resolved by SDS-PAGE and analyzed by immuno-blotting. 
 
The Sgo2-Mad2 interaction could also influence mitotic protein stability by other means. 
For example, it could modulate the other Mad2 interactions with Mad1 or Cdc20 in a 
way that either Mad1 would become unstable or that Cdc20 would be stabilized. 
The hypothesis was tested by comparing protein stability in control cells to that in Sgo2 
depleted cells. Therefore, again a cycloheximide shutoff experiment was carried out in 
nocodazole treated cells. Sgo2 depletion was successful as determined by 
immunoblotting. However, no change in protein stability could be detected for Mad1 or 
Cdc20 upon Sgo2 depletion compared to the control (Fig. 18). From the above 
experiment, it can be concluded that Sgo2 and hence also its interaction with Mad2 do 
not modulate the stability of either Mad1 or Cdc20 in a SAC arrest. 
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4.2.5. Sgo2 is not required for normal mitotic progression 
In the current literature, there are conflicting data on the importance of Sgo2 in mitosis. 
The Tim Yen laboratory has published experiments showing a strong mitotic phenotype 
characterized by a significantly prolonged mitosis (about 3-fold) upon Sgo2 depletion by 
siRNA (Huang et al., 2007). This phenotype has been attributed to a downstream 
mislocalization of the microtubule depolymerizing kinesin MCAK. This in turn was 
proposed to lead to the accumulation of erroneous microtubule-kinetochore attachments. 
These errors, sensed by the tension sensitive SAC, were the authors explanation for the 
mitotic delay. Contrasting results arose from studies on mouse sgo2-/- embryonic 
fibroblasts (MEFs), which did neither show a mitotic delay nor a SAC defect (Llano et 
al., 2008). Yet, this later study suffered from the fact that two closely related Sgo2s are 
expressed in mouse but that only one of the corresponding genes was targeted.  
To resolve the question whether or not Sgo2 influences mitotic timing, the original Yen 
laboratory experiments were revisited. The duration of mitosis was measured in Hela 
cells treated with an siRNA oligo directed against Sgo2 (Huang et al., 2007). If Sgo2 
played a role in mitotic spindle formation, a prolonged mitosis would be expected. 
However, live cell imaging data show comparable mitotic timing of about 30 min from 
nuclear envelope breakdown (NEBD) to anaphase onset for both control and Sgo2 
depleted cells (Fig. 19A). When cells were additionally challenged with a low dose of 
taxol (10 ng/ml) they responded with a prolonged mitosis, as expected. Also under these 
conditions, Sgo2 depletion had no significant effect on the duration of mitosis (Fig. 19B). 
Another phenotype reported by Yen and coworkers was a significant increase in the 
percentage of cells undergoing anaphase with lagging chromosomes (about 40% upon 
Sgo2 depletion compared to 10% in control cells). This finding could also not be 
reproduced. Both control cells as well as Sgo2 depleted cells showed slightly less than 
20% of aberrant anaphases (lagging chromosomes or chromatin bridges, Fig. 19C). 
Depletion of Sgo2 was greater than 90% and thus comparable to the level achieved by 
Huang et al. (2007). The observed results were validated by showing highly efficient 
Sgo2 depletion by immunoblotting (Fig. 19D). 
It could not be resolved why the results shown here strongly contradict previously 
published findings from the Yen laboratory. One possible reason could be variations 
between different lines of Hela cells which had been cultivated independently for many 
years. Nevertheless, similar results were also obtained with HCT-116 human colon 
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cancer cells (data not shown). In summary, the results presented here strongly argue 
against an overt role of Sgo2 in mitotic progression in human cancer cells. 
 
 
 
 
Fig. 19: Sgo2 is dispensable for normal mitotic progression in human cultured cells. (A)-(D) 
Cells were treated with control or Sgo2 siRNA (40 nM) for a total of 55 h. Live cell imaging was 
performed following release from a single thymidine block. (A and B) Hela cells were imaged by 
phase contrast microscopy at a time resolution of 5 min per frame. Duration of mitosis was 
determined as the time interval between the first signs of cell rounding and initiation of cleavage 
furrow ingression. Error bars show standard deviation. Cells were cultured either in (A) DMEM 
or in (B) DMEM with 10 ng/ml taxol. (C) Hela cells stably expressing histone 2B-eGFP were 
imaged using fluorescence microscopy. (D) Sgo2 depletion efficiency was determined semi-
quantitatively by immunoblotting of different amounts of lysate. Detection of tubulin served as a 
loading control. Number of cells counted per data point: (A) n>100, (B) n>70, (C) n>60. 
A B 
C D 
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4.3. The Sgo2-Mad2 complex resembles the SAC complexes Mad1-Mad2 
 and Cdc20-Mad2 
4.3.1. The Sgo2-Mad2 complex can be isolated from living cells 
So far, only yeast-2-hybrid data were available to demonstrate the Sgo2-Mad2 interaction 
for human proteins. Considering the lack of obvious mitotic phenotypes, further proof 
was required to demonstrate the specificity of the interaction. Therefore, it was tested 
whether Sgo2 and Mad2 also interacted at the level of endogenous proteins in human cell 
culture. Lysates were prepared from nocodazole arrested 293T cells and Sgo2 was 
immunoprecipitated using a specific antibody. Non-specific IgG was used as a negative 
control. By immunoblotting, Mad2 could be specifically found in the Sgo2 immuno-
precipitate (I.P.) but not in the control (Fig. 20A). Thus, Mad2 binds Sgo2 in human 
cells.  
 
Fig. 20: The Sgo2-Mad2 exists in cells under endogenous conditions. (A) and (B) For each 
sample, 293T cells from 750 cm2 confluent culture dish area were lysed (LP2+ with additional 
250 mM NaCl) and subjected to immunoprecipitation using antibodies directed against Sgo2 (4 
µg) bound to 20 µl of Protein G beads. Non-specific IgG was used as negative control. Samples 
were eluted using SDS-PAGE sample buffer and resolved by SDS-PAGE. Immunoblotting was 
used to detect Sgo2, Mad2 and PP2A. (A) Co-I.P. experiment of endogenous Sgo2 from 
nocodazole arrested cells. (B) The co-I.P. of Sgo2 and Mad2 was compared between interphase 
("I", 15 h treatment with 2 mM thymidine) and mitosis ("M", 15 h treatment with 200 ng/ml 
nocodazole). Detection of the PP2A catalytic subunit (PP2A-C) served as a positive control.  
 
A potential caveat of an interaction between two at least partially chromosome associated 
factors is that the interaction could be bridged via chromatin. This possibility was largely 
excluded by the addition of ethidium bromide at a high concentration (200 µg/ml) to the 
co-I.P. experiment, a method commonly used to displace proteins from DNA (Lai and 
A B 
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Herr, 1992). The Sgo2-Mad2 interaction was stable under these condition, supporting 
that it was not chromatin bridged (Suppl. fig. 3). 
Given the mitosis specific function of Mad2, it was also of interest whether the Sgo2-
Mad2 interaction was confined to mitosis or present also during other cell cycle phases. 
To distinguish between the two possibilities, Hela cells were arrested either in interphase 
(G1/S-transition) using thymidine or in mitosis using nocodazole. Then, interaction 
between Sgo2 and Mad2 was studied by co-I.P. of endogenous Sgo2. In both samples, 
comparable amounts of Mad2 associated with Sgo2. The same was true for the Sgo2-
PP2A interaction (Fig. 20B). In conclusion, Sgo2 and Mad2 interact in a cell-cycle 
independent manner.  
Mad2 is a member of a protein family characterized by the presence of the so-called 
HORMA domain (Aravind and Koonin, 1998; Luo et al., 2000). This domain has been 
identified by sequence analysis in proteins involved in meiosis, DNA repair and the SAC 
and has been named with an acronym using the initials of its founding members (Hop1, 
Rev7 and Mad2). 
 
 
Fig. 21: Mad2 binding to Sgo2 is not a 
common feature of HORMA domain 
containing proteins. 293T cells were 
transfected with plasmids coding for 
tagged versions of Sgo2 (Flag), 
HORMAD2 and Mad2 (both Myc). 
Myc-tagged proteins were affinity 
isolated using anti-Myc beads and 
samples were probed for binding of 
Sgo2 by immunoblotting against the 
Flag-epitope. 
 
 
 
In mouse, two meiosis specific members of the protein family have recently been 
identified, HORMAD1 and HORMAD2 (Fukuda et al., 2009; Wojtasz et al., 2009). 
Interestingly, in metaphase of meiosis I they co-localize with Sgo2. Therefore the 
question had to be resolved whether Sgo2 can interact with HORMA domain containing 
proteins in general or whether the interaction is confined to Mad2. Towards this end, 
either HORMAD2 or Mad2 were co-expressed with Sgo2 in 293T cells. Subsequently, 
HORMAD2 and Mad2 were affinity-isolated from cell lysates and checked for 
associated Sgo2 by immunoblotting (Fig. 21). Sgo2 was specifically detected only in the 
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Mad2 I.P. but not in the HORMAD2 I.P. Thus, Sgo2 binding is not mediated by 
HORMA domains per se but is instead a specific property of Mad2. 
4.3.2. The Mad2 binding site is located between amino acid residues  
 101 and 200 of xSgo1 
A point mutation that disrupts binding is one of the best proofs for specificity of a newly 
found protein-protein interaction. A first step towards finding such a shugoshin mutant 
was the mapping of the Mad2 binding site. 
        
Fig. 22: Mapping of Mad2 binding sites. (A) The Mad2 binding site of Xenopus Sgo1 (xSgo1) 
is located between amino acid 101 and 200. Fragments of xSgo1 (length indicated in amino acid 
residues) fused to the Gal4 transactivating domain (AD) were tested for interaction with Mad2 
fused to the Gal4 DNA binding domain (DBD) in a yeast-2-hybrid assay. Equal amounts of three 
independent clones were spotted for each construct on either YPD (input control) or SC-Leu-Trp-
His ("Sel.", selective medium for interaction) (B) The N-terminal 250 amino acid residues of 
human Sgo2 (hSgo2) are sufficient for Mad2 binding. The indicated AD and DBD fusions were 
tested for auto-activation and specific interaction in a yeast-2-hybrid assay. Full-length Sgo2 
served as positive control. 
 
A 
B 
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To this end, fragments of about 100 a.a. covering the whole length of xSgo1 were tested 
in a yeast-2-hybrid-assay for interaction with Mad2 (Fig. 22A). Only a fragment 
encoding a.a. 101-200 of xSgo1 showed growth on selective medium when Mad2 was 
simultaneously expressed, indicating that this N-terminal part of xSgo1 harbors the Mad2 
binding site. It was further of interest whether Mad2 binding to the N-terminus of the 
shugoshin partner was evolutionary conserved. Therefore it was tested if an N-terminal 
250 amino acid fragment of hSgo2 retains the ability to interact with Mad2 (Fig. 22B).  
 
         
Fig. 23: The Mad2-D10 mutant is interaction deficient for Sgo2. (A) Co-I.P. experiment: 
293T cells were transfected with plasmids encoding Flag-Sgo2 as well as Myc-tagged Mad2-wt 
or Mad2-D10. Sgo2 was immunoprecipitated from cell lysates with anti-Flag agarose. Beads 
were washed and then eluted with SDS-PAGE sample buffer. Following SDS-PAGE, tagged 
proteins were visualized by immunoblotting as indicated. (B) Yeast-2-hybrid experiment: 
S. cerevisiae strain PJ69-4A was transformed with the indicated plasmids. Yeast suspensions of 
positive transformants were plated either on SC-Leu-Trp plates (control for comparable cell 
numbers) or on SC-Leu-Trp-His plates (selection for protein-protein interaction). Note that single 
constructs did not show non-specific growth, i.e. auto-activation. 
 
While none of the constructs gave rise to false-positive signals on their own, co-
transformation of 2-hybrid vectors coding for Mad2 and Sgo21-250 enabled growth on 
A 
B 
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selective medium. The interaction between full-length Sgo2 and Mad2 served as a 
positive control. Therefore, also in the human system, the N-terminus of the Mad2-
binding Sgo2 is sufficient for interaction. 
4.3.3. Only Mad2 in its closed conformation can bind to Sgo2 
The interactions of Mad2 with Mad1 and Cdc20 have been characterized in great detail 
and, surprisingly turned out to be highly similar (Luo et al., 2000; Sironi et al., 2002). 
This raised the question whether the newly identified Sgo2-Mad2 complex might also 
share mutual aspects of Mad1-Mad2 and Cdc20-Mad2. A series of Mad2 mutants have 
been identified that compromise its function. One example is a deletion of 10 amino acid 
residues from its C-terminus (Fang et al., 1998) which renders the resulting Mad2-D10 
unable to interact with Mad1 and Cdc20 (Chen et al., 1999; Sironi et al., 2001). This is 
because Mad2-D10 is permanently locked in its "open" comformation (Luo et al., 2004). 
If the Sgo2-Mad2 interaction resembled the known complexes of Mad2, then Sgo2 
should be unable to interact with Mad2-D10. The question was first resolved by a co-I.P. 
experiment. 293T cells were transfected with plasmids encoding tagged versions of Sgo2 
along with wild-type Mad2 (Mad2-wt) or Mad2-D10. When Sgo2 was affinity isolated 
from cell lysates, only co-transfected Mad2-wt but not Mad2-D10 was found to be 
associated (Fig. 23A). In a negative control, no unspecific binding of transiently 
expressed Mad2-wt to the affinity matrix was detected.  
Therefore, quite similar to the known Mad2 interactions, the newly identified Sgo2-
Mad2 complex does not form when Mad2 is constitutively locked in the "open" 
conformation. The same conclusion could be drawn from a yeast-2-hybrid assay. Also in 
this system, specific interaction between Sgo2 and Mad2-wt but not Mad2-D10 could be 
observed (Fig. 23B). 
4.3.4. Mad2 phosphorylation is incompatible with Sgo2 binding 
Once a functional mitotic spindle has assembled, the SAC is switched off to allow cells 
to exit from mitosis. Among other mechanisms, phosphorylation of Mad2 has been 
suggested as a negative regulator of the SAC (Wassmann et al., 2003a). In the same 
study, a mutant version of Mad2 has been described, in which 3 serine/threonine residues 
are mutated to either aspartate or alanine residues in order to mimick a constitutively 
phosphorylated or de-phosphorylated state, respectively. The phosphorylation mimicking 
mutant lost binding to Mad1 while the alanine mutant retained full Mad1 binding 
capacity.  
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Again, the question arose whether the Mad2 phosphorylation site mutants would show 
similar behavior towards the new interactor Sgo2. Since the kinase Plk1 has been 
implicated in Mad2 regulation (Katja Wassmann and Olaf Stemmann, personal 
communications) two additional mutations in Plk1 consensus motifs were introduced 
(Mad2-5xD or Mad2-5xA). 
 
 
 
Fig. 24: A phosphorylation mimicking mutant of Mad2 does not bind to Sgo2. (A) In vitro 
pulldown assay: 10 µg recombinant MBP-xSgo11-207 were bound to 10 µl of amylose resin prior 
to incubation with 5 µg each of either His6-tagged recombinant Mad2-wt, Mad2-D10, Mad2-5xD 
or Mad2-5xA. After washing, proteins that eluted upon boiling of the beads in 50 µl SDS-PAGE 
sample buffer were analyzed by SDS-PAGE and Coomassie staining. (B) Co-I.P. experiment: 
293T cells were transfected with the indicated combinations of plasmids. Anti-Flag agarose 
beads were used to affinity purify Flag-tagged Sgo2 and associated proteins. SDS eluates were 
resolved by SDS-PAGE and analyzed by imunoblotting against the Flag-(Sgo2) and Myc-(Mad2) 
epitopes. 
 
First, the mutants were tested in an in vitro pulldown assay. Therefore, Mad2-wt, Mad2-
5xD, Mad2-5xA and, as a negative control, Mad2-D10 were expressed as His6-tagged 
proteins in E. coli and purified. A recombinant N-terminal fragment of Xenopus laevis 
Sgo1 (xSgo11-207) was immobilized on beads and incubated with the different versions of 
Mad2. Material bound to the beads was analyzed by SDS-PAGE and Coomassie staining 
(Fig. 24A). As expected, Mad2-wt interacted with xSgo1 (positive control) while the 
A 
B 
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Mad2-D10 mutant did not bind (negative control). Interestingly, no binding was 
observed for Mad2-5xD while Mad2-5xA bound to xSgo1 with wild-type characteristics.  
A similar finding for human Sgo2 (hSgo2) could be obtained using co-I.P. experiments 
performed on lysates from transfected 293T cells (Fig. 24B). When hSgo2 was 
immobilized on beads, only co-transfected Mad2-wt and Mad2-5xA bound while Mad2-
5xD did not. 
Hence, mimicking phosphorylation of Mad2 negatively influences its binding to Sgo2. 
This is a similar binding behavior as it has been observed for the Mad1-Mad2 as well as 
for the Cdc20-Mad2 interaction by Wassmann et al. (2003a). Given that one of the 
mutated residues lies within the C-terminal safety belt, it is conceivable that 
phosphorylation induces Mad2 to adopt an open conformation. 
4.3.5. xSgo1 and Cdc20 compete for Mad2 binding 
If complex formation between shugoshin and Mad2 resembled the known checkpoint 
complexes like Cdc20-Mad2, then also the binding site on Mad2 should be the same. If 
this really were the case then Mad2 should not be able to bind xSgo1 and Cdc20 at the 
same time. Towards an experimental test of this hypothesis, an in vitro pulldown assay 
was performed. Recombinant xSgo1, Cdc20 and Mad2 carrying three different tags were 
mixed and incubated to allow binding. Subsequently, in separate pulldown experiments 
each of the factors was immobilized on beads via its specific affinity tag. When Mad2 
was immobilized (Ni2+-NTA pulldown), both Cdc20 and xSgo1 could interact (Fig. 25), 
a result still consistent with mutually exclusive binding or a trimeric complex.  
However, when xSgo1 (Amylose pd.) or Cdc20 (GSH pd.) were bound to beads, only 
Mad2 was found in the eluate. The fact that the respective other Mad2 interactor could 
not be identified in both cases showed that xSgo1 and Cdc20 bind to Mad2 in a mutually 
exclusive manner. 
The result is consistent with xSgo1 and Cdc20 occupying the same or a similar binding 
site on Mad2. Strictly, from this experiment it cannot be excluded that the two factors 
each induce conformational changes of Mad2 that prevent binding of the other interactor. 
However, this second hypothesis could be ruled out by a 2D-NMR experiment shown in 
chapter 4. 
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Fig. 25: Binding of Cdc20 and xSgo1 to Mad2 is mutually exclusive. In vitro binding assay: 
for each sample, recombinant MBP-xSgo11-207 (10 µg), GST-Cdc20 (5µg) and His6-Mad2 (5 µg) 
were incubated for 4 h at 4°C. An input sample was directly mixed with SDS-PAGE sample 
buffer. For the pulldown assays, either 10 µl each of Ni2+-NTA agarose, amylose or 
glutathione(GSH)-sepharose beads (10 µl) were added for 1 h. After washing the beads, all 
bound proteins were eluted with SDS-PAGE sample buffer. The figure shows a Coomassie 
stained SDS-PAGE gel of the samples. 
 
4.3.6. A conserved putative Mad2 binding motif in xSgo1 and hSgo2 
For both Mad1 and Cdc20, the Mad2 binding sites have been mapped. Interestingly, 
Mad1 as well as Cdc20 contain a well conserved motif of four amino acids which is 
required for the interaction with Mad2 (Hwang et al., 1998; Luo et al., 2000; Luo et al., 
2002). In the solved crystal structure of the Mad1-Mad2 complex, the Mad2 interacting 
motif (MIM) of Mad1 is in close contact with residues of Mad2 including those of the C-
terminal safety belt (Sironi et al., 2002)(see also Fig. 26B). 
Considering the similarities of complex formation, it was possible that also Mad2 
binding to Sgo2 was mediated by a MIM. Sequence alignments were carried out 
comparing the known MIMs with amino acid residues 101-200 of xSgo1, to which Mad2 
binding had been mapped (see chapter 4.3.2). Indeed, a short conserved stretch 
comprising four characteristic MIM residues was identified in xSgo1 (a.a. 168-171). 
Additionally, this sequence was followed by a proline residue, which also occurs 
downstream of most known MIMs (Luo et al., 2002). Next, it was tested whether the 
MIM was conserved between Mad2 binding shugoshin proteins. Using an alignment of 
the N-termini of xSgo1 and hSgo2, a potential MIM could be located in hSgo2 (a.a. 151-
154) (Fig. 26A). This raised the possibility that the shugoshin-Mad2 interaction is 
mediated by a motif similiar to the ones present in Mad1 and Cdc20.  
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Fig. 26: A conserved putative Mad2 interacting motif (MIM) in X. laevis Sgo1 and H. 
sapiens Sgo2. (A) Sequence alignment of MIMs from human and X. laevis Mad1 and Cdc20 as 
well as xSgo1 and hSgo2. (B) Modified ribbon visualization of the hMad1-hMad2 crystal 
structure (Sironi et al., 2002) showing Mad2 in shades of red and a Mad1 fragment in shades of 
blue. The safety belt of Mad2 is drawn in dark red while the MIM is colored in dark blue.  
 
A comparison of the Sgo1 and Sgo2 protein sequence shows that the MIM sequence 
present in Sgo2 is not well conserved in Sgo1 (data not shown). This result is consistent 
with the finding that Sgo1 is not a Mad2 interactor (see chapter 4.1.7). 
4.3.7. The MIM is required for Mad2 binding to hSgo2 
The MIM of known SAC factors Mad1 and Cdc20 is essential for their function. For 
example Cdc20 mutants leading to SAC deficiency have been mapped to its MIM 
(Hwang et al., 1998). In addition, mutations in the MIMs of Mad1 or Cdc20 abolished 
Mad2 binding (Luo et al., 2002). If the putative MIM sequence in Sgo2 would be the 
critical determinant for Mad2 binding then mutations within this motif should interfere 
with Mad2 binding. To test this hypothesis, a conserved arginine residue within the 
hSgo2 MIM (R153) was changed to alanine using site-directed mutagenesis of the Sgo2 
coding DNA sequence. To test the mutant binding capacity, first a co.I.P. experiment was 
carried out. Towards this end, 293T cells were depleted from endogenous Sgo2 using 
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siRNA and at the same time siRNA resistant versions of wild-type Sgo2 or the MIM 
mutant Sgo2-R153A were overexpressed together with HA-tagged Mad2. Sgo2 was 
immunoprecipitated from cell lysates using a specific antibody.  
 
 
Fig. 27: Mutation of the Sgo2 MIM strongly reduces its interactions with Mad2. (A) 293T 
cells were co-transfected with Sgo2 siRNA and plasmids coding for HA-Mad2 along with wild-
type or R153A mutant Sgo2. Sgo2 was affinity-isolated from cell lysates (LP2+ with additional 
200 mM NaCl) using an anti-Sgo2 antibody. Precipitated proteins were eluted with SDS-PAGE 
sample buffer, resolved on an SDS-PAGE gel and analyzed by immunoblotting with anti-Sgo2, 
anti-HA (transfected Mad2) and anti-Mad2 antibodies. (B) In a yeast-2-hybrid assay, the 
indicated DBD or AD fusion constructs were transformed into the S. cerevisiae strain PJ69-4A. 
Comparable amounts of positive transformants were spotted either on SC-Leu-Trp agar plates 
(spotting control) or on SC-Leu-Trp plates (selective medium for interaction) and incubated at 
30°C for the indicated periods of time. (C) Yeast cells transformed with the indicated constructs 
(Mad2: DBD-Mad2, Sgo2: AD-Sgo2) were grown over night in SC-Leu-Trp liquid cultures. 
Whole cell lysates were analyzed by SDS-PAGE and immunoblotting using antibodies against 
the Gal4 AD or DBD tags.  
 
The degree of Mad2 binding was measured by immunoblotting for the HA-tag as well as 
for endogenous Mad2 (Fig. 27A). Both Sgo2 constructs were expressed at comparable 
levels but in the I.P. samples much less Mad2 was detected bound to the R153A mutant 
compared to wild-type Sgo2. Therefore, Sgo2 contains a functional MIM that enables its 
interaction with Mad2. 
A 
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This finding was further supported by a yeast-2-hybrid experiment using N-terminal 250 
a.a. fragments of hSgo2 containing the MIM (Fig. 27B). Wild-type Sgo2 and Sgo2-
R153A were compared for their ability to interact with Mad2. After 3 days, wild-type 
Sgo2 but not Sgo2-R153A allowed for growth on selective medium. All constructs were 
expressed at equal levels as determined by Western blotting (Fig. 27C). It should be 
mentioned that at later time points also for the R153A mutant growth was detected, 
which could have been caused by residual binding (data not shown).  
One possible, undesirable explanation could be that the R153A mutation affected the 
global protein structure of Sgo2 or at least of its N-terminus. To exclude this possibility, 
binding of another N-terminal Sgo2 interactor, PP2A was determined in the yeast-2-
hybrid assay (Fig. 27B). Both wild-type Sgo2 and the R153A mutant gave rise to growth 
on selective medium in combination with PP2A-B'delta. Therefore, the R153A mutation 
specifically affects Mad2 binding and does neither interfere with expression levels of 
Sgo2 nor with PP2A binding to Sgo2. This indicates that the R153A amino acid 
exchange is compatible with structural integrity of Sgo2. 
4.3.8. Sgo2 binding induces a global confomational change of Mad2 
The structure of Mad2 has been visualized in 2D NMR spectra, in which chemical shift 
peaks can be assigned to distinct amino acid residues (Luo et al., 2000). When a 15N 
labeled version of Mad2 is used, an unlabeled peptide can be titrated in to perform 
binding studies using a 1H-15N-HSQC experiment. The resulting changes of chemical 
shifts in the 2D spectrum give an indication as to which amino acids are involved in the 
protein-protein interaction. In a previous study, unbound Mad2 was compared to Cdc20 
bound Mad2 in 2D-NMR. There, many chemical shifts changed, indicating a global 
structural change of Mad2 (Luo et al., 2000). This has been attributed to a switch of 
Mad2 from its open into the closed conformation upon Cdc20 binding. Furthermore, 
comparative 2D-NMR has been used to demonstrate similar changes of chemical shifts 
upon formation of Mad1-Mad2 and Cdc20-Mad2 complexes and, hence, similar binding 
modes for both (Luo et al., 2002). Binding behavior of Mad2 mutants to shugoshin 
suggested that there might be a similarity in complex formation compared to Cdc20-
Mad2 or Mad1-Mad2 (see above). Since this should also be reflected in the 2D-NMR 
spectrum, binding of either a Mad1 peptide or a xSgo1 peptide to Mad2 was studied in 
collaboration with the laboratory of Tad Holak (MPI for Biochemistry, Martinsried). 
Reproducing the original finding (Luo et al., 2000), global structural rearrangements 
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were detected for binding of Mad2 to a Mad1 peptide (Fig. 28A). Strikingly, when an 
xSgo1 peptide harboring the Mad2 binding site was titrated to Mad2, highly similar 
changes of the 2D-NMR spectrum were observed (Fig. 28B). Formation of the Sgo2-
Mad2 complex is therefore comparable to that of the well characterized Mad1-Mad2 
complex. The 2D-NMR data strongly suggest that Mad2 undergoes a structural 
rearrangement from open to closed conformation upon association with shugoshin. 
Furthermore, strong splitting of NMR peaks during titration indicated a high binding 
affinity of xSgo1 and Mad2 (estimated KD < 1 µM).  
 
 
    
Experiment performed by U. Rothweiler and T. Holak 
 
Fig. 28: Similar amino acid residues of Mad2 are involved in binding of Mad1 and xSgo1 
peptides. His6-Mad2 expression was performed in minimal medium with [15N]ammonium 
chloride as the only nitrogen source and purified as described in the Methods section. For the 
NMR experiments, protein concentrations of 0.2 mM Mad2 in PBS containing 10% D2O were 
used. (A) Mad1 peptide (Sequence: TKVIHLSLN) was added in 4 steps to the Mad2 protein 
solution leading to a molar ratio of: 2.5:1;  1,25:1;  0.8:1; 0.2:1 Mad2:Mad1; red: reference 
spectrum; green: 1,25:1, blue: final step) (B) xSgo1 peptide (Sequence: SAILRLPIH) was added 
in 4 steps to the Mad2 protein solution leading to a molar ratio of: 2.5:1;  1,25:1;  0.8:1;  0.2:1 
Mad2:Mad1; red: reference spectrum; yellow: 2.5:1; green: 1,25:1, blue: final step). Note that 
some of the final peak positions upon titration might differ due to different compositions of the 
peptides and hence different chemical environents. 
 
4.3.9. p31 binding to Sgo2 is modulated by Mad2 levels 
p31 has been described as a factor contributing to inactivation of the SAC. Its mechanism 
of action involves the binding to a preformed Mad1-Mad2 complex. This in turn blocks 
the catalysis of Mad2 conformational activation. Importantly, only Mad2 in the closed 
conformation, i.e. bound to Mad1 or Cdc20, is a cognate binding partner for p31 (Xia et 
al., 2004; Yang et al., 2007). This qualifies p31 as a molecular probe for detection of 
closed Mad2. If Sgo2 bound Mad2 were indeed in the closed conformation, then Sgo2 
should be able to interact with p31 in the cellular context. To test this hypothesis, binding 
A B 
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was tested in a co-I.P. experiment using lysates from 293T cells transfected with 
plasmids coding for Myc-Sgo2 and Flag-p31 or with a Flag-p31 plasmid alone (negative 
control). When Sgo2 was bound to beads, co-I.P. of p31 could be detected while in the 
control only a very weak signal for p31 was observed (Fig. 29A). 
 
 
 
Fig. 29: p31 interaction strength with Sgo2 correlates with Mad2 levels. (A)-(C) 293T cells 
were transfected with plasmids coding for Sgo2 (Myc-tag), p31 (Flag-tag) or Mad2 (HA-tag). 
Myc-Sgo2 (A) or Flag-p31 (B and C) was isolated from cell lysates by bead-coupled epitope 
specific antibodies (10 µl beads per sample). Detection was carried out by immunoblotting for 
the epitope tags or for endogenous Mad2 (A)-(C). (C) When indicated, control (GL2) or Mad2 
siRNA was transfected along with the plasmids using the calcium phosphate method (Final 
concentration of dsRNA oligo in the culture medium: 50 mM). Densitometric measurements of 
Western blots referenced to the GL2 control were performed to measure relative amounts of 
Sgo2 and Mad2. 
 
p31 is therefore able to interact with Sgo2. Considering the known p31 complexes, it was 
assumed that Sgo2-p31 interaction was bridged via Mad2. If this were the case, then 
changing the levels of Mad2 should proportionately affect Sgo2-p31 binding. This was 
tested by two different approaches. (1) Mad2 overexpression: in a co-I.P. experiment, 
p31 was immobilized on beads and binding of Sgo2 was determined by immunoblotting. 
When the experiment was performed with lysates from cells overexpressing Sgo2, p31 
and Mad2, the Sgo2-p31 interaction was enhanced compared to samples without 
concomitant Mad2 overexpression (Fig. 29B). (2) Mad2 depletion: to study the effect of 
A B 
C 
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decreased Mad2 levels on the Sgo2-p31 interaction, cells were transfected either with 
control (GL2) or Mad2 siRNA along with the plasmids. Decreased Mad2 levels were 
observed upon Mad2 siRNA transfection in the input sample, confirming successful 
RNA interference (Fig. 29C). As expected, less Mad2 (approx. 3-fold) was associated 
with p31 in the Mad2 siRNA sample compared to the GL2 control. At the same time, 
about twofold less Sgo2 was bound to p31 upon Mad2 depletion (Fig. 29C). In 
conclusion, Mad2 overexpression and depletion experiments are consistent with a hetero-
trimeric Sgo2-Mad2-p31 complex in which Sgo2 and p31 interact only indirectly via 
Mad2 in the closed conformation. The complex very likely comprises a direct Mad2-p31 
interaction, indicating that Sgo2 bound Mad2 is in its closed conformation.  
4.3.10. xSgo1 forms a trimeric complex with Mad2 and PP2A in vitro 
PP2A binding (N58, Fig. 9) and Mad2 binding (R153, Fig. 27) have been mapped to 
closely juxtaposed positions within Sgo2's primary sequence. Two scenarios can be 
envisioned: first, both binding partners are able to interact at the same time on one Sgo2 
molecule. Second, steric constraints allow binding of either Mad2 or PP2A but not of 
both.  
Fig. 30: xSgo1 can bind to Mad2 and 
PP2A at the same time. 5 µg of His6-
Mad2 (wt or D10 mutant) were 
immobilized on 10 µl of Ni2+-NTA 
agarose. To these, 100 µl of cell extract 
from Myc-PP2A-B'delta overexpressing 
293T cells were added in the presence or 
absence of 10 µg MBP-xSgo11-207. 
Following incubation and extensive 
washing of the beads, immobilized 
proteins were eluted with SDS-PAGE 
sample buffer and analyzed by SDS-
PAGE. Mad2 and xSgo1 were visualized 
by Coomassie staining, while PP2A-
B'delta was detected by immunoblotting 
using anti-Myc antibodies. 
 
To distinguish between the two models, in vitro pulldown experiments were performed. 
The following proteins were used: hMad2 and an N-terminal xSgo1 fragment were 
purified from bacterial expression cultures, while a lysate of 293T cells overexpressing 
Myc-tagged PP2A-B'delta served as a source of PP2A. First, Mad2 was immobilized on 
beads and incubated with PP2A alone. No binding of PP2A to Mad2 was detected (Fig. 
30). Consistently, no interaction between the two proteins has been described in the 
wt 
D10 
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literature. However, when immobilized Mad2 was incubated with PP2A and xSgo1 
together, both proteins were found in association with Mad2. Binding of xSgo1 to Mad2 
was specific, since it was strongly reduced for the binding deficient Mad2-D10 mutant.  
This finding is most consistent with a model, in which the interaction of PP2A with 
Mad2 is bridged by xSgo1. Furthermore, it implies that xSgo1 can interact with both 
Mad2 and PP2A simultaneously. 
4.3.11. Sgo2 can form multimers 
A common characteristic of shugoshin familiy members is the presence of a coiled-coil 
region at their N-termini (Kerrebrock et al., 1995; Rabitsch et al., 2004). In many cases, 
coiled-coil regions mediate protein-protein interactions, such as homodimerization or 
formation of higher multimers.  
 
Fig. 31: Sgo2 interacts with itself. 293T cells were transfected with plasmids encoding Flag-
tagged and/or Myc-tagged Sgo2. Following an anti-Flag-I.P. from cell lysates, beads were eluted 
with SDS-PAGE sample buffer. The samples were separated on an SDS-PAGE gel and analyzed 
by immunoblotting using antibodies directed against the Flag- and Myc-epitopes. 
 
To clarify whether Sgo2 might also interact with itself, a co-I.P. experiment was carried 
out using as a starting material transfected 293T cells expressing Flag- and Myc-tagged 
Sgo2 either together or individually. When anti-Flag beads were used for the I.P., Myc-
Sgo2 could only be co-precipitated when Flag-Sgo2 was bound to the beads (Fig. 31). 
Therefore, human Sgo2 exhibits self-interaction. Whether it forms just homodimers or 
higher order multimers could not be resolved in this experiment. This result is consistent 
with a previous publication reporting that the only Drosophila shugoshin, Mei-S332, 
does also interact with itself (Tang et al., 1998). 
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4.4. Regulation of the Sgo2 subcellular localization 
4.4.1. Localization pattern of Sgo2 during mitosis 
Both in mitosis and in meiosis II, a change of Sgo2 localization has been observed 
(Gomez et al., 2007; Huang et al., 2007). While at centromeres throughout prometaphase, 
Sgo2 switches to the kinetochore as the cell reaches metaphase. In order to determine the 
subcellular localization pattern of Sgo2 in more detail, immunofluorescence microscopy 
was carried out using co-staining of Hec1 to visualize outer kinetochores (Fig. 32). 
Consistent with previous reports (Huang et al., 2007), localization to the centromere in 
prometaphase as well as to the kinetochore in metaphase could be reconciled. In 
interphase, Sgo2 displayed a diffuse nuclear localization (data not shown).  
 
 
Fig. 32: Sgo2 localization pattern in mitosis. Asynchronous Hela cells growing on glass 
coverslips were fixed with formaldehyde and stained with antibodies against Sgo2 (green) and 
the outer kinetochore marker Hec1 (red). DNA was counterstained with Hoechst 33342. Cell 
cycle phases were determined by chromatin morphology. The panels on the right show single 
kinetochore pairs at higher digital magnification. Scale bars are 8 µm for low magnification 
images and 1 µm for high magnification images. 
 
When the first punctate Sgo2 localization could be observed, which presumably occurred 
in late G2 phase, interestingly, it partially colocalized with the kinetochore marker 
protein Hec1. This early recruitment of Sgo2 to the kinetochore has not been observed 
before. The reported concentration at centromeres took place only later, in prophase and 
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prometaphase. Thus, as cells progress from G2 via prophase into metaphase, Sgo2 travels 
from kinetochores to centromeres and back. 
4.4.2. Microtubule attachment promotes Sgo2 relocalization 
Relocalization of Sgo2 in metaphase has been attributed to spindle forces pulling it away 
from centromeres and towards kinetochores (Gomez et al., 2007). Formally, other traits 
of metaphase could be responsible for the change of localization. Specifically, it was 
tested whether microtubule attachment to kinetochores is sufficient for Sgo2 
relocalization or whether sister kinetochores also have to be under tension. To answer 
this question, Hela cells were treated with different spindle poisons and the subcellular 
localization of Sgo2 was determined by immunofluorescence microscopy (Fig. 33). 
 
 
Fig. 33: Sgo2 partially translocates to kinetochores upon microtubule attachment. Hela cells 
were treated with Nocodazole or Taxol (200 ng/ml each) for 6h, then fixed and stained with 
antibodies directed against Sgo2 (green, S) and Hec1 as a kinetochore marker (red, H). DNA, 
labeled with Hoechst 33342 staining is shown in blue (D). The panels on the right show single 
kinetochore pairs at higher digital magnification. Scale bars are 8 µm for low magnification 
images and 0.5 µm for high magnification images. 
 
When cells were treated with nocodazole to depolymerize microtubules, Sgo2 localized 
to the centromere reminiscent of the prometaphase situation. In taxol treated cells Sgo2 
was frequently found at the kinetochores while a fraction was still retained at 
centromeres. Taxol allows chromosome attachment to the mitotic spindle but inhibits 
spindle dynamics and hence tension across the centromeres. Consequently, this result 
shows that attachment alone is, at least in part, sufficient for Sgo2 relocalization to the 
kinetochores. 
 
4.4.3. Sgo2 mutants localize correctly in mitotic human cells 
As direct interactors of Sgo2, PP2A and Mad2 might influence its dynamic localization 
during mitosis. To test this possibility, recombinant PP2A and Mad2 binding deficient 
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mutants were compared to wild-type Sgo2 in their ability to replace the endogenous 
protein. To this end, Hela cells were first transfected with corresponding siRNA (Fig. 
34A, compare "Ctrl" and "Sgo2 RNAi"). Then, cells were transfected with one of 
different Sgo2 "rescue plasmids", in which the Sgo2 coding sequence had been altered to 
introduce four silent point mutations in the stretch targeted by the siRNA. Since RNAi 
requires a precise match, the rescue constructs were resistant to the respective siRNA 
oligo. Using this approach, wild-type and mutant (N58I or R153A) Sgo2s could be 
compared in terms of their subcellular localization by immunofluorescence microscopy 
(Fig. 34A). Cells transfected with rescue constructs could be easily identified since the 
vector used (pBOS SR-eGFP) also coded for soluble GFP. In nocodazole arrested cells, 
all three Sgo2 versions localized properly, i.e. to a single dot (green) in between Hec1-
labeled kinetochores (red). 
Therefore, neither binding of PP2A to Sgo2 nor its interaction with Mad2 are required 
for the characteristic centromeric localization of Sgo2 in prometaphase.  
Huang et al. (2007) observed a delay in mitosis upon Sgo2 depletion. The defect was 
related to mislocalization of the microtubule depolymerase MCAK. In this work, Sgo2 
could be depleted from human cells without much effect (see section 4.2). An immediate 
question was whether at least MCAK mislocalization in response to lack of Sgo2 could 
be reproduced. To test this, Hela cells were depleted of Sgo2 as before and the 
localization pattern of MCAK was determined by immunofluorescence microscopy (Fig. 
34B). In wild-type cells ("Ctrl") MCAK signals gave a punctate pattern. Individual dots 
being surrounded by two Hec1 signals indicated proper centromeric localization of 
MCAK. In the absence of Sgo2 ("Sgo2 RNAi"), only a diffuse cytoplasmic signal for 
MCAK was observed. Thus, the dependence of MCAK localization on Sgo2 could be 
reproduced. The MCAK mislocalization phenotype was indeed a specific effect, since it 
could be rescued by expression of wild-type Sgo2 in trans ("Sgo2 RNAi+Sgo2 wt"). 
In addition, the dependence of MCAK localization on binding of Mad2 or PP2A to Sgo2 
was studied (Fig. 34B). Especially PP2A was an interesting candidate, since the 
phosphorylation status of MCAK can affect its localization to chromosomes (Zhang et 
al., 2007). However, the Mad2 ("R153A") and PP2A ("N58I") binding deficient mutants 
were both able to functionally replace endogenous Sgo2 in terms of MCAK localization. 
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Fig. 34 (previous page): Analysis of the influence of Mad2 or PP2A binding to Sgo2 on the 
subcellular localization of Sgo2 and MCAK. (A) and (B) An siRNA rescue experiment was 
performed. Towards this end, Hela cells were either mock treated ("Ctrl", transfection reagent 
only) or transfected with siRNA directed against the endogenous Sgo2 mRNA. Then, rescue 
constructs were transfected, expressing wild-type Sgo2 ("wt"), Mad2 binding deficient Sgo2 
("R153A") or PP2A binding deficient Sgo2 ("N58I"). Cells were synchronized by a thymidine-
nocodazole protocol and finally fixed with formaldehyde. (A) Subcellular localization of Sgo2. 
Immunofluorescence staining was done using antibodies against Sgo2 (green) and Hec1 (red, 
kinetochore marker). (B) Subcellular localization of MCAK. Immunofluorescence staining using 
antibodies against MCAK (green) and Hec1 (red). In both (A) and (B) Hoechst 33342 was used 
to label DNA. Cells transfected with rescue constructs or with the empty vector pBOS-SReGFP 
were identified by expression of soluble eGFP. n.d.: GFP fluorescence not determined. Scale bar 
is 8 µm. 
 
In summary, recruitment of MCAK to centromeres is the only detectable function of 
hSgo2 in mitosis. This function is properly executed irrespectively of whether or not 
PP2A or Mad2 can bind to hSgo2. 
4.4.4. The C-terminus of Sgo2 is required for localization 
The protein sequences of shugoshin homologs from differerent species are only weakly 
conserved. The central region is the most divergent while a somewhat better conservation 
is found at the N- and C-termini. Evolutionary conservation is often interpreted as an 
indication of functional relevance. Based on the findings from this work and from others, 
the shugoshin N-terminus is important for mediating protein-protein interactions. 
 
 
Fig. 35: The C-terminus of Sgo2 is required for its centromeric localization pattern in 
mitosis. In an siRNA rescue experiment, Hela cells were depleted from endogenous Sgo2 and 
subsequently transfected with rescue constructs encoding Myc-tagged full-length Sgo21-1265 or a 
C-terminally deleted version, Sgo21-1066. Localization was determined by immunofluorescence 
microscopy. Staining for Hec1 was used as a kinetochore marker. An untransfected cell which 
has been imaged using an equal exposure time for the green channel is shown as a negative 
control for background fluorescence. DNA is shown in blue and was visualized with Hoechst 
33342 stain. Scale bar is 8 µm. 
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In the case of hSgo2 binding of interaction partners like Mad2 or PP2A has been mapped 
to the N-terminal region (see chapter 4.3.2). Nevertheless, binding deficient Sgo2 
mutants still show correct localization to centromeres. The hypothesis arose that Sgo2 
chromatin localization could potentially be a conserved function of the C-terminus for 
the following reasons: the C-terminal conserved region is characterized by abundance of 
basic amino acids, a common feature of DNA binding proteins. In addition, point 
mutations within hSgo1's C-terminal part lead to its mislocalization (Yamagishi et al., 
2008). 
Quite similar, the hSgo2 C-terminus might be important for its recruitment to 
centromeres. To test this hypothesis, the C-terminal 199 amino acids were deleted from 
Sgo2 and the corresponding mutant Sgo21-1066 was compared to the full-length protein 
Sgo21-1265 in terms of centromeric localization (Fig. 35). Sgo2 depletion by siRNA 
combined with the transfection of rescue constructs was used to avoid effects due to 
interaction of endogenous Sgo2 with the truncation mutants (see chapter 4.3.11). While 
Myc-tagged wild-type Sgo2 localized like the endogenous protein, i.e. to centromeres in 
nocodazole arrested cells, Sgo21-1066 was found to be completely cytoplasmic. In 
conclusion, the C-terminal 199 a.a. are required for Sgo2 to be recruited to its 
centromeric binding site. Interestingly, in the presence of endogenous Sgo2, the mutant 
Sgo21-1066 localized properly, i.e. to centromeres (data not shown). This was most 
probably due to homotypic interaction between endogenous wild-type Sgo2 and the 
exogenous deletion construct, supporting functionality of the latter. Furthermore, it is a 
strong indication of multimeric Sgo2 at centromeres in vivo. 
4.4.5. Sgo2 is a predominantly chromatin associated protein 
From the immunofluorescence experiments, chromatin localization of Sgo2 was evident. 
However, no conclusions could be drawn as to the relative distribution between cytosol 
and chromatin. To resolve this issue, lysates from mitotic Hela cells were prepared in the 
presence of increasing salt concentrations and separated into a soluble cytosol (S) and 
insoluble chromatin (C) fraction via centrifugation (Fig. 36). Staining for tubulin and 
core histones as markers for cytosol and chromatin, respectively, confirmed the success 
of this fractionation under all conditions. At lower salt concentrations, Sgo2 was almost 
exclusively recovered in the chromatin fraction. However, beginning at a NaCl 
concentration of 300 mM, Sgo2 was increasingly displaced from chromosomes with 
increasing ionic strength. In this regard, Sgo2 behaved similarly but not identically to 
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Topo II, which could be quantitatively solubilized at 400 mM NaCl. Sgo2 is therefore an 
almost exclusively chromatin associated protein that can be extracted from DNA at 
moderate salt concentrations. 
 
           
Fig. 36: The quantitative association of Sgo2 with mitotic chromosomes is sensitive to salt. 
Hela cells were harvested and processed for chromatin fractionation, as described in the methods 
section. Buffer A was supplemented with the indicated NaCl concentrations. Detection of tubulin 
by Western blot and of core histones by Coomassie staining served as controls for the purity of 
the cytoplasmic and the chromatin bound fraction, respectively. Topoisomerase II was extracted 
at NaCl concentrations between 300 and 400 mM, while Sgo2 was solubilized between 300 and 
500 mM NaCl. 
 
4.4.6. Sgo2 is a mitotic phosphoprotein 
The observed early mitotic relocalization of Sgo2 from kinetochores to the centromere 
correlates in timing approximatly with the activation of mitotic kinases like Cdk1, 
Aurora B or Plk1. In order to test whether Sgo2 might be phosphorylated during mitosis, 
first the Sgo2 migration behavior was analyzed in SDS-PAGE. Phosphorylation of 
proteins often leads to a slower migration in SDS-PAGE due to diminished SDS binding. 
Indeed, Sgo2 from mitotic cells was detected at an apparently higher molecular weight 
compared to Sgo2 isolated from interphase cells (Fig. 37A). To confirm that the upshift 
was due to phosphorylation rather than other post-translational modifications, mitotic 
extracts were treated with Lambda phosphatase. This treatment reverted the apparent 
molecular weight of Sgo2 back to interphase level (Fig. 37A). 
Which kinase contributes to Sgo2 phosphorylation? Aurora B was chosen as a first 
candidate since it had already been implicated in the regulation of Sgo2 and since it 
colocalizes with Sgo2 in prometaphase of mitosis (Huang et al., 2007). Aurora B loss of 
function experiments can easily be performed by specific chemical inhibition (Ditchfield 
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et al., 2003; Hauf et al., 2003). When mitotic Hela cells were treated with Aurora B 
inhibitor for 30 min prior to lysis, Sgo2 migrated faster compared to the control with 
active Aurora B but slightly above interphase level (Fig. 37B).  
In conclusion, Sgo2 becomes phosphorylated during mitosis and this depends at least in 
part on Aurora B.  
 
 
Fig. 37: Sgo2 is phosphorylated in mitosis. (A) Hela cells were synchronized in mitosis or in 
interphase by a 15h treatment with nocodazole or thymidine, respectively. Cell lysates were 
prepared and treated with Lambda phosphatase when indicated. The relative migration behavior 
of Sgo2 was analyzed by SDS-PAGE and subsequent immunoblotting. (B) Cells were treated as 
in (A) but 10 µM ZM447439 was added to the indicated sample 30 min before cell lysis. p-Sgo2 
and pp-Sgo2 denote increasingly phosphorylated Sgo2 species. 
 
4.4.7. Aurora B catalytic activity is required for proper Sgo2 localization 
Aurora B starts to phosphorylate nuclear targets (e.g. Histone H3) in early mitosis (Giet 
and Glover, 2001). This correlates with the first relocalization of Sgo2 from kinetochores 
to centromeres (see chapter 4.4.1). Direct or indirect influence of the Aurora B kinase 
could potentially be responsible for this change of localization. 
 To investigate whether Sgo2 localization is influenced by Aurora B activity, Hela cells 
were synchronized in mitosis with nocodazole and then treated for 30 min with an 
Aurora B inhibitor or the corresponding solvent DMSO as a control. Immuno-
fluorescence staining of control cells ("Ctrl.") revealed in most cases a single Sgo2 
signal, which was located between the two kinetochores (Fig. 38A). Upon Aurora B 
inhibition ("ZM447439"), Sgo2 showed a more diffuse pattern and stretched between the 
two kinetochores. In some cases the signal even split into two dots close to the 
kinetochores, reminiscent of early mitosis or metaphase in unperturbed cells (overall 
mislocalization frequency about 60%, Fig. 38B). 
 
! "
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Fig. 38: Aurora B inhibition leads to premature kinetochore localization of Sgo2. Hela cells 
were arrested in mitosis with nocodazole and collected by shake-off. Cells were then spun on 
coverslips and treated for 30 min with the Aurora B kinase inhibitor ZM4474439 (10 µM) or the 
solvent DMSO (Ctrl.). (A) Immunofluorescence staining showing Sgo2 (green) and the 
kinetochore marker Hec1 (red). DNA stained with Hoechst 33342 dye is labeled in blue. Scale 
bars are 8 µm for low magnification images and 1 µm for enlarged kinetochore pairs. (B) 
Quantitative analysis of Sgo2 localization: correct centromeric localization (one dot) is shown as 
blue bars, diffuse localization including kinetochore signals (stretch/two dots) is shown in red. 
 
Also, the localization of MCAK was analyzed in cells treated with Aurora B inhibitor. 
Very similar to Sgo2, MCAK mislocalized to kinetochores in prometaphase cells (Suppl. 
fig. 4). 
Other studies have so far only used depletion of Aurora B by siRNA to study its impact 
on Sgo2 (Huang et al., 2007). While the loss of Aurora B abrogates Sgo2 chromatin 
localization completely, the short chemical inhibition presented here suggests that 
Aurora B catalytic activity is required to concentrate Sgo2 at the centromere in 
prometaphase.  
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5. Discussion 
5.1. The shugoshin-Mad2 interaction resembles the known SAC 
interactions Mad1-Mad2 and Cdc20-Mad2 
A role of shugoshin family members in the spindle assembly checkpoint has been 
demonstrated in the two yeast species S. pombe and S. cerevisiae (Indjeian et al., 2005; 
Kawashima et al., 2007). Specifically, yeast shugoshin is required for the function of the 
tension sensitive branch of the mitotic SAC. It is dispensable, however, for the 
attachment sensitive branch of SAC.  
So far, only the phenotypes of shugoshin mutant yeast strains have been described. A 
putative involvement of shugoshin homologs in the SAC of higher eukaryotes has not yet 
been studied. Furthermore, it remains enigmatic how yeast shugoshin feeds into the SAC 
signaling pathway at the mechanistic level. 
Shugoshin is conserved in higher eukaryotes: there is one shugoshin homolog in X. laevis 
(xSgo1) and two homologs in humans (hSgo1 and hSgo2). For both xSgo1 and hSgo2 a 
novel interaction with Mad2 was identified (Fig. 13, Fig. 14). This is the first direct link 
between shugoshin and a downstream component of the spindle assembly checkpoint. 
The following reasons argue for the specificity of the shugoshin-Mad2 interaction: (1) it 
is evolutionary conserved, (2) it can be isolated in co-I.P. experiments not only when 
Sgo2 and Mad2 are overexpressed but also at the level of endogenous proteins (Fig. 20, 
Fig. 21), and (3) it can be observed in diverse assays like yeast-2-hybrid (Fig. 14) and in 
vitro pulldown assays using recombinant proteins (Fig. 24). The latter experiment also 
proves that there is a direct interaction between Mad2 and Sgo2 that is not bridged by 
other proteins. 
Mad2 can exist in two distinct native folds, named "open" and "closed". Mad2 
interactions depend on its conformational state. Two types of Mad2 interactions can be 
distinguished: first, Mad2 in its open conformation can interact with Mad2 in its closed 
conformation to form an asymmetric homodimer (Mapelli et al., 2007). Second, Mad2 in 
its closed conformation can not only bind open Mad2 but also a partner that contains a 
Mad2 interaction motif (MIM). Up to now, Mad1 and Cdc20 have been the two only 
known Mad2 binding partners of this kind. 
The shugoshin-Mad2 interaction can be assigned to this second class of closed-Mad2-
MIM interaction. For example, hSgo2 fails to bind to a Mad2 mutant (Mad2-D10) that is 
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locked in its open conformation (Fig. 23). Identical behavior of the Mad2-D10 mutant 
towards Mad1 and Cdc20 has been described (Luo et al., 2000; Sironi et al., 2002). 
Another hint that Sgo2 associated Mad2 is in its closed conformation comes from the 
analysis of the p31 protein, a negative regulator of SAC, which structurally mimics open 
Mad2. It engages with closed Mad2 into a complex very similar to the asymmetric Mad2 
dimer (Yang et al., 2007). However, p31 is unable to bind open Mad2 (Xia et al., 2004). 
Structural data suggest a trimeric complex, in which closed Mad2 bridges p31 and Mad1 
(Yang et al., 2007). During this work a new interaction between p31 and Sgo2 could be 
identified (Fig. 29). The response of p31-Sgo2 complex formation to changing Mad2 
levels was consistent with indirect p31-Sgo2 interaction, i.e. one that is bridged by Mad2. 
Given p31's preference for closed Mad2, this indicates that Mad2 bound to Sgo2 is in the 
closed conformation.  
The Mad2 binding proficient shugoshin contains a conserved Mad2 interaction motif 
(MIM) both in X. laevis and in H. sapiens (Fig. 26). A point mutation (R153A) within 
the MIM of hSgo2 leaves shugoshin intact in terms of expression levels, cellular 
localization, ability to recruit MCAK and interaction with itself or PP2A (Fig. 27, 34, 
Suppl. fig. 5 and data not shown). All this indicates that the amino acid exchange has no 
gross effect on structure. Yet, the corresponding mutant is largely compromised in Mad2 
interaction demonstrating that the MIM in shugoshin is functional and constitutes an 
important determinant of Sgo2's affinity for Mad2. 
Nevertheless, this single point mutation does not completely abolish association of Sgo2 
with Mad2 (Fig. 27). The residual binding could be due to the mutation leaving the MIM 
partially intact. This is unlikely since supposedly stronger MIM mutants were also tested 
and they, too, retained partial Mad2 binding ability. For example, no additional 
weakening of Mad2 binding was observed for Sgo2-4xAla (positions 150-153) compared 
to Sgo2-R153A. More likely, the residual Mad2 binding of Sgo2-R153A can be 
attributed to additional contacts between both partners. In binding assays it could be 
observed that the effect of the R153A mutation on Mad2 binding was weaker when full-
length Sgo2 instead of an N-terminal fragment was analyzed (data not shown). However, 
attempts to further compromise Mad2 binding by additionally deleting parts of the Sgo2-
R153A mutant were unsuccessful (data not shown). Therefore, the MIM around amino 
acid residue 153 of hSgo2 is an important Mad2 binding site, but there could be 
additional weaker contacts. 
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According to the template model of the SAC, Mad1 and Cdc20 can be assigned to a 
signaling pathway from unattached kinetochores to the APC/C. In this model, Mad1 is an 
upstream source of the "wait anaphase" signal while Cdc20 is the downstream target. It 
can only be speculated on the question whether shugoshin as a Mad2 interactor rather 
resembles Mad1 or Cdc20. While Cdc20 binds Mad2 only when the SAC is active 
(Wassmann and Benezra, 1998), the Mad1-Mad2 complex is constitutively present 
throughout the cell cycle (Chen et al., 1999). In that respect Sgo2 behaves like Mad1 
(Fig. 20). Another difference between the known SAC interactors is that Cdc20 is 
destabilized by the SAC (Ge et al., 2009; Nilsson et al., 2008) while Mad1 is stable (Fig. 
18). Again, Sgo2 behaves more like Mad1 than Cdc20. The data at hand suggest, 
therefore, that Sgo2 could play the role of an upstream source of SAC signal, like Mad1. 
In this work, the Sgo2-Mad2 interaction was identified and characterized. However, no 
cellular function of this complex could be demonstrated, so far. A current dogma in the 
mitotic checkpoint field is that the SAC signaling pathway is not branched. It has a single 
signal source (Mad1) and a single target (Cdc20). The finding of a Mad1/Cdc20 like 
interaction between shugoshin and Mad2 challenges this dogma and suggests branching 
of the SAC. Sgo2 could be an upstream checkpoint component which emits a "wait 
anaphase" signal in response to a spindle defect not sufficiently sensed by Mad1. 
Alternatively, Sgo2 might be a new downstream target of the SAC being regulated in its 
function by association with Mad2 (see chapter 5.7 for a more detailed discussion of 
these two hypotheses). 
5.2. The shugoshin recruitment cascade in human cells 
During this study, the binding site of PP2A in hSgo2 has been mapped (see chapter 
4.3.2). This enabled the generation of a single point mutant of hSgo2 that is no longer 
able to interact with PP2A (Fig. 9). The PP2A binding deficient hSgo2-N58I was 
analyzed for its subcellular localization. In prometaphase cells, it showed a clear 
centromeric signal, like wild-type hSgo2 (Fig. 34A). For hSgo1, a different behavior has 
been described. A PP2A binding deficient version of hSgo1 is no longer able to bind to 
chromosomes and shows a diffuse signal (Tang et al., 2006). The fact that PP2A is 
dispensable for hSgo2 localization but required for hSgo1 localization is consistent with 
the published literature. hSgo1, hSgo2 and PP2A localize to the centromere of 
prometaphase cells. An interdependence of their localization has been described by 
siRNA depletion experiments (Kitajima et al., 2006). According to this study, hSgo2 is 
the most upstream of the three factors and PP2A localization depends on hSgo2. hSgo1 
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recruitment in turn depends on PP2A. A prediction would be that in cells expressing 
hSgo2-N58I as the only source of Sgo2, PP2A should not localize properly. Due to 
problems with PP2A immunostaining, this prediction could not be tested, so far. There 
are still open questions concerning the shugoshin recruitment cascade. Specifically, it is 
unclear in the light of the above findings why the absence of Sgo2 does not lead to 
mislocalization of Sgo1 (Kitajima et al., 2006). As a direct consequence, effects of the 
hSgo2-N58I mutant on PP2A localization can also not be indirectly assessed by Sgo1 
immunostaining. 
5.3. Evolutionary conservation of the PP2A binding motif 
In both Sgo1 and Sgo2 from various vertebrate species, the protein sequence around the 
PP2A binding site is well conserved (see chapter 4.1.2). It frequently consists of two 
asparagine residues, followed by one positively charged and several hydrophobic amino 
acid residues. The di-asparagine motif is an especially crucial determinant of PP2A 
binding. Mutations within this motif interfere with PP2A binding to hSgo1 and hSgo2 
(Tang et al., 2006; Fig. 9). However, it was not clear whether the respective asparagine 
residues are directly involved in molecular contacts with PP2A or whether the 
introduction of the bulky isoleucine residue sterically interferes with a nearby binding 
site. Meanwhile, the crystal structure of the mouse Sgo1-PP2A complex has been solved 
(Xu et al., 2009). The structure clearly shows that the di-asparagine motif of Sgo1 is in 
direct contact with amino acid residues of PP2A, more precisely, with its catalytic C-
subunit. This fact strongly suggests that the corresponding amino acid residues in Sgo2 
also engage in direct contacts with PP2A-C. Therefore, Sgo1 and Sgo2 contain an 
evolutionary conserved PP2A binding site. 
The trimeric PP2A holoenzyme derives its specificity from a wide variety of regulatory 
B subunits, which fall into the three main categories B, B' and B'', that can be further 
subdivided according to isotypes and splice variants. Sgo1 has a clear preference for 
PP2A complexes containing regulatory B' subunits (Riedel et al., 2006). This can be 
explained by additional contacts between amino acid residues around E88 of Sgo1 and 
the B' subunit of the PP2A holoenzyme (Xu et al., 2009). Therefore, it can be assumed 
that the first binding site around N61 is responsible for basal binding to all forms of 
PP2A, while the second site around E88 confers specificity to a certain B subunit. 
Importantly, the second binding site is not able to sustain binding on its own, as 
demonstrated by the hSgo1N61I mutant (Tang et al., 2006). 
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In contrast to Sgo1, Sgo2 is less specific in terms of preference for a certain type of 
PP2A. In vitro, it can bind B, B' and B'' equally well (Xu et al., 2009). The amino acids 
around E88 of Sgo1 are only weakly conserved in Sgo2, making the presence of a 
secondary PP2A binding site in Sgo2 questionable. Alternatively, Sgo2 might interact 
with PP2A exclusively via its NN-motif. In future experiments, this question could be 
elegantly resolved by exchanging the respective sequence motifs between Sgo1 and Sgo2 
and subsequent analysis of binding specificity for PP2A subtypes. 
Is the shugoshin-PP2A binding motif more commonly used for PP2A interaction or is it 
confined to the shugoshin protein family? Many cellular processes are regulated by PP2A 
and require binding of PP2A to specific substrates or locations. One example is the 
modulation of separase activity by PP2A (Holland et al., 2007). A stretch of amino acid 
residues within separase could be identified that faintly resembles the shugoshin-PP2A 
interaction motif. However, mutational analysis showed, that these residues are not 
crucial for binding of PP2A to separase (Benjamin Sünkel, Bachelor's thesis). In another 
approach, homology searches identified a series of proteins containing short sequence 
streches similar to the shugoshin-PP2A binding motif (data not shown). However, in the 
few cases, in which the corresponding proteins were cloned and tested in I.P. 
experiments, no binding of PP2A could be detected (data not shown). Therefore, the 
shugoshin-PP2A motif is highly conserved among shugoshin orthologs and paralogs but 
there is no indication for it representing a general hallmark of PP2A interactors. 
5.4. Sgo2 stimulates PP2A activity 
In an in vitro pulldown experiment, a trimeric complex could be isolated, in which PP2A 
and Mad2 are linked by Sgo2 (Fig. 30). The binding sites of PP2A (N58) and Mad2 
(R153) both map to the N-terminus of Sgo2. Nevertheless, Mad2 and PP2A apparently 
do not clash sterically when bound to Sgo2. 
There is potential for mutual influences between the members of the trimeric complex. In 
this study it could be shown, that Sgo2 has a stimulatory effect on bound PP2A (Fig. 10). 
Considering the direct contacts between Sgo2 and the catalytic C-subunit of PP2A 
(PP2A-C) it is conceivable that binding of Sgo2 induces conformational changes within 
PP2A-C that increase its catalytic activity. When the two available crystal structures of 
Sgo1-bound and unbound PP2A-C were analyzed in an overlay (using MacPyMol, 
Suppl. fig. 6), most amino acid residues were hardly changed. A remarkable exception is 
Y90, which is rotated by about 90° around the axis of the hydroxyl group upon Sgo1 
binding to PP2A. However, this residue is located rather far from the catalytic cleft, 
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making it hard to reconcile how this conformational change could influence phosphatase 
activity. Consistently, Xu et al (2009) did not detect an impact of their Sgo1 peptide on 
PP2A binding. Given the fact that a short shugoshin fragment was co-crystalized with 
PP2A and that Sgo1 instead of Sgo2 was used, it remains possible, however, that binding 
of full-length Sgo2 has a more profound influence on the PP2A-C active center. 
In a phosphatase assay using purified Sgo2-PP2A complex, the effect of recombinant 
Mad2 on phosphatase activity was also investigated. In comparison with a Mad2 mutant, 
which does not interact with Sgo2 (Mad2-D10), wild-type Mad2 did not detectably 
change the phosphatase activity of Sgo2-PP2A (Suppl. fig. 7). Another possibility of 
mutual influence arose from the fact that mimicking phosphorylation of Mad2 has a 
negative influence on Sgo2 binding (Fig. 24). Thus, PP2A might stabilize the Sgo2-
Mad2 complex in vivo by keeping Mad2 in a dephosphorylated state. As attempts to 
identify the relevant kinase failed (data not shown), this hypothesis could not be tested in 
vitro. Therefore, it was tested instead how much Mad2 was associated with PP2A 
binding deficient Sgo2-N58I relative to the wild-type protein upon immunoprecipitation 
from transfected cells (data not shown). As no differences in Mad2 binding could be 
detected, stimulation of PP2A catalytic activity by Sgo2 is the only detectable mutual 
influence within the trimeric Sgo2-Mad2-PP2A complex. 
5.5. A three-step model for the removal of cohesive elements in mitosis 
While DNA catenation is not sufficient to sustain sister chromatid cohesion in the 
absence of cohesin function, clearly, DNA catenation persists until the onset of anaphase 
(Baumann et al., 2007; Chan et al., 2007). This raised two main questions. First, what is 
the protective factor that blocks topoisomerase II (TOPO II) from acting on centromeric 
catenations until anaphase? Second, what are potential functions of residual catenations? 
The removal of catenations at anaphase onset could in theory be caused by multiple 
factors. Cdk1-Cyclin B1 activity drops and dephosphorylation events could activate 
centromeric TOPO II. Alternatively, an as yet unknown protector of catenation could act 
specifically at the centromere prior to anaphase onset. Finally, separase activation could 
directly stimulate centromeric TOPO II or do so indirectly via cohesin cleavage. Since 
these possibilities were difficult to resolve in vivo, an in vitro assay was chosen to test 
one of the hypotheses, i.e. the one that centromeric cohesin would interfere with 
decatenation (Fig. 12). This assay showed that in an isolated system with purified 
components, removal of cohesin precedes decatenation by TOPO II. The model most 
consistent with the experimental results is that cohesin itself protects centromeric 
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catenation. Cohesin could exert this function either by locally inhibiting TOPO II 
enzymatic activity or, more likely, by posing a sterical constraint to TOPO II. Another 
possibility is that the presence of cohesin still allowed TOPO II action but, by keeping 
the two DNA strands in close proximity, would prevent that microtubule dependent 
pulling on sister chromatids gives directionality to TOPO II's enzymatic activity. Though 
the in vitro chromatid separation assay relies on purified components, native metaphase 
chromosomes isolated from human cells come with a multitude of associated proteins. 
Thus, it cannot be completely excluded that another separase target distinct from cohesin 
is responsible for the observed effects. However, the only separase substrates known in 
mitotic mammalian cells are the cohesin subunit Scc1 and separase itself, which 
undergoes auto-cleavage. 
In summary, resolving paired sister chromatids in mitosis is at least a three-step process. 
First, cohesin is phosphorylated and thus removed from chromosome arms by action of 
the "prophase pathway". Next, at the metaphase-to-anaphase transition, separase-
mediated cohesin cleavage removes the remaining centromeric cohesin complexes. 
Finally, centromeric DNA catenations are resolved during anaphase. 
Why should DNA catenations be preserved, if decatenation is not independently 
regulated but instead just passively follows cohesin removal? In fact, incomplete 
resolution of contacts between sister chromatids at anaphase onset might even result in 
DNA breakage, thereby threatening genome integrity. Persistent anaphase catenations 
could potentially contribute to continued silencing of the spindle assembly checkpoint 
(SAC). The SAC is switched off once all chromosomes have aligned properly on the 
metaphase plate. For this to happen, it is crucial that all centromeres/kinetochores are 
under tension. However, when separase cleaves cohesin complexes and sister chromatids 
spring apart, the tension at kinetochores would immediately dissipate. Hence, 
kinetochores of separating sister chromatids could in theory reactivate the SAC. 
Reactivation of the SAC in anaphase could stabilize residual securin and cyclin B1 and 
promote their re-accumulation by re-synthesis. Indeed, many aspects of anaphase can be 
reverted – even very late in mitosis – by artificial reactivation of Cdk1 (Potapova et al., 
2006). DNA catenations might prolong the time period, in which kinetochores are under 
tension, thereby ensuring complete ubiquitylation and degradation of APC/CCdc20 targets. 
5.6. The roles of Sgo1 and Sgo2 in mitotic cohesin protection 
The published data on mammalian shugoshin homologs led to conflicting ideas about the 
importance of Sgo2 for mitotic cohesin protection. While Kitajima et al. (2006) report a 
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significant loss of cohesion upon depletion of Sgo2, Huang et al. (2007) do not see such 
an effect. Both studies use different dsRNA oligos for targeting Sgo2's mRNA. Thus, the 
discrepancies might be explained by off-target effects in one but not in the other case. In 
this work (Fig. 11) it could clearly be shown that cells depleted of Sgo2 do not lose 
centromeric cohesion. 
There is consent in the literature about the essential requirement of Sgo1 in mitotic 
cohesin protection. Also in this work, Sgo1 depletion has consistently led to premature 
sister chromatid separation (Fig. 11). That loss of Sgo2 does not compromise centromeric 
cohesion is difficult to reconcile with the report that the levels of PP2A at the centromere 
are markedly reduced when Sgo2 is depleted (Kitajima et al., 2006). It is also unexpected 
that Sgo1 depletion leads to premature sister chromatid separation without obviously 
affecting PP2A localization. These findings could only be reconciled if Sgo1 had a PP2A 
independent effect on cohesin protection, e.g. by physically shielding cohesin from 
access of kinases like Plk1. However, since depletion or chemical inhibition of PP2A 
does give rise to strong cohesion defects (Minshull et al., 1996), both Sgo1 and PP2A 
would have to collaborate to protect centromeric cohesin (Kitajima et al., 2006). 
5.7. Potential implications of the Sgo2-Mad2 complex in meiosis 
The following functions have been evoked for Sgo2 in mitosis: protection of centromeric 
cohesin (Kitajima et al., 2006), formation of spindles and proper microtubule-
kinetochore interactions (Huang et al., 2007) and robustness of the SAC (Huang et al., 
2007). The data presented in this work falsify all of these claims and are in agreement 
with more recent studies (Lee et al., 2008; Llano et al., 2008). The only "function" of 
mitotic Sgo2 that could be reproduced is the recruitment of the microtubule 
depolymerase MCAK to centromeres. Thus, the functions of Sgo1 and Sgo2 seem to be 
largely confined to mitosis and meiosis, respectively. As a consequence, the Sgo2-Mad2 
interaction could potentially play a role in meiosis, affecting either Sgo2 and/or Mad2 
functions. In the following, meiotic functions of Sgo2 and Mad2 - and possible mutual 
influence - will be discussed. 
5.7.1. A role of Mad2 in meiotic cohesion is unlikely 
Assuming that Sgo2 resembles a Cdc20-like downstream target of the SAC, it is – a 
priori – not obvious whether Mad2 will influence Sgo2 in a positive or negative way. 
Mad2 may act as a co-factor of Sgo2, thus helping to protect centromeric cohesin. 
Alternatively, Mad2 might be responsible for the mysterious inactivation of Sgo2 prior to 
Discussion 
  - 85 - 
anaphase of meiosis II (see below). However, circumstantial evidences against both these 
models do exist. Murine oocytes depleted of Mad2 show missegregation of homologous 
chromosomes. However, when analyzed in metaphase of meiosis II, nearly all sister 
chromatids are still paired at centromeres indicating that Sgo2 function remains intact  
(Homer et al., 2005). SAC deficient oocytes also retain their ability to separate sister 
chromatids in anaphase of meiosis II, largely ruling out that Sgo2 cannot be switched off 
(Tsurumi et al., 2004). Taken together, there is currently no indication for a positive or 
negative role of Mad2 in cohesion of sister centromeres during meiosis. It is therefore 
unlikely that the function of the Sgo2-Mad2 complex lies in meiotic protection of 
centromeric cohesion. 
5.7.2. Shugoshin 2 as a Mad1-like activator of the meiotic SAC? 
A more promising hypothesis to test is an involvement of Sgo2 in the meiotic spindle 
assembly checkpoint. There has been some debate as to the importance of the SAC in 
meiosis. It seems that the meiotic SAC is more "sloppy" than the mitotic SAC since it 
ignores single chromosomes, which occur in X0 mice (Hunt et al., 1995; LeMaire-
Adkins et al., 1997). The single X-chromosome can in theory be attached to the meiotic 
spindle but since it lacks its homologous counterpart, it will not experience tension. 
Apparently, this single tensionless chromosome is not detected by the meiotic SAC. 
However, the SAC in oocytes is able to detect loss of tension when several homologous 
chromosomes are unpaired. This is the case, for example, in mlh1-/- mice that have 
defects in recombination and formation of chiasmata (Woods et al., 1999). Therefore, the 
meiotic SAC has difficulties detecting minor errors, which is in sharp contrast to its 
mitotic counterpart. A possible reason could be the diffusible nature of the "wait 
anaphase" signal together with SAC inactivation mechanisms that constitutively 
challenge this signal. With an increasing cytoplasm:DNA ratio, it will become more and 
more difficult to generate enough active Mad2 species to inhibit the APC/C in the entire 
cell. Similar effects are observed for the DNA damage checkpoint in early 
embryogenesis (Conn et al., 2004). Along these lines, mouse oocytes with a diameter of 
about 70 µm (Elder and Dale, 2000) can still respond to microtubule depolymerizing 
drugs by executing a SAC mediated arrest in meiosis I (Wassmann et al., 2003b). The 
much larger Xenopus laevis oocytes with a diameter of about 1 mm (Elder and Dale, 
2000) are unable to do so. When the cytoplasm:DNA ratio is lowered in X. laevis egg 
extracts by addition of sperm chromatin at high concentrations, a SAC can readily be 
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established. All these findings lead to the conclusion that it is rather difficult to establish 
a robust spindle checkpoint response in oocytes. 
Also in unperturbed murine meiosis, the SAC is triggered and required. Mouse oocytes 
that lack Mad2 will progress significantly faster from prophase to anaphase of meiosis I. 
This has dramatic consequences on the fidelity of homolog segregation (Homer et al., 
2005). 
While other components of the SAC, like Bub1 and Bub3, have also been found to be 
important in meiosis (Li et al., 2009; McGuinness et al., 2009; Yin et al., 2006), there are 
much less data about the upstream activator Mad1. While clear immunofluorescence data 
are available that show kinetochore signals of Mad2 (Wassmann et al., 2003b; Zhang et 
al., 2004), Mad1 localization in meiosis is apparently more diffuse (Zhang et al., 2005). 
This is consistent with a model, in which centromeric Sgo2-Mad2 can act in parallel to 
kinetochore bound Mad1-Mad2 as an alternative source for conformationally activated 
Mad2. Studying meiosis will be crucial to put this model to a test. More specifically, 
depletion of Mad1 and/or Sgo2 by microinjection of corresponding siRNAs should be 
combined with live cell imaging. If Sgo2 indeed took part actively in the meiotic SAC, 
one would expect faster progression of oocytes through meiosis I or their inability to 
arrest in response to spindle drugs. In addition, Sgo2 could play a role in the SAC of 
meiosis II. In male meiosis of sgo2-/- mice, many spermatocytes progress beyond meiosis 
II despite the presence of separated sister chromatids and, hence, lack of kinetochore 
tension. Male sgo2-/- mice are nevertheless sterile due to massive chromatid 
missegregation. The fact that the SAC seems to be inefficient in this special type of cell 
division is indicative of a potential SAC function of Sgo2. 
5.8. The role of Aurora B in Sgo2 localization 
Close examination of Sgo2 localization in normal mitosis revealed that Sgo2 first 
localized to kinetochores in prophase, then to centromeres in prometaphase and, finally, 
back to kinetochores in metaphase. How can this dynamic localization pattern be 
explained on a mechanistic level? Sgo2 localization in mammalian cells depends on 
Aurora B. The published phenotype for siRNA mediated depletion of Aurora B is a 
complete failure of Sgo2 to associate with chromatin (Huang et al., 2007). It had not been 
tested previously, whether the catalytic activity of Aurora B is necessary for its role in 
Sgo2 localization. In this work, catalytic inhibition of Sgo2 by the small molecule 
ZM447439 was used to analyze specifically the contribution of Aurora B kinase activity 
to Sgo2’s subcellular localization. Surprisingly, Sgo2 was not lost from chromosomes 
Discussion 
  - 87 - 
when mitotic cells were treated with ZM447439. Instead, premature relocalization of 
Sgo2 from centromeres to kinetochores was observed (see chapter 4.4.7). Even when the 
inhibitor was present during mitotic entry, the result was still kinetochore bound Sgo2 
rather than complete delocalization (data not shown). Thus, Aurora B has a non-catalytic 
role in the initial recruitment of Sgo2 to chromosomes. Its kinase activity is required only 
later, i.e. to establish and to maintain the focused centromeric Sgo2 pattern during 
prometaphase. 
The early requirement of Aurora B protein rather than kinase activity makes it tempting 
to speculate that Aurora B delivers Sgo2 to kinetochores by direct physical interaction. 
This prediction could now be tested by asking whether both proteins co-I.P. and whether 
Aurora B – like Sgo2 – transiently localizes to kinetochores in prophase before 
concentrating at centromeres. One can further speculate that Aurora B, like other mitotic 
kinases, reaches full enzymatic activity only by prometaphase. Consistent with the data 
shown in Fig. 37, it would now mediate Sgo2 phosphorylation, thereby creating an 
affinity of Sgo2 for some unknown centromeric structure. 
But how then can Sgo2 relocalize from centromeres to kinetochores in metaphase when 
Aurora B kinase activity is still high? One possible explanation could be the activation of 
an as yet unknown phosphatase upon microtubule attachment to kinetochores. The 
exertion of tension as a triggering event is less likely here, since Sgo2 partially 
relocalizes in taxol- but not nocodazole-arrested cells (see chapter 4.4.2). Whatever the 
phosphatase, it is probably not PP2A, since PP2A binding deficient Sgo2 retains normal 
relocalization behavior. Instead, PP1, a known antagonist of other Aurora B functions, is 
a strong candidate because it localizes to kinetochores and dephosphorylates substrates 
like dynein at the time of SAC inactivation (Trinkle-Mulcahy et al., 2003; Whyte et al., 
2008). A testable prediction would therefore be that a PP1 specific inhibitor should 
interfere with proper centromere-kinetochore traveling of Sgo2 in metaphase cells. 
A corollary of the above model is that kinetochore- and centromere-localized Sgo2 
should be hypo- and hyperphosphorylated, respectively. Raising peptide antibodies that 
specifically recognize only dephosphorylated or only phosphorylated Sgo2 might enable 
one to test this hypothesis by future immunofluorescence microscopy. 
5.9. Downstream factors of Aurora B in the tension SAC 
Many aspects of the tension sensitive branch of the SAC still remain unresolved. One 
example is the ongoing search for a molecular tension sensor. Another one concerns the 
events downstream of Aurora B, an essential component of the tension sensitive SAC. 
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There are two competing models. One model proposes that Aurora B takes part in the 
SAC in a rather active manner. It assumes that the signaling pathway, which is triggered 
by tensionless MT-kinetochore linkages, would branch downstream of Aurora B. One 
pathway would mediate the correction of erroneous kinetochore-microtubule 
attachments, but an additional one would directly trigger the SAC by an as yet unknown 
mechanism (Vader et al., 2007). A second, simpler model predicts that Aurora B only 
mediates depolymerization of false k-fibers. The resulting unattached kinetochores would 
then automatically recruit Mad1-Mad2 and trigger the SAC (Pinsky et al., 2006). A 
recent publication (Yang et al., 2009) indirectly supports the second model. Intermediate 
taxol concentrations stabilize erroneous kinetochore-microtubule attachments and hence 
trigger the tension sensitive SAC. In contrast, high taxol concentrations are a worse 
trigger of mitotic arrest. This finding is consistent with an excessive stabilization of 
attachments, impeding creation of free kinetochores. The remainder of this chapter will, 
therefore, deal with the nature of the pathway linking Aurora B with the creation of 
unattached kinetochore. 
The microtubule depolymerizing kinesin MCAK has been evoked as the player chiefly 
responsible for the destabilization of tensionless k-fibers (Kline-Smith et al., 2004; Lan et 
al., 2004). This is based on experiments in the Xenopus system, in which the interference 
with MCAK apparently removes an essential microtubule depolymerase (Desai et al., 
1999). In human cells, Aurora B recruits Sgo2, which in turn recruits MCAK to 
kinetochores/centromeres (Andrews et al., 2004; Huang et al., 2007; Lan et al., 2004). 
Consequently, Sgo2 depletion leads to delocalization of MCAK in mitotic HeLa cells. If 
human MCAK were essential to resolve kinetochore-microtubule contacts, such Sgo2-
less cells should suffer from inability to correct erroneous attachments. However, this is 
clearly not the case, as Sgo2 depleted HeLa cells pass through mitosis with normal 
kinetics and no signs of lagging chromosomes (see chapter 4.2.5). This observation is 
consistent with the fact that depletion of MCAK from human cells likewise has little or 
no effect on error correction and chromosome segregation fidelity (Manuel Kaulich, 
personal communication). Thus, in marked contrast to Aurora B, Sgo2 and MCAK seem 
to be dispensable for correction of faulty attachments and triggering of the tension 
sensitive branch of the SAC in humans. Consequently, one has to propose the existence 
of an alternative route in humans that relays the signal from misattached chromosomes 
via Aurora B to error correction (Fig. 39). This could involve microtubule depolymerases 
other than MCAK and/or direct phosphorylation of microtubule-kinetochore attachment 
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sites. Consistently, a tension sensitive SAC was Aurora B dependent, even in the absence 
of Sgo2 (Suppl. fig. 8). 
Given that MCAK seems to be indispensable for error correction in X. laevis, it seems 
worth studying potential mitotic roles of xSgo1 in the future. To this end, one would 
have to establish siRNA dependent knock-down in cultures of somatic frog cells and to 
then analyze mitosis and chromosome segregation by live cell imaging. As a downstream 
factor of xSgo1, MCAK also qualifies as a potential target of the newly identified xSgo1-
Mad2 interaction. In future experiments, it should therefore be tested whether MCAK 
localization or function is modulated by Mad2 in Xenopus cell culture systems. 
 
 
Fig. 39: Pathways linking the recognition of erroneous kinetochore-microtubule 
attachments with  their correction. In the error correction pathway of S. pombe, Aurora B is 
downstream of Sgo2. In contrast, Aurora B is upstream of hSgo2 or xSgo1 in humans or 
Xenopus, respectively. While in Xenopus there is a strong requirement for MCAK in correcting 
erroneous kintochore-microtubule attachments, in human cells MCAK is largely dispensable. 
This suggests an alternative pathway in parallel (marked by "?"). 
 
The mutual dependencies of shugoshin and Aurora B in terms of chromosomal 
localization differ from yeast to vertebrate cells. As mentioned above, Aurora B is 
upstream of hSgo2 in human cells. Similarly, Aurora B is upstream of xSgo1 in X. laevis 
Discussion 
  - 90 - 
(Boyarchuk et al., 2007). Interestingly, the situation in S. pombe is the opposite: Here, 
Sgo2 is required for Aurora B localization (Kawashima et al., 2007). This might also 
account for the different Sgo2 loss of function phenotypes in terms of the tension 
sensitive branch of the SAC. So far, a role of a shugoshin homolog in the checkpoint 
dependent sensing of tension has only been demonstrated in yeast, i.e. when the essential 
SAC factor Aurora B is under control of shugoshin. 
5.10. Sgo2 inactivation in meiosis 
For Sgo2 inactivation in meiosis II, relocalization from centromere to kinetochore likely 
constitutes an important step. It has been proposed that by this means Sgo2 is physically 
separated from Rec8. Only then, Rec8 is phosphorylated and subsequently cleaved by 
separase. Relocalization of Sgo2 has been attributed to spindle-associated pulling forces 
occuring at kinetochores. Why then does Sgo2 stay at centromeres throughout meiosis I? 
There, two homologous chromosomes are tethered by means of chiasmata and arm 
cohesin forming a so-called bivalent. Within a bivalent, each homolog shows mono-
orientation of fused sister kinetochores. In such a "pseudo-syntelic" arrangement, sister 
centromeres will not experience tension. In contrast, they will come under tension in 
meiosis II when sister kinetochores biorient as they do in mitosis. Perservation or 
disappearance of Sgo2 from centromeric cohesin has therefore been attributed to lack or 
presence of centromeric tension, respectively. 
Is tension really necessary and sufficient to redirect Sgo2 from centromeres to 
kinetochores? In this thesis, mitotic cells were treated with taxol to address this question. 
Although this results in abrogation of spindle forces, attachment of kinetochores to 
microtubules is still possible. Surprisingly, relocalization of Sgo2 from centromeres to 
kinetochores still occurred under these conditions, i.e. in the absence of centromeric 
tension (Fig. 33). Thus, attachment can already cause relocalization. This raises the next 
question, namely, why MT-kinetochore interaction does not trigger premature 
dissociation of Sgo2 from centromeres in meiosis I? This could be explained by a 
meiosis I specific mechanism that prevents attachment induced relocalization of Sgo2 at 
this early stage of meiosis. The literature provides some evidence for this hypothesis to 
be actually correct. Before homologous recombination and the appearance of crossing-
overs, mouse homologous chromosomes associate with each other by means of the 
synaptonemal complex (SC) in prophase of meiosis I. Mice lacking Scp3, an SC 
component, show less crossing-overs (Yuan et al., 2000). In such mice, cells enter 
meiosis not only with bivalents but instead with some mitosis-like chromosomes 
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(univalents). Another effect observed in the scp3 knockout is bipolar attachment of these 
chromosomes already in meiosis I (Kouznetsova et al., 2007). The resulting meiosis I 
spindle is therefore partially reminiscent of meiosis II or mitosis. Although sister 
centromeres of the bioriented chromosomes are necessarily under tension, separation of 
sister chromatids is not observed in all cases when the corresponding oocytes progress 
through this abnormal meiosis I (Kouznetsova et al., 2007). It remains to be 
demonstrated that Sgo2 indeed persists at centromeres in meiosis I of scp3-/- mice. 
Nevertheless, the work of Kouznetsova and colleagues strongly suggests that Sgo2 
relocalization is suppressed by an as yet unknown mechanism during meiosis I. Further 
investigation of this idea could involve creation of a subtractive plasmid library 
representing transcripts present specifically in meiosis I and not in meiosis II with the 
subsequent screening of this library for factors artificially inhibiting sister chromatid 
separation in meiosis II. 
In summary, centromeric tension is neither necessary nor sufficient for the redirection of 
Sgo2 from centromeres to kinetochores. 
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6. Materials and methods 
If not indicated otherwise, companies are situated in Germany. 
6.1. Materials 
6.1.1. Hard- and software 
This work was written on an "Apple MacBook5.2" (Apple Inc., Cupertino, CA, USA) 
using "Microsoft Word 2008" (Microsoft Corporation, Redmond, WA, USA). "Microsoft 
Excel 2008" (Microsoft Corporation, Redmond, WA, USA) as well as "OpenOffice" 
were used for generation of diagrams. Chemiluminescence signals of Western blots as 
well as Coomassie stained gels were digitized using an "LAS-4000" system (Fuji Film 
Europe, Düsseldorf). The image analysis software MultiGauge (Fuji Film Europe, 
Düsseldorf) was used to quantify chemiluminescence signals from immunoblots. X-Ray 
structure visualization was performed with "MacPyMol" (DeLano Scientific, Palo Alto, 
CA, USA). Image processing was performed with "Adobe Photoshop CS4" (Adobe 
Systems Inc., San Jose, CA, USA). Figures were generated using "Adobe Ilustrator CS4" 
(Adobe Systems Inc. , San Jose, CA, USA) and "Microsoft Powerpoint 2008" (Microsoft 
Corporation, Redmond, WA, USA). "DNASTAR Lasergene" (GATC Biotech, 
Konstanz) was used for analysis of DNA and protein sequences. Literature and database 
searches were done with electronic online services provided by the "National Center for 
Biotechnology Information" (http://www.ncbi.nlm.nih.gov/). A service of the European 
Bioinformatics Institute was used for sequence aligments ("EMBOSS Pairwise 
alignment" algorithm, http://www.ebi.ac.uk/Tools/emboss/align/index.html). 
6.1.2. Protocols 
The methods described in this section are based on standard techniques or follow the 
manufacturer’s instructions. When protocols have been modified, detailed information is 
provided. For all methods, de-ionized sterile water and – when appropriate – sterile 
solutions and sterile flasks were used. 
6.1.3. Chemicals and reagents 
Unless otherwise noticed, chemicals and reagents (pro analysis grade) were purchased 
from AppliChem (Darmstadt), Biomol (Hamburg), Biorad (München), , Fermentas (St. 
Leon-Rot), Invitrogen (via Fisher Scientific, Schwerte), Merck/Calbiochem (Darmstadt), 
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New England Biolabs (NEB, Frankfurt a. M.), GE Healthcare (Munich), Promega 
(Mannheim), Roche Diagnostics (Mannheim), Roth (Karlsruhe), Serva (Heidelberg), 
Sigma-Aldrich (Steinheim), Millipore (Schwalbach) and Pierce/Fisher Scientific 
(Schwerte). 
6.1.4. Antibodies 
Antibodies and affinity matrices were as follows: sheep polyclonal anti-BubR1 (Kind gift 
from Steven S. Taylor, Manchester, UK) mouse monoclonal anti-Hec1 (Genetex, Irvine, 
CA, USA), mouse monoclonal anti-Myc (Clone 4A6, Millipore, Schwalbach), mouse 
monoclonal anti-Flag M2 (Sigma-Aldrich, Steinheim), rabbit polyclonal anti-Mad2 
(Bethyl, Montgomery, TX, USA), mouse monoclonal anti-Mad2 (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), rabbit polyclonal anti-MCAK (kind gift from 
Thomas U. Mayer, Konstanz), rat polyclonal anti-PICH (kind gift from Erich A. Nigg, 
Basel, Switzerland), rabbit polyclonal anti-Sgo2 (Bethyl, Montgomery, TX, USA), 
mouse monoclonal anti-β-tubulin (Developmental Studies Hybridoma Bank, clone E7), 
unspecific rabbit (Bethyl, Montgomery, TX, USA) IgG (Sigma-Aldrich, Steinheim) and 
IgG sepharose (4 Fast Flow; GE Healthcare, Munich). Polyclonal goat anti-mouse-IgG, 
anti-sheep-IgG or anti-rabbit-IgG coupled to peroxidase (Sigma-Aldrich, Steinheim) 
were used as secondary antibodies in immunoblotting. Polyclonal goat anti-mouse-Cy3 
and goat anti-rabbit-Alexa488 (Invitrogen/Fisher Scientific, Schwerte) were used for 
secondary detection in immunofluorescence.  
6.1.5. DNA oligonucleotides 
Primer Sequence 
5'Fse-hSgo1 5'-AATGGCCGGCCAGGCATGGCCAAGGAAAGATGCCT-3' 
hSgo1-3'Asc 5'-TTAGGCGCGCCTCATTGTATTTGTTTCATACTTTTTTTAG-3' 
5'Fse-Sgo2 5'-AATGGCCGGCCAGGCATGGAGTGCCCAGTGATGGAAAC-3' 
hSgo2-3'Asc 5'-TTAGGCGCGCCTCATCTTCTCATCTTGTCTCTGAGGCT-3' 
hSgo2-N250-3'Asc 5'-AGATGGCGCGCCTCACATTAGAGAAGTCTTAGAACT-3' 
hSgo2-N1066-3'Asc 5'F-TACTGGCGCGCCTTACTCTCCTTCTTTTATTTCTTCCAC-3'A 
5'Fse-xSgo1 5'-ATAGGCCGGCCCGGCATGGTAAAGGAAAGATGCCCAAAGCA-3' 
xSgo1-3'Asc 5'-TTAGGCGCGCCTCATCTGCGGCAGCCAACAAATACT-3' 
xSgo1-100-3'Asc 5'- TTAGGCGCGCCCCCGTAACATAAATAT-3' 
xSgo1-101-5'Fse 5'-ATAGGCCGGCCCGGCCGCAGGCTGCAGTCA-3' 
xSgo1-200-3'Asc 5'- TTAGGCGCGCCCTTTGTCTTTGAAATT-3' 
xSgo1-201-5'Fse 5'- ATAGGCCGGCCCGGCGTGGTTTTGGAAGCC-3' 
xSgo1-300-3'Asc 5'- TTAGGCGCGCCCGTCTGTCCTACTTTC-3' 
xSgo1-301-5'Fse 5'- ATAGGCCGGCCCCGAGAAATAGACAATGTTGA-3' 
xSgo1-400-3'Asc 5'- TTAGGCGCGCCCATGAATTCAGGGAAGA-3' 
xSgo1-401-5'Fse 5'- ATAGGCCGGCCCGGCGGAGATGCCTTTGAC-3' 
xSgo1-500-3'Asc 5'- TTAGGCGCGCCCTCTTGTAATTTTCTT-3' 
xSgo1-501-5'Fse 5'- ATAGGCCGGCCCGGCAACGGCTTGAAAAGG-3' 
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Hormad1-5'Fse 5'-AATGGCCGGCCAATGGCCACTGCCCA-3' 
Hormad1-3'Asc 5'-AATGGCGCGCCTTATATATGTTCCTTTGGTTCAC-3' 
CK2beta-5'Fse 5'F-AATGGCCGGCCGATGAGCAGCTCAGAGGAGGTGT-3'A 
CK2beta-3'Asc 5'F-TATGGCGCGCCTCAGCGAATCGTCTTGACTGGGCT-3'A 
PP2A-B'delta-5'Fse 5'F-TAAGGCCGGCCCATGCCCTATAAACTGAAAAAGGAG-3'A 
PP2A-B'delta-3'Asc 5'F-TTTGGCGCGCCTCAGAGAGCCTCCTGGCTG-3'A 
hSgo2-R153A 5'-AGTGCAAGTTGATGGCTCTTCCATTTGCAAG-3' 
hSgo2-N58I-S 5'-TATCTTTAAAGCACAACATCAGGGCATTAGCTCA-3' 
hSgo2-N58I-A 5'-TGAGCTAATGCCCTGATGTTGTGCTTTAAAGATA-3' 
hSgo2-Yen#2res-S 5'-AGAAACTGAATTTTGAGAATACGTTTCTTCGGCTTAAGCTAAA 
TAACTTGA-3' 
hSgo2-Yen#2res-A 5'-TCAAGTTATTTAGCTTAAGCCGAAGAAACGTATTCTCAAAATTC 
AGTTTCT-3' 
6.1.6. Target sequences for dsRNA oligonucleotides 
Target mRNA siRNA target sequence  
Sgo1 5'-CAGTAGAACCTGCTCAGAA-3'  
Sgo2 5'-GAACACATTTCTTCGCCTATT-3'  
Mad1 5'-CCAGCGGCTCAAGGAGGTTTT-3'  
Mad2 5'-GAGTCGGGACCACAGTTTATT-3'  
6.1.7. Plasmids 
Plasmid Insert Tag Vector 
pBM684 hSgo1 N-Flag3-Tev2- pCS2 
pBM720 hSgo1 N-Flag3-Tev2- -His6FlagHis6Flag-C 
pCS2 
pBM787 hSgo1 N-Gal4-AD- pACT 
pBM798 hSgo11-66 N-Gal4-AD- pACT 
pBM799 hSgo134-100 N-Gal4-AD- pACT 
pBM800 hSgo167-133 N-Gal4-AD- pACT 
pBM801 hSgo1101-166 N-Gal4-AD- pACT 
pBM802 hSgo1134-200 N-Gal4-AD- pACT 
pBM803 hSgo1167-233 N-Gal4-AD- pACT 
pBM804 hSgo1201-266 N-Gal4-AD- pACT 
pBM805 hSgo1234-300 N-Gal4-AD- pACT 
pBM806 hSgo1367-333 N-Gal4-AD- pACT 
pBM807 hSgo1301-366 N-Gal4-AD- pACT 
pBM808 hSgo1334-400 N-Gal4-AD- pACT 
pBM809 hSgo1367-433 N-Gal4-AD- pACT 
pBM810 hSgo1401-466 N-Gal4-AD- pACT 
pBM811 hSgo1434-500 N-Gal4-AD- pACT 
pBM812 hSgo1467-533 N-Gal4-AD- pACT 
pBM813 hSgo1501-end N-Gal4-AD- pACT 
pBM815 xSgo11-100 N-Gal4-AD- pACT 
pBM816 xSgo1101-200 N-Gal4-AD- pACT 
pBM817 xSgo1201-300 N-Gal4-AD- pACT 
pBM818 xSgo1301-400 N-Gal4-AD- pACT 
pBM819 xSgo1401-500 N-Gal4-AD- pACT 
pBM820 xSgo1501-end N-Gal4-AD- pACT 
pMO937 xSgo11-207 N-MBP- pMal 
pBM794 hMad2 (Mad2L1) N-Gal4-DBD- pAS 
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pBM795 hMad2-D10 N-Gal4-DBD- pAS 
pBM995 hMad2 N-Myc6- pCS2 
pBM1007 hMad2-D10 N-Myc6- pCS2 
pBM940 hMad2-5xD N-Myc6- pCS2 
pBM942 hMad2-5xA N-Myc6- pCS2 
pMO1091 hMad2 N-HA3- pCS2 
pAS900 hMad2 N-His6- pQE80 
pMO919 hMad2-D10 N-His6- pQE80 
pAS899 hMad2-5xD N-His6- pQE80 
pAS902 hMad2-5xA N-His6- pQE80 
pBM1884 hCdc20111-138 N-GST- pGex 
pMO677 hp31 N-Flag3-Tev2- pCS2 
pEB1056 hCK2beta N-HA3- pCS2 
pEB1060 hCK2beta N-Gal4-DBD- pAS 
pJH2112 hPP2A-B'delta N-Flag3-Tev2- pCS2 
pBM911 hPP2A-B'delta N-Gal4-DBD- pAS 
pMO1067 hSgo2 N-Flag3-Tev2- pCS2 
pBM1172 hSgo2 N-Myc6- pCS2 
pBM1140 hSgo2-R153A N-Flag3-Tev2- pCS2 
pBM1145 hSgo2-N58I N-Flag3-Tev2- pCS2 
pBM1153 hSgo21-250 N-Flag3-Tev2- pCS2 
pJH2245 hSgo2
1-1066; 
Yen#2 siRNA-res N-Myc6- pCS2 
pEB1134 hSgo2 N-Gal4-AD- pACT 
pAS1157 hSgo21-250 N-Gal4-AD- pACT 
pAS1158 hSgo21-250-R153A N-Gal4-AD- pACT 
pBM2222 - - pBOS SR-eGFP 
pBM2223 hSgo2-wt; 
Yen#2 siRNA-res - 
pBOS 
SR-eGFP 
pBM2224 hSgo2-R153A; 
Yen#2 siRNA-res - 
pBOS 
SR-eGFP 
pBM2225 hSgo2-N58I; 
Yen#2 siRNA-res - 
pBOS 
SR-eGFP 
 
Source: pBM – this study; others – Stemmann laboratory plasmid collection 
 
 
6.2. Microbiological techniques 
6.2.1. E. coli strains 
XL-1 blue (Molecular cloning, plasmid production):  
E. coli supE44 hsdR17 recA1 gyrA46 thi relA1 lac – F'[proAB+ lacIq Δ(lacZ)M15 
Tn10(tet r)] (Stratagene/Agilent Technologies, Santa Clara, CA, USA) 
 
Rosetta 2 (Protein expression): 
E. coli F- ompT hsdSB(rB- mB-) gal dcm pRARE2 (CamR) (Novagen/Merck, Darmstadt)  
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6.2.2. E.coli vectors 
pGEX4T1 (GE Healthcare, Munich) with modified MCS (FseI/AscI sites inserted) 
pMal (New England Biolabs) with modified MCS (FseI/AscI sites inserted) 
pQE80 (Qiagen, Hilden) with modified MCS (FseI/AscI sites inserted) 
6.2.3. E. coli media 
LB medium  
1% (w/v) Tryptone (Difco, BD Bioscience, Heidelberg) 
0.5% (w/v) yeast extract (Difco, BD Bioscience, Heidelberg) 
1% NaCl (w/v) 
dissolved in ddH2O and sterilized by autoclaving 
 
LB agar  
LB-medium with 1.5% agar (Roth, Karlsruhe) 
 
6.2.4. Cultivation and storage of E. coli 
E. coli strains were grown in LB medium by shaking at 200 rpm at 37°C, LB agar plates 
were incubated at 37°C. Antibiotics for selection of transformed bacteria were added to 
media at 100 µg/ml (ampicillin) and 30 µg/ml (kanamycin) final. Culture densities were 
determined by measuring the absorbance at a wavelength of 600 nm (OD600). Cultures on 
agar plates were stored at 4°C for up to 30 days. For long term storage, liquid cultures 
were supplemented with glycerol to 20% final concentration, subsequently snap frozen 
and stored at -80°C. 
6.2.5. Preparation of chemically competent E. coli 
Tbf1 buffer  
30 mM  KAc 
50 mM  MnCl2 
100 mM KCl 
15% (v/v)  glycerol 
pH adjusted to 5.8 
 
Tbf2 buffer  
10 mM  MOPS-NaOH 
75 mM  CaCl2 
10 mM  KCl 
15% (v/v) glycerol 
pH adjusted to 7.0 
SOB medium 
0.5% (w/v)  NaCl 
0.5% (w/v)  yeast extract 
2% (w/v)  tryptone 
2.5 mM  KCl 
pH 7.0 with NaOH 
dissolved in ddH2O and sterilized by 
autoclaving 
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For preparation of chemically competent bacteria, 300 ml SOB medium was inoculated 
with 4 ml of an overnight culture derived from a single E. coli colony and grown at 37°C 
to an OD600 of 0.5. 
After chilling the culture flask on ice for 15 min, cells were harvested by centrifugation 
(4°C, 3,000 g, 15 min). All following steps were performed with prechilled sterile 
materials and solutions at 4°C. Sedimented bacteria were carefully resuspended in 90 ml 
Tbf1 buffer and chilled on ice for 15 min (XL-1 blue) or 45 min (Rosetta 2). After a 
second centrifugation (4°C, 1500 g, 15 min), bacteria were resuspended in 15 ml Tbf2 
buffer and chilled on ice for 5 min. Finally, the suspension of bacteria was aliquoted, 
snap-frozen and stored at -80°C. 
6.2.6. Transformation of plasmid DNA into chemically competent E. coli 
Chemically competent bacteria were thawed on ice. For chemical transformation, 50 µl 
of competent bacteria were mixed with 1 µl of plasmid DNA or 5 µl ligation reaction and 
incubated on ice for 30 min. A heat shock at 42°C was performed for 45 s. Subsequently, 
the cell suspension was incubated on ice for 2 min and after addition of 1 ml SOB 
medium without antibiotics incubated on a shaker at 37°C for 45 min. After recovery, 
transformed cells were selected by streaking out the bacteria suspension on LB agar 
plates containing the respective antibiotic(s) and incubated overnight at 37°C. 
 
6.2.7. Expression of proteins in E. coli 
For expression of recombinant proteins, the E. coli strain Rosetta 2 (Novagen/Merck, 
Darmstadt) was used. LB medium was inoculated with a dilution of 1:100 of an 
overnight culture from a freshly transformed colony. Besides the appropriate selection 
conditions for the transformed plasmid, chloramphenicol was used to prevent loss of 
pRARE2 encoding for low abundance tRNAs. In the case of MBP-tagged constructs, 
glucose was added to a final concentration of 0.2% (w/v) to suppress amylase expression. 
The culture was grown at 37°C and expression of protein(s) was induced by addition of 
IPTG (1 mM final concentration) at an OD600 of 0.5 - 0.7. After shaking for 2 h at 37°C, 
cells were cooled on ice and subsequently harvested by centrifugation (4°C, 5,000 g, 
10 min). Pellets were either processed directly or stored at -80°C after snap-freezing. 
6.2.8. S. cerevisiae strain 
PJ69-4A: MATa trp-901 leu2-3,112 ura3-52 his3-200 gal4Δ gal80Δ LYS2::GAL1-HIS3 
GAL2-ADE2 met2::Gal7-lacZ (James et al., 1996) 
Materials and Methods 
  - 98 - 
6.2.9. Yeast media 
YPD medium 
1% (w/v)  yeast extract (Difco, BD Bioscience, Heidelberg) 
2% (w/v) Bacto Peptone (Difco, BD Bioscience, Heidelberg) 
The solution was autoclaved and subsequently supplemented with sterile filtered glucose 
solution to a final concentration of 2% (w/v) glucose. 
 
Amino acid supplement 
Amino acid supplement was used for the preparation of SC medium. An amino acid 
mixture was prepared using the following quantities: 2.0 g adenine hemisulfate, 2.0 g 
arginine-HCl,  2.0 g histidine-HCl, 2.0 g isoleucine, 2.0 g leucine, 2.0 g lysine-HCl, 2.0 g 
methionine,  3.0 g phenylalanine, 2.0 g serine, 2.0 g threonine, 3.0 g tryptophan,  2.0 g 
tyrosine,  1.2 g uracil, 9.0 g valine. To ensure homogeneity, the mixture was 
mechanically inverted over night. 
 
Synthetic complete (SC) medium 
0.65% (w/v)  yeast nitrogen base 
2% (w/v)  glucose 
0.083%  amino acid supplement 
 
The pH was set to 5.6 and the solution subsequntly autoclaved. To prepare dropout 
medium for plasmid selection in auxotrophic yeast strains, the respective amino acids 
were omitted from the supplement mixture. SC agar plates were made by addition of 
2% (w/v) Bacto agar (Difco, BD Bioscience, Heidelberg) before autoclaving. Approx. 25 
ml of agar containing SC medium were poured on a 10 cm plastic dish (Greiner Bio-One, 
Kremsmünster, Austria). 
6.2.10. Yeast vectors 
pAS, pACT (Clontech, BD Biosciences, Heidelberg) with modified MCS (FseI and AscI 
site inserted) 
6.2.11. Preparation of chemically competent S. cerevisiae 
SORB solution 
0.1 M  lithium acetate 
10 mM  Tris-HCl pH 8.0 
1 mM  EDTA 
1 M  sorbitol 
(0.2 µm sterile filtered) 
 
50 ml of YPD were inoculated with an overnight culture of the yeast strain PJ69-4A to 
achieve an OD600 of 0.1. The culture was shaken at 30°C until it reached an OD600 of 0.5. 
Cells were harvested by centrifugation at 1,000 g and washed once with 25 ml sterile 
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ddH2O. The pellet was resuspended in 1 ml of SORB solution and transfered to a 1.5 ml 
reaction tube. After centrifugation at 1,000 g for 3 min, the cells were resuspended in 360 
µl SORB solution. As a carrier for transformation, 40 µl of salmon sperm DNA 
(10 mg/ml; Invitrogen/Fisher Scientific, Schwerte) were heated to 95°C for 10 min, 
quickly cooled on ice and finally mixed with the cell suspension. The now competent 
yeast cells were stored for up to 2 h on ice. 
6.2.12. Plasmid transformation in S. cerevisiae 
PEG solution 
0.1 M  lithium acetate 
10 mM  Tris-HCl pH 8.0 
1 mM  EDTA 
40% (w/v)  polyethylene glycol PEG-3350 
(0.2 µm sterile filtered) 
 
10 µl of chemically competent yeast cells were mixed with 1 µl plasmid DNA (250 
ng/µl) and 65 µl PEG solution in a sterile 1.5 ml reaction tube. The contents were mixed 
by vortexing at maximum speed for 5 s and incubated at room temperature for 25 min 
followed by a heat shock at 42°C for 10 min. The cells were centrifuged at 1,000 g 3 
times for 1 min. Between centrifugation steps, the tubes were turned 180° in the rotor to 
facilitate sedimentation of the yeast cells in the viscous liquid. The supernatant was 
discarded, the pellet resuspended in 100 µl of water and finally plated onto SC dropout 
agar plates. Leucine and tryptophan auxotrophy were used to select for transformants. 
6.2.13. Yeast-2-Hybrid assay 
Yeast-2-Hybrid assays were used to study protein-protein interactions. The system 
exploits the fact that the yeast transcription factor Gal4p can be split into two separate 
domains, the DNA binding domain (DBD) and the transactivation domain (AD). If the 
two fragments are brought into close proximity, they reconstitute a functional Gal4 
transcription factor. To test protein-protein interaction, the coding sequences of the two 
candidates were cloned into the vectors pAS (DBD-fusion) and pACT (AD-fusion) and 
transformed into the yeast strain PJ69-4A. This strain is devoid of the endogenous Gal4 
transcription factor. In addition, one of the genes required for histidine biosynthesis is 
expressed under the control of a GAL promoter. Cells are only able to survive on SC-His 
medium if they are two plasmids encoding fusion proteins that interact physically. Since 
certain AD or DBD fusion proteins show Gal4-like activity on their own ("auto- 
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activation"), control transformations are required. For that reason, the respective fusion 
construct was tested in combination with the complementary empty vector. 
6.2.14. Preparation of denatured cell extracts from S. cerevisiae 
HU buffer 
8 M  urea 
5%  SDS 
200  mM Tris-HCl pH 6.8 
1 mM  EDTA 
A few crystals bromophenol blue 
100 mM DTT (added immediately before use) 
 
Cells from a yeast culture (equivalent to 1 ml at OD600=1) were harvested by 
centrifugation (1,000 g, 2 min), resuspended in 1 ml cold ddH2O, and lysed with 150 µl 
1.85 M NaOH / 7.5% β-Mercaptoethanol. After incubation for 15' on ice, the proteins 
were precipitated by addition of 150 µl 55% trichloroacetic acid (TCA) for 10 min, and 
centrifuged for 10 min at 4°C, 16,000 g. The pellet was resuspended in 100 µl HU-buffer 
with freshly added DTT (from 1 M stock, 1/10 volume). The samples were heated to 
65°C for 10 min before loading on SDS-PAGE gels,. 
 
6.3. Molecular biological methods 
6.3.1. Isolation of plasmid DNA from E. coli 
3ml of LB medium containing the appropriate antibiotic was inoculated with a single E. 
coli colony harboring the DNA plasmid of interest and shaken for 8-14 h at 37°C. 
Plasmid-DNA was purified via alkaline lysis of the bacteria and subsequent isolation by 
anion exchange columns according to the manufacturer’s instructions (Qiagen (Hilden) 
Plasmid Purification Handbook, Plasmid Mini Preparation for up to 20 µg DNA). Larger 
amounts of DNA for transfection of human cells were isolated from a 250 ml overnight 
culture according to the manufacturer’s protocol (Qiagen (Hilden) Plasmid Purification 
Handbook, Plasmid Maxi Preparation for up to 1 mg DNA). 
6.3.2. Determination of DNA/RNA concentration in solution 
DNA or RNA concentrations were determined by measuring the absorbance at a 
wavelength of 260 nm (OD260) with a ND-1000 Spectrophotometer (Peqlab, Erlangen). 
An OD260=1 equals a concentration of either 50 µg/ml double-stranded DNA or 40 µg/ml 
RNA. 
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6.3.3. Restriction digestion of DNA 
Sequence-specific cleavage of DNA with restriction enzymes was performed according 
to standard protocols (Sambrook and Russell, 2001) and the instructions of the 
manufacturer (New England Biolabs, NEB, Frankfurt a. M.). Usually, 5-10 units of 
restriction enzyme were used for digestion of 1 µg DNA. Reaction samples were 
incubated in appropriate buffer at the recommended temperature for 30 min to 1 h. 
Restriction digestion was then stopped by addition of DNA loading buffer. 
6.3.4. Dephosphorylation of DNA fragments 
To avoid religation of linearized vectors, the 5' end of vector DNA was dephosphorylated 
by adding 0.1 units of shrimp alkaline phosphatase and the appropriate buffer concentrate 
(Roche, Mannheim) followed by incubation for 1 h at 37°C. Finally, shrimp alkaline 
phosphatase was heat-inactivated at for 20 min at 72°C. 
6.3.5. Separation of DNA fragments by gel electrophoresis 
TBE buffer  
90 mM  Tris base 
90 mM  Boric acid 
2.5 mM  EDTA 
 
DNA loading buffer (5x)  
0.5%  SDS 
0.25%  Orange G 
25%  Glycerol 
25mM  EDTA (pH 8,0) 
 
For analysis or preparative isolation, DNA fragments were electrophoretically separated 
on agarose gels (0.8-2.0% of agarose in TPE) containing ethidium bromide (0.5 µg/ml 
final concentration). DNA samples were mixed with DNA loading buffer and separated 
at 100 V in TBE buffer. DNA fragments could be visualized by intercalation of ethidium 
bromide into DNA by using a UV transilluminator (324 nm). The size of the fragments 
was estimated by standard size markers (O'GeneRuler 1 kb or 100 bp DNALadder, 
Fermentas, St. Leon-Rot). 
6.3.6. Isolation of DNA from agarose gels 
After gel electrophoresis DNA fragments were isolated by excising the respective piece 
of agarose using a scalpel. DNA was extracted from the gel slice using QiaExII Gel 
Extraction kit (Qiagen, Hilden) according to manufacturer’s instructions and eluted with 
30 µl TE buffer (5 mM Tris-HCl pH 8.0, 1 mM EDTA). 
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6.3.7. Ligation of DNA fragments 
Amounts of isolated DNA fragments ("insert") and linearized vectors were estimated on 
an ethidium bromide-containing agarose gel. For a ligation reaction an approximate 
molar ratio of 1:3 of vector to insert was used. The reaction sample with a total volume 
of 10 µl usually contained 50 ng of vector DNA and 4 U of T4 DNA Ligase (Fermentas, 
St. Leon-Rot) and was incubated for 1 h at RT in the appropriate reaction buffer 
(Fermentas, St. Leon-Rot). Following heat inactivation for 10 min at 72°C 5 µl of the 
ligation reaction were transformed into 50 µl chemically competent XL1-Blue cells. 
6.3.8. Sequencing of DNA 
Sequencing PCR and sample preparation were performed with the DYEnamic ET 
Terminator Cycle Sequencing Premix kit according to the manufacturer’s instructions 
(GE Healthcare, Munich). One sample usually contained 1 µg of plasmid DNA and 
20 pmol of primer. DNA sequencing was carried out by the core facility of the MPI for 
biochemistry (Martinsried) with an Abi-Prism 377 sequencer (Perkin Elmer) or by an 
external commercial provider (SeqLab, Göttingen). 
6.3.9. Site-directed mutagenesis of DNA 
First approach 
Site directed mutagenesis was perfomed using a fusion PCR based approach using two 
reverse complementary oligos harboring the desired mutation(s). In two separate PCR 
reactions each oligo was used to create an upstream and a downstream fragment, 
respectively. The outer primers were designed to terminate at useful restriction sites. 
After gel purification the two products were combined and fused in a PCR reaction with 
the two outer primers. The resulting fragments were restriction cloned into the respective 
wild-type sequence. Verification was done by sequencing. 
 
Second approach 
Specific point mutations in gene sequences were inserted by the GeneEditor in vitro site-
directed mutagenesis system (Promega, Mannheim) according to the manufacturer’s 
instructions. The underlying principle is the use of two oligonucleotides, one containing 
the desired point mutation and the other one introducing a mutation into the AmpR gene 
leading to resistance against the “GeneEditor” antibiotic. After denaturation of the 
plasmid of interest, both oligos were allowed to anneal and the second strand was 
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completed by PCR. Subsequently, the double stranded plasmid was transformed into 
bacteria that were then selected on “GeneEditor” antibiotic containing agar plates. 
Introduced mutations were verified by sequencing. 
6.3.10. Polymerase chain reaction (PCR) 
PCR reactions were performed in a final volume of 20 µl with 2.5 µl each of forward and 
reverse oligonucleotide primer (10 µM each), 5 µl deoxyribonucleotide mix (each 10 
mM, NEB, Frankfurt a. M.) and 0.3 µl of DNA polymerase (Phusion, Finnzymes, Espoo, 
Finland) in the corresponding PCR buffer (Phusion HF or GC buffer, Finnzymes). As a 
template, either 20 ng of plasmid DNA or 2 µl of cDNA library (thymus, testis; BD 
Bioscience, Heidelberg) were used. Alternatively, self-made first-round cDNA derived 
by RT-PCR served as PCR template. Amplification was carried out in a TC-512 
temperature cycler (Techne, Burlington, NJ, USA). The denaturing step was done at 
98°C for 12 s, elongation time was 30 s/kbp and annealing temperature were optimized 
for the individual primer pairs. 
6.3.11. Reverse transcription (RT)-PCRs  
Total RNA was isolated from Hela cells using a spin column kit (Qiagen, Hilden). 
Reverse transcription was carried out in a total volume of 20 µl by incubation of 50 - 
100 ng of total Hela RNA with 1 µl of M-MuLV Reverse Transcriptase (200 U/µl, 
Fermentas, St. Leon-Rot), 2 µl Oligo(dT) primer (10 µM), 2 µl of deoxynucleotide mix 
(10 mM each, NEB, Frankfurt a. M.), 0.5 µl of RNasin (Promega, Mannheim) and in the 
corresponding M-MuLV buffer (Fermentas, St. Leon-Rot). The reaction mix was 
incubated for 1 h at 42°C. Subsequently, 2 µl were used as template (instead of plasmid 
DNA) in a PCR carried out as described above. 
 
6.4. Protein methods 
6.4.1. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
7x Bis-Tris/HCl  
2.5 M  Bis-Tris 
1.5 M  HCl 
adjusted to pH 6.5 
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6% gel solution  
42.2 ml  H2O 
13 ml  30% acrylamide; 0.8% 
bisacrylamide 
9.3 ml  7x Bis-Tris/HCl 
163 µl  20% SDS (w/v) 
54.2 µl  TEMED 
325 µl  10% APS (w/v) 
15% gel solution  
16.5 ml H2O 
4.6 ml 2,5 M sucrose 
30 ml 30% acrylamide; 0.8% 
bisacrylamide 
8.6 ml 7x Bis-Tris/HCl 
150 µl 20% SDS 
25 µl TEMED 
300 µl 10% APS 
 
Sample buffer (4x)  
40% glycerol 
564 mM  Tris base 
424 mM  HCl 
8%  SDS 
2.04 mM  EDTA/NaOH 
0.88 mM  Coomassie G250 
0.7 mM  Phenol red 
2 M  beta-mercaptoethanol 
MOPS running buffer  
50 mM MOPS 
1 mM EDTA 
0.1% SDS 
50 mM Tris base 
 
For the separation of proteins under denaturing conditions, SDS-PAGE was performed 
with the NuPAGE system (Adapted from Invitrogen/Fisher Scientific, Schwerte). 6-15% 
gradient gels were poured with a gradient mixer using pre-cooled 6% and 15% gel 
solutions. Prior to loading, protein samples were mixed with sample buffer and denatured 
at 95°C for 5 min. As a molecular weight standard, PageRuler Prestained Protein Ladder 
(Fermentas, St. Leon-Rot) was used. Alternatively, commercially available neutral 
gradient gels (Serva, Heidelberg) were used. Electrophoresis of NuPAGE and Serva gels 
was carried out at 40 mA in MOPS buffer and at 25 mA Laemmli running buffer, 
respectively. 
6.4.2. Immunoblotting 
Blotting buffer  
25 mM  Tris 
192 mM  Glycine 
15%  Methanol 
0.01%  SDS 
 
TBS-w  
25 mM  Tris, pH 7.5 
137 mM  NaCl 
2.6 mM  KCl 
0.05%  Tween-20 (v/v) 
 
After separation via SDS-PAGE, proteins were transfered electrophoretically to a 
polyvinylidene fluoride (PVDF) blotting membrane (Immobilon P, Millipore, 
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Schwalbach). For that purpose a sandwich consisting of gel and membrane covered with 
blotting paper and sponges on both sides was assembled in a wet blotting apparatus 
(XCell II, Invitrogen/Fisher Scientific, Schwerte). Sandwich assembly was done 
submersed in blotting buffer. The hydophobic PVDF membrane was made accessible for 
the aqueous blotting buffer by a brief incubation in 100% methanol. Transfer was done at 
constant voltage of 25 V for 80 min at 10 - 15°C. 
The membrane was blocked for unspecific binding with 5% skim milk and 1% BSA in 
TBS-w for 20 min at RT. This was followed by incubation in primary antibody diluted in 
RotiBlock (Roth, Karlsruhe) either at RT for 1 h or at 4°C o/n. The membrane was then 
rinsed twice briefly with TBS-w and washed two times with TBS-w for 10 min each. 
After incubation with secondary horse radish peroxidase (HRP) coupled antibody the 
membrane was washed in TBS-w for a total of 45 min with at least 5 exhanges of buffer. 
Detection was carried out using the chemiluminescence protocol provided with the kit 
(ECL, GE Healthcare, Munich) and a LAS-4000 camera system (Fuji). 
6.4.3. Coomassie staining 
Colloidal Coomassie suspension: to prepare the staining solution, 80 g (NH4)2SO4 were 
dissolved in 760 ml ddH2O. Then 18.8 ml 85% phosphoric acid were added. In a second 
vessel, 800 mg Coomassie Brilliant Blue G-250 were dissolved in 16 ml ddH2O. 
Subsequently, the two solutions were combined while stirring with a magnetic stir bar.  
For Coomassie staining, gels were incubated in freshly mixed 80% (v/v) colloidal 
Coomassie stain with 20% (v/v) Methanol after SDS-PAGE for either 4 h or over night. 
To remove unspecific stain, gels were repeatedly washed with deionized water for 1 to 2 
days. For long-term storage, Coomassie-stained gels were dried on a whatman paper in a 
"GD2000" slab gel dryer (Hoefer, Holliston, MA, USA). 
6.4.4. Purification of proteins - common buffers and steps 
Lysis Buffer 
537 mM  NaCl 
2.7 mM  KCl 
8 mM Na2HPO4 
1.4 mM  KH2PO4 (pH 7.4) 
Dialysis Buffer 
10 mM  Tris-HCl pH 8.0 
100 mM  NaCl 
0.5 mM  EDTA 
1 mM  DTT 
 
Protein expression was done as described in chapter 6.2.7. A bacterial pellet obtained 
from 1 l of E. coli culture was resuspended in 35 ml of ice cold Lysis Buffer. Cells were 
lysed in a high pressure homogenizer (Avestin, Ottawa, Canada) by cycling the cell 
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suspension for 10 min. The lysate was cleared from debris by centrifugation in an JA-
25.50 rotor (Beckman Coulter, Krefeld) at 25,000 g for 30 min. 
6.4.5. Amylose affinity purifiction of maltose binding protein (MBP)-tagged 
proteins 
Amylose affinity purification was used to purify MBP-tagged protein fusions of N-
terminal X. laevis Sgo1 fragments (xSgo11-207; expression plasmid: pMal). Quite 
similarly, a short fragment of human Cdc20 was expressed with an N-terminal GST-tag 
(hCdc20111-138; expression plasmid pGEX-4T1). Lysate obtained from 1 l equivalent of 
expression culture (see chapter 6.4.4) was incubated with 2 ml of amylose resin (MBP-
tag, NEB, Frankfurt a. M.) or 1 ml of glutathion sepharose (GST-tag, GE Healthcare, 
Munich) for 4 h at 4°C on a rocking and rotating mixer. After centrifugation for 5 min at 
400 g, the bead pellet was resuspended in 10 ml of lysis buffer. The suspension was 
transfered to a 20 ml column (Biorad, München). When nearly drained, the resin bed was 
washed extensively with a total of 100 ml of lysis buffer. Finally, the beads were eluted 
with 2 ml of lysis buffer supplemented with 50 mM maltose (MBP-tag) or 50 mM 
Glutathion (GST-tag). The purified protein solution was dialyzed 4 times against dialysis 
buffer (4°C, 500 ml each, 24 h in total). Aliquots were snap-frozen using liquid nitrogen. 
 
6.4.6. Ni2+-NTA affinity purification of 6x-Histidine-tagged proteins 
Wash Buffer 
50 mM  Hepes KOH, pH 7.0 
100 mM  NaCl 
15 mM  imidazole 
5 mM  2-mercaptoethanol 
0.1%  Tween-20 
Elution Buffer 
50 mM  Hepes KOH, pH 7.0 
100 mM  NaCl 
200 mM  imidazole 
5 mM  2-mercaptoethanol 
0.1%  Tween-20 
  
Ni2+-NTA affinity purification was used to isolate recombinant His6-tagged Mad2 from 
E. coli lysates (prepared as described in chapter 6.4.4). Lysate derived from 1 l of 
expression culture was incubated with 500 µl of Ni2+-NTA resin (Qiagen, Hilden) for 2 h 
at 4°C with gentle shaking. Beads were washed once with 10 ml of wash buffer and 
transfered to a 20 ml column (Biorad, München). After extensive washing with 100 ml of 
wash buffer, bound protein was eluted using 4 times 1 ml of elution buffer. Protein 
containing fractions were pooled and dialyzed 4 times against 500 ml each of dialysis 
buffer. Purified protein was aliquoted, snap-frozen using liquid nitrogen and 
subsequently stored at -80°C. 
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6.4.7. Coupled in vitro transcription/translation 
In vitro transcription/translation in reticulocyte lysate supplemented with SP6 RNA 
polymerase was carried out using "TNT Quick Coupled Transcription/Translation 
System" (Promega, Mannheim). For a single reaction, 20 µl TNT Quick Master Mix, 
1 µl of pCS2 plasmid DNA (500 ng/µl), 1 µl of [35S]methionine and 3 µl of RNase free 
water were combined and incubated for 90 min at 30°C.  
6.4.8. In vitro pulldown assay 
Buffer DP1 
10 mM  Tris-HCl pH 8.0 
100 mM  NaCl 
0.5 mM  EDTA 
0.01%  Triton X-100 
 
In order to test direct protein-protein interactions, in vitro pulldown assays were 
performed using recombinant purified proteins. One of the candidates was immobilized 
via its affinity tag to an appropriate matrix in a final volume of 100 µl DP1 for 1 h at 
4°C. Beads were then incubated with the putative binding partner as indicated. Beads 
devoid of immobilized bait served as negative control. At least 5 washing steps with 1 ml 
each of DP1 were followed by elution using SDS-PAGE sample buffer. Eluates were 
subjected to SDS-PAGE and Coomassie staining.  
6.4.9. Phosphatase activity assay 
Phosphatase assays were performed using a Ser-/Thr-Phosphatase assay kit (Millipore, 
Schwalbach) essentially following the manufacurers instructions. Briefly, phosphatase 
activity was measured by dephosphorylation of a phosphopeptide substrate and 
subsequent detection of liberated inorganic phosphate by the malachite green method. 
6.4.10. Lambda phosphatase treatment 
This method was used to determine whether differential migration behavior of proteins in 
SDS-PAGE was caused by phosphorylation. For each sample approx. 105 cells were 
lysed by repeated pipetting on ice in 75 µl LP2+ (see chapter 6.5.8, omitting NaF and 
beta-glycerophosphate). MnCl2 was set to a final concentration of 2 mM. To each sample 
400 U Lambda phosphatase (NEB, Frankfurt a. M.) were added and the samples were 
incubated for 30 min at 30°C. This was followed by addition of 25 µl SDS-PAGE sample 
buffer, 5 min boiling at 95°C and SDS-PAGE/immunoblotting. 
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6.5. Cell biological methods 
6.5.1. Mammalian cell lines 
293T   Human embryonic kidney cell line transformed SV40 and adeno viral  
  sequences (e.g. t antigens) 
HeLa  Human cervix epithelial adenocarcinoma 
HeLaS3 HeLa cells adapted to culture in suspension 
6.5.2. Vectors for cell culture 
pCS2  (Turner and Weintraub, 1994) with modified MCS (FseI, AscI sites 
 introduced) 
pBOS-SReGFP  the H2B-GFP coding sequence of pBOS-H2B-GFP (BD Bioscience, 
 Heidelberg) was replaced by a linker containing FseI and AscI 
 restriction endonuclease cleavage sites. An additional FseI restriction 
 site had been deleted from the vector. Furthermore, the eGFP open 
 reading frame was placed under the control of a separate pSRalpha 
 promoter present in the vector sequence. 
6.5.3. Cultivation of mammalian cells 
PBS  
137 mM  NaCl 
2.7 mM  KCl 
8 mM  Na2HPO4 
1.4 mM  KH2PO4, pH 7.4 
 
HeLa and 293T cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM, 
PAA, Pasching, Austria). Media were supplemented with 10% heat inactivated (56°C, 30 
min) fetal bovine serum (Biochrom, Berlin), 100 units/ml penicillin and 0.1 mg/ml 
streptomycin (PAA, Pasching, Austria). Monolayer cultures were grown in cell culture 
dishes (Greiner Bio-One, Kremsmünster, Austria) at 37°C in a 5% CO2 atmosphere and 
were split at a ratio of 1:4 to 1:8 twice a week. To split cells, medium was removed, cells 
were washed once with PBS and subsequently incubated with 16 µl/cm2 Trypsin/EDTA 
solution (PAA, Pasching, Austria) at 37°C for 1 min (293T cells) or 5 min (Hela cells). 
By repeated pipetting in fresh medium, cells were detached from each other as well as 
from the culture dish. Subsequently, the cell suspension was diluted in medium and 
distributed on new cell culture dishes. Cell concentrations of suspensions were 
determined with a Vi-Cell counter (Beckman Coulter, Krefeld).  
6.5.4. Storage of mammalian cells 
Cells were harvested at 80% confluence by trypsination as described above, resuspended 
in freezing medium (10% DMSO, 90% fetal bovine serum, Biochrom, Berlin), and 
Materials and Methods 
  - 109 - 
aliquoted in cryovials (Nalgene). The cell suspension was then slowly frozen in a 
cardboard box at –80°C. For long-term storage cryo vials were transfered to a liquid 
nitrogen tank. 
Cryo-stocks were rapidly thawed in a 37°C water bath. To remove DMSO, tubes were 
briefly centrifuged (300 g, 2 min). The supernatant was discarded and the cell pellet 
resuspended in DMEM (PAA, Pasching, Austria) and transfered to an appropriate cell 
culture dish conatining DMEM (PAA, Pasching, Austria). 
6.5.5. Transfection of 293T cells 
2x HBS (50 ml)  
800 mg  NaCl 
37 mg  KCl 
10.65 mg  Na2HPO4 
100 mg  Glucose 
500 mg  HEPES 
pH 7.05 adjusted with NaOH, sterile filtered (0.2 µm pore size) 
 
293T cells were transfected by the calcium phosphate method. 3·106 cells per cell culture 
dish (∅ 10 cm) were spread and grown overnight. Shortly before transfection the next 
day, chloroquin was added to the medium to a final concentration of 20 µM. For one 
transfection mix, 5-20 µg (depending on the construct) of plasmid DNA were mixed first 
with 680 µl water and then with 99.2 µl sterile 2 M CaCl2. Then 800 µl of 2x HBS 
solution were slowly added in small drops while gently vortexing. After incubation for 
10 min at RT, the transfection mix was dropped onto the medium of the prepared cells. 
12 h later medium was exchanged. 24 h after transfection, nocodazole was added to the 
medium at a final concentration of 0.2 µg/ml to arrest cells in mitosis (unless interphase 
samples were prepared). 36 h after transfection, cells were harvested by rinsing the plate 
with the used cell culture medium. Following centrifugation (300 g, 3 min) cell pellets 
were washed once with PBS. Cell pellets were subsequently either lysed directly or snap 
frozen in liquid nitrogen and stored at -80°C for further use. 
6.5.6. Transfection of HeLa cells 
HeLa cells were transfected based on nucleic acid packaging into liposomes formed by 
cationic lipids. Commercial transfection reagents were Lipofectamine 2000 
(Invitrogen/Fisher Scientific, Schwerte) for plasmid DNA and Lipofectamine RNAi-Max 
or Oligofectamine (Invitrogen/Fisher Scientific, Schwerte) for transfection of double 
stranded RNA (siRNAs). Transfections were carried out according to the manufacturers 
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instructions. In the case of Lipofectamine 2000 a 1:2 ratio for DNA(µg):Lipo-
fectamine(µl) was used. 
6.5.7. Synchronization of mammalian cells 
Synchronization at the G1/S boundary: thymidine was used to interfere with the cellular 
nucleotide mtabolism and to block DNA replication. 2 mM Thymidine (Sigma-Aldrich, 
Steinheim) was added to the culture medium for 16 h. Cells were then released from the 
block by washing twice with medium followed by a 30 min incubation in the cell culture 
incubator and another medium change. In the case of a double thymidine block, 2 mM 
thymidine was readded 7 h after the release. 16 h later cells were released as described 
above. 
Synchronization in prometaphase: nocodazole was used to disrupt the microtubule 
cytoskeleton. 0.2 ng/ml nocodazole were added either to an asynchronous cell population 
for 12-16 h or 6 h after release from thymidine block for another 8 h.  
6.5.8. Co-Immuno-Precipitation (Co-I.P.) experiments from transfected 293T cells 
LP2 
20 mM  Tris-HCl, pH7.6 
100 mM  NaCl 
10 mM  NaF 
20 mM  beta-glycerophosphate 
5 mM  MgCl2 
0.1%  Triton X-100 
5%  glycerol 
 
LP2+ 
supplemented with 1x protease inhibitior cocktail (Roche, Mannheim) and 1 mM PMSF 
 
Cells were harvested by scraping from a 10 cm cell culture dish. After centrifugation for 
2 min at 400 g at RT, cells were washed once with 1x PBS (see chapter 6.5.3) and 
centrifuged again. From here on all steps were carried out either on ice or in at 4°C. The 
cell pellets were resuspended in 500 µl LP2+ and lysed with 14 strokes with a "tight" 
pestle in a glass dounce homogenizer (Wheaton, Millville, NJ, USA). Lysates were 
centrifuged at 16,000 g for 25 min and the supernatant was transfered to a new tube. An 
input sample of 20 µl was mixed with 40 µl 2x SDS-PAGE sample buffer. Subsequently 
10 µl of the appropriate affinity matrix were washed twice with 1 ml LP2 and combined 
with the lysates. The suspensions were incubated on a turning wheel for 2 h. Next the 
samples were centrifuged briefly in a tabletop micro-centrifuge and the pelleted beads 
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were washed 6 times with 1 ml LP2. Subsequently, the pellet was resuspended in 250 µl 
LP2 and transfered to a Mobicol microcolumn (Mobitec, Göttingen). The column was 
allowed to drain, capped at the bottom and proteins bound to the beads were eluted by 
gentle shaking with 35 µl of 2x SDS-PAGE sample buffer (without beta-
mercaptoethanol) at 85°C for 5 min. The bottom plug was removed and the eluate 
centrifuged into a 1.5 ml reaction tube at 200 g for 1 min. Samples were mixed with 
0.2 µl beta-mercaptoethanol and finally incubated for 5 min at 95°C. 
6.5.9. Co-I.P. experiments of endogenous proteins 
Co-I.P.s of endogenous proteins were carried out essentially as for overexpressed 
proteins. Approximately 2 µg of specific antibodies were coupled to 10 µl of Protein G 
Sepharose (GE Healthcare, Munich) beads in 50 µl PBS (see chapter 6.5.3). For that 
purpose, the bead suspension was incubated at 4°C over night with gentle agitation. Cells 
from confluent 150-750 cm2 of culture dishes were lysed in 1-5 ml LP2 and cleared by 
centrifugation. The supernatant was incubated with the prepared antibody beads for 4 h at 
4°C. Protein G Sepharose coupled non-specific IgG served as negative controls. After 
washing 6 times with LP2, bound proteins were eluted with 35 µl 2x SDS-PAGE sample 
buffer (with beta-mecaptoethanol). 
6.5.10. Competitive elution 
TBS 
50 mM  Tris-HCl pH 7.5 
137 mM NaCl 
2.7 mM KCl 
 
A competitive approach was used for elution of native Flag-tagged proteins bound to 
anti-Flag agarose. Beads from an I.P. experiment as described in 6.5.8 were washed with 
TBS. Elution buffer was prepared by dissolving 15 µg of Flag3 peptide (Sigma-Aldrich, 
Steinheim) in 100 µl of TBS. Beads were mixed with 30 µl of elution buffer and 
incubated for 45 min at 4°C with gentle agitation. The supernatant was either used 
directly or aliquoted and snapfrozen using liquid nitrogen. Samples were then stored in a 
-80°C freezer. 
6.5.11. Elution by TEV protease cleavage 
TEV protease cleavage was used for native elution of proteins carrying a Flag3-Tev2 tag 
from anti-Flag agarose beads. At the same time, the untagged proteins could be obtained. 
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Beads derived from an I.P. experiment (6.5.8) were washed twice with TBS (see 6.5.10). 
TEV-Elution buffer was prepared by mixing 1 part of His6-tagged TEV protease (12,000 
U/ml, Core facility, MPI Martinsried) with 5 parts of TBS. Beads carrying Flag3-Tev2-
tagged proteins were incubated with 20 µl of TEV-elution buffer for 1 h at 18°C with 
gentle agitation. The supernatant was then used for further experiments (for example 
phosphatase assay, see chapter 6.4.9). 
6.5.12. Plasmid transfection of HeLa cells 
Plasmid DNA was transfected using the commercial cationic lipid reagent Lipofectamine 
2000 (Invitrogen/Fisher Scientific, Schwerte). The amounts given here refer to the 
transfection of one well of a 12-well plate. On the day prior to transfection cells were 
seeded at a density of 3.5·105 cells/ml in DMEM (PAA, Pasching, Austria) with fetal 
bovine serum (Biochrom, Berlin) but without antibiotics. 1 ml of cell suspension was 
plated per well. Transfection mixes were prepared in two steps. First, 1.6 µg of DNA was 
diluted in 100 µl OptiMEM (Invitrogen/Fisher Scientific, Schwerte). In a separate tube, 
3.2 µl of Lipofectamine 2000 were mixed well with 100 µl of OptiMEM by flicking the 
tube 20 times. After a 10 min incubation, the DNA solution was pipetted to the 
Lipofectamine solution and mixed well. Following another incubation for 20 min, the 
transfection mix was added to the cells. To limit cytotoxicity, medium had to be changed 
after 6 h, again using antibiotics-free medium. 
6.5.13. siRNA transfection of HeLa cells 
Transfection of dsRNAs for RNAi experiments was done with Lipofectamine RNAiMax 
(Invitrogen/Fisher Scientific, Schwerte). Amounts are given for transfection of one well 
of a 12-well plate. First, two tubes were prepared containing 100 µl of OptiMEM 
(Invitrogen/Fisher Scientific, Schwerte) each. 50 pmol of dsRNA were added to the first 
tube. In the second tube, 2 µl of transfection reagent were added and mixed by flicking 
the tube 20 times. Then, immediately the two solutions were combined, mixed well and 
incubated for 15 min. The transfection complexes were then added to the cells. 
6.5.14. siRNA rescue experiment 
In order to study mutant constructs of Sgo2 in a loss of function background, a 
combination of siRNA and plasmid transfection was used. Hela cells were plated at a 
density of 1.6·105 cells/ml in DMEM (PAA, Pasching, Austria) with serum but without 
antibiotics. On the next day, Sgo2 siRNA transfection was performed. One day later, 
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medium was changed and Sgo2 rescue plasmids were transfected as described using 
Lipofectamine 2000. These constructs were mutated at 4 wobble positions leading to 
resistance to the siRNA oligo without changing the amino acid sequence. The modified 
pBOS vector used in rescue experiments carried in addition the gene for soluble eGFP 
thus allowing for selection of transfected cells in microscopic downstream analysis. 
6.5.15. Immunofluorescence staining and microscopy 
PBS: see chapter 6.5.3 
Fixation Solution (FS): 3.7% Formaldehyde in PBS 
(+0.3% Triton X-100 for anti-Mad2 staining) 
Quenching Solution (QS): 100 mM glycine in PBS 
Washing Solution (WS): 0.1% Triton X-100 in PBS 
Permeabilization Solution (PS): 0.5% Triton X-100 in PBS 
Blocking Solution (BS): 1% BSA in PBS 
Mounting medium: 0,233 g DABCO (Diaza-bicyclo(2.2.2)octane), dissolved in  
800 µl ddH2O+ 200 µl 1 M Tris-HCl pH 8.0 + 9 ml 87% glycerol 
 
For immunofluorescence stainings, cells grown on coverslips were washed once with 
PBS in a 24-well culture plate. The samples were then fixed for 10 min in FS followed 
by 2 washes with QS and 1 wash with PBS. Cells were permeabilized by incubation in 
PS for 5 min. After washing once with PBS samples were incubated in BS for 20 min to 
overnight. Coverslips were transfered onto Parafilm and placed in a wet chamber. 
Staining was done by incubation with a dilution of primary antibodies in BS for 1h 
followed by 4 washes with WS. After incubation with a dilution of fluorescently labeled 
secondary antibodies for 40 min, samples were washed once with WS, once with 1 µg/ml 
Hoechst 33342 in WS and again 4 times with WS. Coverslips were finally mounted on a 
small drop of Mounting Medium placed on a glass slide. Images were aquired using an 
Axiovert upright microscope equipped with a Plan-APOCHROMAT 100x/0.4 objective 
(Carl Zeiss MicroImaging, Jena). 
6.5.16. Determination of the mitotic index by flow cytometry 
Buffers see Immunofluorescence 
Cells were harvested by trypsination and the resuspended cells were pooled with the 
material derived from culture supernatant and PBS wash. Cells were fixed by addition of 
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1/10 volume of 16% formaldehyde in PBS for 15 min. Cells were washed twice with QS 
and then permeabilized with methanol precooled at -20°C for 15 min on ice. Following 2 
washing steps with PBS, cells were blocked for 30 min with BS and then incubated for 1 
h with anti-phospho Histone H3 antibodies (1:100 in BS, Sigma-Aldrich, Steinheim). 
The cell pellet was washed again twice with PBS and subsequently stained with a 
secondary antibody labeled with the fluorescent dye Cy3 (1:100 in BS; Millipore, 
Schwalbach). Following two PBS washing steps, the cell suspension was analyzed in a 
"Cytomics FC-500" flow cytometer (Beckman Coulter, Krefeld) using the FL-2 channel. 
6.5.17. Live cell imaging 
Live cell imaging was carried out on a DMI 6000 inverted microscope stand (Leica 
Microsystems, Wetzlar) equipped with a digital camera (Leica Microsystems, Wetzlar) 
and with an HCX PL FLUOTAR L 20x/0.4 objective (Leica Microsystems, Wetzlar). 
Cell culture conditions were provided by a temperature controled chamber maintained at 
37°C and a small lid covering the sample for application of a humidified 5% CO2 
atmosphere (Pecon, Erbach). Cells were seeded at least 10 h prior to imaging on standard 
multi-well cell culture plates (Ibidi, Planegg-Martinsried). A typical movie was aquired 
with the phase contrast method at a frame rate of 5 min. Live cell imaging was used to 
determine the duration of mitosis. The time point of mitotic entry was defined as a 
marked rounding of the cell and end of mitosis was identified by the first signs of 
cleavage furrow ingression and/or separation of the DNA masses. 
6.5.18. Chromosome spreads 
 
Hypotonic buffer I:  
30 mM  Tris-HCl pH 8.2 
50 mM  sucrose 
17 mM  sodium citrate 
400 ng/ml  nocodazole 
 
Fixative:  
1%  Formaldehyde 
5 mM  sodium borate pH 9.2 
0.15% (v/v) Triton X-100 
Hypotonic buffer II:  
100 mM  sucrose 
400 ng/ml  nocodazole 
 
 
Hela cells were synchronized via a thymidine nocodazole protocol and mitotic cells were 
harvested by shake-off. 5·105 cells were resuspended in 250 µl hypotonic buffer I. Then 
the cell suspension was mixed with another 250 µl, and in a third round mixed with 2 ml 
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hypotonic buffer I Following incubation for 7 min at room temperature, cells were spun 
down (400 g, 2 min) and resuspended in 100 - 250 µl hypotonic buffer II. A small 
volume of the cell suspension (approx. 10 µl) was dropped onto a slide glass that had 
been dipped in fixative and dispersed on the slide by continuous tilting. After drying in 
partially opened wet chamber, coverslips were washed with PBS (see 6.5.3) and blocked 
in 2% BSA in PBS for 20 min. Samples were then treated as described in the section 
"Immunofluorescence". Anti-Hec1 staining (kinetochores) and DNA staining with the 
dye Hoesct-33342 were performed and the chromosome spreads were counted by 
fluorescence microscopy (as described for immunofluorescence) for the degree of sister 
chromatid separation. 
6.5.19. Preparation of Xenopus laevis egg extract 
All glasware used for buffers or extract preparation was rinsed twice with ddH2O prior to 
use to remove especially contaminating calcium ions. 
 
25x MMR (pH 7.8 with NaOH) 20x XB salts Dejellying solution 
2.5 M NaCl 
50 mM  KCl 
25 mM  MgCl2 
50 mM  CaCl2 
2.5 mM  EDTA-NaOH pH8.0 
125 mM  HEPES-NaOH pH7.8 
2 M  KCl 
2 mM  CaCl2 
20 mM  MgCl2 
2% (w/v) Cysteine in 
0.5x XB salts 
pH 7.8 (set with KOH) 
CSF-XB (pH 7.7 with KOH) SD buffer 25x CaCl2 
100 mM  KCl 
0.1 mM  CaCl2 
2 mM  MgCl2 
10 mM Hepes-KOH pH 7.7 
50 mM  sucrose 
5 mM  EGTA-KOH pH 8.0 
1 mM  MgCl2 
100 mM  KCl 
150 mM  sucrose 
5 mM Hepes-KOH pH 
7.7 
15 mM CaCl2  
in SD buffer 
Cytochalasin B   
10 mg/ml in DMSO   
 
To induce egg laying, female frogs were injected with human chorionic gonadotropin 
(hCG, 200 U/ml in ddH2O, Sigma-Aldrich, Steinheim). Depending on the size of the 
frog, about 0.7-1.0 ml of hCG solution were injected into the dorsal lymph sac using a 
27-gauge needle. 6-8 h later, frogs were transfered to single vessels containing 2 l of 1x 
MMR each. About 22 h after injection, the frogs were put back to their tanks, MMR was 
discarded and the eggs were transfered to flat-bottomed glas dishes. Eggs with undesired 
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morphology were removed at this stage. After two washes with CSF-XB, the supernatant 
was completely removed in preparation for the dejellying procedure. Then eggs were 
briefly rinsed with and then incubated in dejellying solution with gentle agitation. 
Removal of the jelly coat took about 5-10 min and resulted in dense packaging of the 
eggs. The procedure was terminated by 5 washes in CSF-XB. Only eggs with appropriate 
morphology (white and brown hemispheres) were used in further steps. All aspects of 
egg extract preparation were performed by centrifugation (packaging of eggs, crushing 
and separation). Towards this end, 1 ml CSF-XB and 10 µl Cytochalasin were added to a 
thin-walled 12 ml centrifuge tubes (Beckman Coulter, Krefeld). Then eggs were 
transfered to the tube using a disposable 5 ml plastic pipet which had been cut at the tip 
to increase its opening diameter. After removal of excess liquid, the tubes were subjected 
to the following centrifugation steps: first, eggs were packed by a 1 min spin at 200 g and 
a 1 min spin at 600 g. Again, buffer that had accumulated on top of the packed eggs was 
removed. Next, eggs were crushed and fractionated in a single centrifugation step for 10 
min at 13,000 g. Egg lysate was thereby separated into three distinct layers: a lipid phase 
(white) on top, then in the middle the cytoplasmic layer ("egg extract") and cellular 
debris on the bottom of the tube. The tube was poked with a 18-gauge syringe needle at 
the lower end of the middle layer and egg extract was allowed to drop into a fresh 2 ml 
reaction tube by gravity flow. 
6.5.20. Purification of active recombinant human separase 
293T cells were cotransfected with separase (Protein A tag) and securin expression 
plasmids (Stemmann et al., 2001). Nocodazole arrested cells were lysed in LP2+ (see 
chapter 6.5.8) and separase was isolated using IgG sepharose. After washing with LP2 
and XB (Murray, 1991), the immobilized separase/securin complexes were incubated 
with X. laevis anaphase egg extract for degradation of securin (1 h, 18°C, 100 ng/ml of 
His-tagged human cyclin B1Δ90 isolated from baculovirus-infected insect cells, Calcium 
chloride from 25x stock; recombinant cyclin B1Δ90 was a kind gift from Olaf 
Stemmann). After washing the beads with LP2 and XB, separase was eluted by cleaving 
off the Protein A tag with Tev-protease (1 h, 18°C).  
6.5.21. Isolation of Metaphase Chromosomes 
Metaphase chromosomes were isolated according to (Gasser and Laemmli, 1987) with 
modifications. At a density of 2·105 cells/ml, HeLaS3 cells grown in suspension (0.5 liter 
culture) were synchronized by a thymidine-nocodazole protocol (Stemmann et al., 2001). 
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Because metaphase-arrested cells could not be stored, they were immediately swollen for 
5 min in 50 ml 1x PME (5 mM Pipes/NaOH pH 7.2, 5 mM NaCl, 5 mM MgCl2, 1 mM 
EGTA). This step was repeated once. Cells were pelleted at 1,000 g for 5 min and the 
supernatant was removed. All following steps were carried out at 4°C. The cells were 
lysed in 25 ml lysis buffer 4 (1x PME, 1% thiodiethylene glycol, protease inhibitors 
without EDTA (Roche, Mannheim) 2.5 mM microcystin-LR, 1 mM okadaic acid, 1 mM 
ATP, 0.2% digitonin) using a dounce homogenizer with loose pestle. The lysate was put 
on top of sucrose step gradients, each consisting of 2 ml HSS (1x PME, 1% 
thiodiethylene glycol, protease inhibitors without EDTA, 1 mM microcystin-LR, 1 mM 
ATP, 1.8 M sucrose) at the bottom and 28 ml LSS (1x PME, 1% thiodiethylene glycol, 
protease inhibitors without EDTA, 1 mM microcystin-LR, 1 mM ATP, 0.9 M sucrose, 
0.02% digitonin) at the top. After centrifugation in a SW28 rotor (Beckman Coulter, 
Krefeld) for 30 min at 4,000 rpm, the cytosol and the LSS layer were aspirated off for all 
but 2 ml. Chromosomes were resuspended in the remaining liquid and combined with 
wash solution (1x PME, 0.25% thiodiethylene glycol, complete protease inhibitor 
cocktail without EDTA (Roche, Mannheim), 1 mM microcystin-LR, 1 mM ATP), 1.6 ml 
0.2 M spermidine, and 0.8 ml 0.2 M spermine (in the given order) to produce a total 
volume of 49 ml. After incubation for 5 min, 31 ml percoll (GE Healthcare, Munich) was 
added. The mixture was dounced and then centrifuged in a 70 Ti rotor (Beckman Coulter, 
Krefeld) for 30 min at 21,000 rpm. Chromosomes were recovered from a diffuse band 1 
cm above the bottom of the tubes, passed through a 70 µm cell strainer (BD Biosciences, 
Heidelberg) and mixed with 35 ml wash solution in a conical tube. After putting 0.3 ml 
of storage solution (1x PME, 70% glycerol) at the bottom of the tube, the tube was spun 
in a RC3C centrifuge (Sorvall, Thermo Fisher Scientific, ) for 30 min at 3300 rpm. 
Chromosomes were recovered from the bottom of the tube, washed once more and 
finally resuspended in 0.3 ml storage solution. 
6.5.22. Metaphase chromosome separation assay 
Metaphase chromosome separation was performed in separase cleavage buffer 
containing 30 mM Hepes/KOH pH 7.7, 30% glycerol, 25 mM KCl, 5 mM MgCl2, 1.5 
mM ATP, 100 µg/ml BSA and 1 mM EGTA. In a total reaction volume of 10 µl, 0.4 µl 
metaphase chromosomes, 1 µl of active or protease-dead separase, and 50 µM ICRF-193 
were used as indicated. The reaction was carried out at 30°C for 1 h, while shaking the 
samples at 300 rpm to prevent chromosome aggregation. To determine the extent of 
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chromosome separation, 5 µl of 4% formaldehyde was added into 5 µl of chromosomes, 
before samples were incubated for 5 min, spotted onto glass slides and air-dried. The 
slides were rinsed twice with PBS-T (PBS see chapter 6.5.3, +0.1% Tween 20), and 
subjected to immunostaining. The rest of the metaphase chromosomes were incubated 
with an equal volume of sample loading buffer, boiled for 5 min and cohesin cleavage 
was determined by immunoblotting. 
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7. Abbreviations 
 
a.a.    amino acid(s) 
AD   transactivation domain (S. cerevisiae Gal4) 
amp    ampicillin 
APS    ammonium peroxodisulfate 
ATP    adenosine 5'-triphosphate 
bp    base pairs 
BSA    bovine serum albumin 
Bub   budding uninhibited by benzimidazole 
CAK   cdk-activating kinase 
Cdk   cyclin-dependent kinase 
CHX    cycloheximide 
co-I.P.   analysis of protein-protein interactions  
   in an immuno-precipitation experiment 
CSF    cytostatic factor 
C-terminal   carboxy-terminal 
C-terminus   carboxy-terminus 
DBD   DNA binding domain (S. cerevisiae Gal4) 
D. melanogaster Drosophila melanogaster 
DMSO   dimethylsulfoxide 
DNA    deoxyribonucleic acid 
dNTP    deoxynucleotide 5'-triphosphate 
DTT    dithiothreitol 
E. coli    Escherichia coli 
EDTA    ethylendiamine tetraacetic acid 
EGTA    ethylen glycol tetraacetic acid 
f.l.    full length 
Fig.    figure 
g    gram or gravitational constant (9.81 m/s2) 
GST    glutathione S transferase 
h    hour or human 
HA    hemagglutinin 
HAc    acetic acid 
HEAT   helical repeat protein domain (Huntingtin, elongation factor 3,  
   PP2A-A, Tor1) 
HECT   homologous to E6AP C-terminus 
HEPES   4-(2-hydroxyethyl)-1piperazineethansulfonic acid 
H.s.    Homo sapiens 
Ig    immunoglobulin 
I.P.    immunoprecipitate 
IPTG    isopropyl-β-D-thiogalactopyranoside 
IVT   coupled in vitro transcription/translation in reticulocyte lysate, 
   the product thereof 
k    kilo 
kb    kilo base pairs 
kDa    kilo dalton 
LB    Luria-Bertani 
m   milli 
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µ    micro 
M    molar 
Mad   mitotic arrest deficient 
MCS    multiple cloning site 
min    minute(s) 
MMR    Marc's modified Ringer 
MOPS    N-morpholinopropane sulfonic acid 
MT    microtubule 
mRNA    messenger RNA 
n    nano 
NEM    N-ethylmaleimide 
NHS    N-hydroxysuccinimid 
NTA    nitrilo tetra acetate 
N-terminal   amino-terminal 
N-terminus   amino-terminus 
OD    optical density 
ORF    open reading frame 
p.a.    pro analysi 
PAGE    polyacrylamide gel electrophoresis 
PBS    phosphate buffered saline 
PCR    polymerase chain reaction 
PEG   polyethylene glycol 
PP2A   protein phosphatase 2A 
PPase   phosphatase 
PVDF    polyvinylidene fluoride 
RING   really interesting new gene 
RNA   ribonucleic acid 
RNase   ribonuclease 
rpm    revolutions per minute 
RT    room temperature 
SAC    spindle assembly checkpoint 
S. cerevisiae   Saccharomyces cerevisiae (baker's yeast) 
SDS    sodium dodecylsulfate 
s   seconds 
hSgo    human shugoshin 
S. pombe   Schizosaccharomyces pombe (fission yeast) 
Suppl. fig.  supplementary figure 
TBS   Tris buffered saline 
TEMED   N,N,N',N'-tetramethylethylenediamine 
Tev    tobacco etch virus 
Tris    tris(hydroxymethyl)aminomethane 
U    unit 
Ub    ubiquitin 
V    volt 
v/v    volume per volume 
w/v    weight per volume 
W.B.   Western Blot 
wt    wild-type 
xErp1   X. laevis Erp1 
xSgo1   X. laevis shugoshin 1 
X. laevis/X.l.  Xenopus laevis 
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9. Supplementary figures 
 
 
 
 
 
Suppl. Fig. 1: Sgo2 mediated stimulation of PP2A also occurs when affinity tags have been 
removed by TEV protease cleavage. (A) Flag-TEV-tagged Sgo2 or PP2A-B'delta were 
expressed in 293T cells and purified via anti-Flag agarose beads. Elution was performed by 
cleavage of the tag using TEV protease. Different dilutions were tested in a malachite green 
phosphatase assay. (B) Immunoblotting of PP2A-B' and Sgo2 preparations using an antibody 
against PP2A-C to judge the amounts of PP2A catalytic subunit equivalents applied for the assay 
in (A).  
Even when twice the amount of free PP2A equivalent was assayed (B' delta 1:10), Sgo2 bound 
PP2A showed a much higher phosphatase activity. Importantly, a twofold difference of 
phosphatase input was appropriately reflected in the assay read (compare B' delta 1:5 and 1:10 
dilution) confirming linearity of the measurements.  
 
 
A B 
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Suppl. Fig. 2: Sgo2 does not protect centromeric DNA catenation. Hela cells were transfected 
with dsRNAs directed against the Sgo2 mRNA or with treated with transfection mix only as 
control (total time of RNAi: 50 h). Cells were synchronized using a single thymidine 
block/release. 2 h after the release, cells were trypsinized and seeded on glass coverslips. 12 h 
from the release, cells were fixed and stained for immunofluorescence microscopy using 
antibodies against tubulin and PICH (red). Hoechst 33342 was used to label DNA (blue). 
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Suppl. Fig. 3: The interaction between Sgo2 and Mad2 is not bridged by chromatin. An I.P. 
experiment for endogenous Sgo2 was performed as described in  with the exception that 200 
µg/ml ethidium bromide was included in the lysis buffer. This ensured dissociation of proteins 
from chromatin. A specific interaction of Sgo2 with Mad2 was observed also in the presence of 
ethidium bromide. Binding of PP2A was used as a positive control. 
 
 
 
Suppl. Fig. 4: Aurora B catalytic activity is required for keeping MCAK at centromeres. 
Hela cells were treated with nocodazole for 6 h. Then, mitotic cells were collected by shake-off. 
The cells were centrifuged on coverslips (2 min, 300 g) and treated either with the Aurora B 
inhibitor ZM447439 or the solvent DMSO for 30 min. Then cells were fixed and stained for 
immunofluorescence microscopy using antibodies against MCAK (green) and Hec1 (red, 
kinetochore marker). DNA was counterstained with Hoechst 33342. While in the control Sgo2 
localized to centromeres, it could be frequently observed at kinetochores upon Aurora B 
inhibition. 
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Suppl. Fig. 5: The Mad2 binding deficient Sgo2 mutant R153A is not compromised in PP2A 
binding. 293T cells were transfected with plasmids coding for the indicated tagged versions of 
hSgo2 or mock transfected ("-", neg. control). Cell lysates were prepared using LP2+ with a total 
NaCl concentration of 350 mM. Myc-tagged Sgo2 was isolated using an anti-Myc affinity 
matrix. Following 6 washes with lysis buffer, bead associated proteins were analyzed by SDS-
PAGE and immunoblotting using anitbodies directed against the Myc-tag (Sgo2) and the PP2A C 
subunit. All three Sgo2 constructs were expressed and immunoprecipitated with similar 
efficiency. Both wild-type Sgo2 and Mad2 binding deficient Sgo2-R153A interacted with PP2A 
equally well. The PP2A binding deficient Sgo2-N58I was used as an additional negative control. 
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Suppl. Fig. 6: Sgo1 binding does not induce major structural changes in the PP2A catalytic 
C subunit. Overlay of crystal structures of the PP2A C subunit (free (green) or in complex with 
Sgo1 (cyan)). Most structural elements align neatly in both structures. The arrow indicates a 
tyrosine residue (Y90) which is the residue with the strongest deviation between the two 
structures. The catalytic cleft is located on the back side of the molecules in this view (Structure 
data 2IAE and 3FGA were derived from Protein Data Bank (http://www.rcsb.org/pdb/ 
home/home.do), visualization and alignment: MacPyMol.  
 
 
 
Suppl. Fig. 7: Mad2 does not change the activity of Sgo2 bound PP2A. A malachite gree 
based peptide dephosphorylation assay was performed (as described in the methods section). 
Different amounts (0.5 µl or 1 µl) of Sgo2-PP2A complex purified from 293T cells were tested. 
Increase of the amount of PP2A in the assay is appropriately reflected by an increased activity 
measured. Either reference buffer or purified recombinant wild-type Mad2 or Mad2-D10 (neg. 
control) were added. Similar phosphatase activites were measured in all three cases. 
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Suppl. Fig. 8: The specific tension SAC signal pathway branches downstream of Aurora B 
and upstream of Sgo2. Hela cells were either transfected with Sgo2 specific siRNA or treated 
with a control transfection mix (total time of RNAi: 50 h). Cells were presynchronized with 
thymidine and 6 h from release, either 200 ng/ml taxol (A) or 200 ng/ml nocodazole (B) were 
added. 12 h from release, miotic cells were enriched by mitotic shake-off and ZM447439 (2 µM) 
was added. The cells were then incubated in the continued presence of either taxol or nocodazole 
for the indicated periods of time. The "0 h" time point in fact a sample incubated for 1.3 h 
without addition of ZM447439. The samples were then analyzed by SDS-PAGE and 
immunoblotting for levels of Cyclin B1 and Mad2 (input control). Sgo2 is not required for both 
mitotic arrests (unchanged 0 h Cyclin B1 levels upon Sgo2 depletion). A nocodazole arrest (B) is 
maintained upon ZM447439 treatment while cells exit from a taxol arrest (A) when treated with 
ZM447439. Also in the absence of Sgo2, an override of the taxol arrest is possible (A). (C) 
Efficiency of Sgo2 RNAi was determined by immunoblotting using antibodies directed against 
Sgo2 and Mad2 (control). 
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